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"There exists a passion for comprehension, just as there exists a passion for music. 
That passion is rather common in children but gets lost in most people later on. 
Without this passion, there would be neither mathematics nor natural science." 
Albert Einstein 
Introduction and Outline of the Thesis 
CHAPTER 1 
Glycosylation in tumor cell migration and invasion 
The ability of cells to adhere to and migrate through the extracellular matrix (ECM) of 
tissues and organs is essential to maintain fundamental processes such as morphogenesis 
and tissue repair. In addition, deregulated cellular adherence can result in cancer invasion 
and metastasis. Adhesion receptors, particularly members of the integrin superfamily, 
are required to mediate and regulate cell adhesion to structural proteins of tissues, 
including flbrillar collagens, laminins, and flbronectin. However, due to the dominant 
contribution of integrins to mechanotransduction and migration in most experimental 
models, additional low-afflnity interactions that might contribute to cell adhesion and 
migration in three-dimensional (30) environments are still poorly understood. Typical 
examples of molecules mediating low-afflnity interactions include alternative adhesion 
receptors carrying compensatory functions such as syndecans (SDCs)I1J or CD44121, 
but their contribution to migration is controversially discussed. Among all potential 
candidates, cell surface carbohydrates that surround cells as a polar outer layer, raised 
increasing attention. The nature oft his so-called glycocalyx is dominated by carbohydrate 
chains carrying high content of sulfation, carboxylation and acetylation in their backbone 
providing the negative charge to this layer.131 These carbohydrate chains are covalently 
bound to protein or lipid cores, classifled as glycoproteins, glycoli pids and proteoglycans 
that are anchor-ed in the cellular membrane or non-covalently linked to binding regions 
of other proteins at the cell surface.141 The thickness of the glycocalyx can vary from 7 nm 
for red blood cells to sever-allOO nm and even up to several 1Jm151 for some epithelial and 
endothelial cells.161 In contrast, integrin adhesion receptors reach only 20 nm from the 
plasma membrane in their extended active conformation 171, with the consequence that 
the flrst encounter of molecules or ligands with the cell surface during attachment will 
constitutively occur through the g!ycocalyx.tst An increasing number of studies, focusing 
on the role of carbohydrates and carbohydrate-containing biomolecules in biological 
systems, indicates the role of cell surface glycans in many physiologically important 
processes such as embryonic development, differentiation, growth, immune responsel91, 
adhesion, migration and metastasis.l3b· 101 Cells embedded in the extracellular matrix 
(ECM) with proteoglycans and glycosaminoglycans as major constituents next to growth 
factors and cytokinesl 111, will in all likelihood face repelling events based on electrostatic 
forces between the negative charges of the cell surface glycocalyx and the immediate 
environment, consistent with local repulsion. Consequently, displacement or reduction 
of glycocalyx thickness has been associated with sites of adhesion and increases in 
adhesion to the substrate.1 12 t A recent model suggests that the glycocalyx provides an 
essential anti-adhesive role in the regulation of cell adhesion and is essential for the 
generation of integrin clusters.IBaJ Other studies in turn revealed highly basic triple helica I 
domains including disaccharide acceptor sitesi131 within collagen 11141 and flbronectin1 151 
as speciflc binding sites for negatively charged glycosaminoglycans, indicating a pro-
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adhesive function of glycans. Thu s, due to these putatively very divergent functions 
of the glycocalyx, mechanisms through which glycans mediate migratory and invasive 
potential of malignant cells direct ly remain unclear. 
In this thes is, the potential role of the glycan component in cell migration and invasion 
independently of the protein cores was investigated. First, a non-cytotoxic approach to 
transiently remove a major portion of the glycocalyx in live cells was developed, which 
allows to: (i) probe and quantify surface-glycan-mediated binding forces to fibrillar 
co llagen; (ii) show the dependence of integrin-independent ce ll migration in three 
dimensional environments in vitro and in mouse models in vivo on the availability of 
surface glycans; and (iii) revea l novel types of glycan-mediated filopodia! and bleb-like 
cell-matrix interactions. Consequent ly, a conceptually and mechanistically novel model 
of glycan-based cell migration was developed, which recognizes the surface glycocalyx 
as generic low-affinity but high-avid ity adhesion scaffold to the ECM. Next to tumor 
ce ll s, glycan-mediated cell adhesion and migration was confirmed for fibroblasts and 
leukocytes, thus combining glycan biology and matrix research to provide new insights 
into cell -tissue interactions, migration and invasion. 
In addition to integrins a selection of alternative adhesion-systems involved in two-
as well as three-dimensional (3D) cell adhesion and migration in vitro and in vivo are 
summarized in Chapter 2. The aim is to present the compl exity in terms of molecular 
structures and associated signaling as well as concerning the cellular processes of 
adaptation to existing requirements of the environment, which ce lls encounter during 
ce ll migration and invasion. In conclusion, integrins cooperate with alternative adhesion 
mechanisms to mediate interstit ial cell migration. 
Although glycans as biopolymers play a key role in numerous biological processesi16l, 
the ana lysis of glycans in live cell models was hampered by the lack of technical tools 
for appropriate staining and visualization. Only more recently, glycan detection in 
living cells has received increased attention due to employment of cationic dyesl171, 
advanced spectroscopic methods and introduction of sensitive live-cell microscopy in 
the expanding field of glycobiology.l3b. lOc. tae. torJ Glycans are not directly encoded in the 
genome and are thus not amenable to imaging techniques that rely on genetic reporters, 
e.g. GFP fluorescent fusion proteins.1181 A widely used method for the visua lizat ion of 
glycoconjugatesi19l is the staining w ith naturally occurring glycan-binding proteins, 
known as lectins120l. However, lectins typically have low affinity for their glycan epitope, 
require multivalency for high-avidity binding121l, alter cell function by crosslinking 
sur·face receptors and are partly even toxic.1221 For these reasons lectins cannot be used 
as neutral reporters in live cell studies. Well characterized antibodies recognize, e.g. 
distinct epi topes within glycosaminoglycans (GAGs)l23l for imaging of live or fixed cells,l24l 
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but the availability of antibodies is rare due to technical limitations in antibody synthesis 
recognizing especially small glycan structures.1251 Hence, in recent years efforts to image 
glycans in living systems have focused on the use of affinity reagents and chemical 
tools.118· 261 As strategy, bioorthogonal labeling was developed for tagging cell surface 
glycans, by combining the simplicity of genetically encoded tags with the specificity of 
antibody labeling and the versatility of small-molecule probes. In recent years a number 
of biorthogonal chemical reporters, probes and related bioorthogonal reactions has 
been developed.126271 In Chapter 3we introduce Bicyclo [6.1.0] nonyne (BCN) as a novel 
probe, which combines its exceptionally easy preparation with high reactivity to visualize 
cell surface sialic acid residues in living cells during cell adhesion and migration. Figure 1 
summarizes the experimental procedure and underlying reactions. 
b: Streptavidin _. ~ 
·la .. Bi:J 
0 
Fig.1: 
Scheme of metabolic labeling. Exogenously added non-native and non-perturbing bioorthogonal chemical 
reporter peracetylated N-azidoacetyl-0-mannosamine (Ac4ManNAz)l28 1, bearing azide as a reactive tag"l, 
can be taken up by cells and is deacetylated by intracellular esterases. Subsequently it enters into the 
salvage pathway, including UDP-GicNAc 2-epimerase/ManNAc-6-kinase (GNE)-mediated phosphorylation 
of ManNAz, the generation of phosphorylated NeuSAc (NeuSAc-9-phosphate) by N-acetylneuraminic acid 
synthase (NeuSAc-9-P synthetase/NANS) and dephosphorylation of NeuSAc by N-acetylneuraminic-acid 
Phosphatase (NeuSAc-9-P Phosphatase/NAN P). After further modifications in the nucleus and the Golgi 
apparatus, the azido-sialic acids appear as a part of glycan moities of glycoproteins at the cell surface.r3o' The 
detection of cell surface azido-sialic acids (SiaNAz) can be performed by using e.g. Bicyclo [6.1.0] nonyne (BCN) 
(a) in a metal-free strain promoted alkyne-azide cycloaddition (SPAAC) reaction, giving stable 1,2,3-triazoles. 
Finally, a fluorophore-conjugated streptavidin (b) can be used to visualize bioorthogonally labeled sialic acids 
using, e.g. confocal microscopy. Figure taken from Schmidt et al. 321 
The composition of the glycocalyx in different cell types varies greatly, and is further 
modified in response to environmental conditions, activation, differentiation signals 
and during cell death.l3b· 163· 331 To experimentally manipulate a broad r·ange of cell surface 
glycan types, a novel and stringent two-step multi-enzyme digestion pmtocol in live cells 
for the removal of a maximum of surface glycan was developed (Chapter 4). Multi-glycan 
14 
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removal included glycosaminoglycans (GAGs) hyaluronic acid (HA), heparan sulfate (HS), 
chondroitin sulfate (CS) and dermatan su lfate (DS) and glycan residues of glycoproteins 
and glycolipids, sialic acids and ~-1,4 coupled galactose quantitatively and transiently in 
a non-toxic manner. Using this approach, digestion efficiencies of more than 95 percent 
could be achieved. The proof for quantitative multi-glycan removal together with intact 
cell viability after treatment with glycosidases is essential for subsequent functional 
stud ies of glycans in cellular processes, such as adhesion and migration. 
The contribution of the surface glycocalyx to cell adhesion and migration was tested 
in live-ce ll models after integrin inhibition. The results are summarized in Chapter 5. 
Interference with expression and function of integrins results in morphologica I transition 
from a spindle shaped to an amoeboid blebbing phenotype w ith the consequence 
that cells maintain the ability to migrate within collagen-based 3D t issue by using an 
amoeboid migration phenotype of lower speed. Migrating ce ll s w it h intact glycocalyx 
maintain adhesion, direct engagement w ith fibrillar collagen via novel "grip-like" contact 
structures of membrane blebsgraspinga collagen fiber and preserve polarized cell-matrix 
contacts. However, adhesion on a 2D substrate was abrogated after integrin blockage,l341 
which makes surface anchoring a prerequisite for migration in 2D and points to only 
low adhesive forces involved in thi s residual adhesion mechanism, which requires an 
additional physical confinement provided by a three dimensional environment.135 1 Using 
glycan targeted approaches for partial and complete digestion of ce ll surface glycans in 
living cells, ~-1,4 coupled galactose residues were identified as non-redundant mediators 
of integr in-independent amoeboid migration, as cells lost the ability to form contact 
structures to collagen fibers and to migrate. The here established novel enzyme-based 
glycan targeted approach promotes the concept that the glycoca lyx provides a generic 
low-affinity but high-avidity scaffold and thereby mediates adhesion through adaptive 
interfaces to mediate integrin-independent mechanocoupling and ce ll migration in 3D 
tissue environments. 
Aim and content of the thesis 
The aim of this thesis was to study the contribution of the glycoca lyx to cell adhesion and 
migration and to identify this polar glycan layer as an alternative mechanism used by cells 
to compensate for their loss of integrin -mediated adhesion and migration. 
In Chapter 2 integrin-dependend and alternative adhesion mechanisms that potentially 
contribute to cell anchoring and migration in vitro and in vivo are crit ica lly reviewed. 
In Chapter 3 a novel bioorthogonal approach for the visuali zation of cell surface sialic 
acids in living cells without influencing cell function is introduced. 
15 
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In Chapter 4 an enzyme-based protoco l that allows a gradua l enzymatic degradat ion of 
ca r-bohydrate chains while mainta ining optimal viabili ty is int r-oduced. 
In Chapter 5 the glycan digestion strategy was applied to probe cell fu nctions, includ ing 
adhesion, migration and formation of ce llular contact structures to the surrounding 
collagenous ECM or ti ssue in an integrin-independent manner. 
In Chapter 6, the fi nd ings and concepts of th is t hesis are summarized and discussed. 
Furt hermore, future direct ions are provided. 
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by the inventor as he sees some creation of the brain unfolding to success ... 
such emotions make a man forget food, sleep, friends, love, everything. 
Nicola Tesla 
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CHAPTER 2 
Abstract 
Adhesion and migration are integrated cell functions that build, maintain and remodel 
the multicellular organism. In migrating cells, integrins are the main transmembrane 
receptors that provide dynamic interactions between extracellular ligands and actin 
cytoskeleton and signalling machineries. In parallel to integrins, other adhesion 
systems mediate adhesion and cytoskeletal coupling to the extracellular matrix 
(ECM). These include multifunctional cell surface receptors (syndecans and CD44) 
and discoidin domain receptors, which together coordinate ligand binding with 
direct or indirect cytoskeletal coupling and intracellular signalling. We review the 
way that the different adhesion systems for ECM components impact cell migration 
in two- and three-dimensional migration models. We further discuss the hierarchy 
of these concurrent adhesion systems, their specific tasks in cell migration and their 
contribution to migration in three- dimensional multi-ligand tissue environments. 
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Cell adhesion and migration are fundamental to the formation and maintenance of 
multicellular organisms. Cell adhesion is provided by adhesion molecules, which are 
expressed at the cell surface of all nucleated cells, mediate extracellular binding to cell 
and tissue substrates and transmit mechanical docking to the intracellular actomyosin or 
intermediatefllament cytoskeleton. Cell adhesion underlies many important physiological 
processes, including cell spreading, polarity, anchoring and differentiation. When cell -
tissue interactions undergo dynamic turnover, adhesion molecules further mediate cell 
migration and positioning during dynamic phases of the body, including morphogenesis, 
wound healing and, in a de-regulated form, during cancer invasion and metastasis (Hood 
and Cheresh 2002; Hynes 2002). Likewise, cell adhesion and migration underlie many 
functions of the immune system, including leukocyte recirculation, pathogen recognition 
and effector function (Friedl and Weigel in 2008). 
To fu lfill these various tasks in the different cell types and tissue contexts, diverse sets of 
adhesion receptors contribute to ce ll interaction w ith tissue components and to migration. 
Adhesion receptor ligands are another cell, a multimeric particle or macromolecules 
that are immobilized in the tissue, such as extracellular matrix (ECM) ligands. Important 
ECM proteins recognized by adhesion receptors are collagens, flbronectin, vitronectin, 
fibrinogen and laminin (van der Flier and Sonnenberg 2001). Non-protein ECM ligands 
comprise proteoglycan polysaccharides, such as heparan sulphate, chondroitin sulphate 
and keratin sulphate, and the non-proteoglycan polysaccharide hyaluronan (I ozzo 1998; 
Heino and Kapyla 2009). 
Severa l classes of cell surface receptors fulfi ll adhesion and cytoskeletal coupling 
functions and provide a range of adhesion strength, specificity and turnover rates 
during ce ll migration (Fig. 1). High affinity adhesion to ECM ligands is predominantly 
provided by receptors of the integrin family (Hynes 2002) and CD44 (Good ison et al. 
1999). Whereas integrins predominantly recognize extracellular protein scaffolds, such 
as interstitial collagen (Takada et al. 2007), CD44 preferentially binds to extracellular 
carbohydrate polymers, such as glycoprote ins, glycosaminoglycans and hyaluronic acid 
(HA; Ponta et al. 2003). In addition to these "classical" adhesion receptors, other surface 
receptors can bind ECM components and induce signalling, including the syndecans 
(Bernfleld et al. 1999) and the receptor tyrosine kinases discoidin domain receptors 
(DDRs; Yoshimura et al. 2005). Whereas integrin- and CD44-mediated adhesions have 
previously received substantial attention (Humphries et al. 2003), alternative adhesion 
mechanisms and their contribution to cell anchoring and migration have been less well 
studied. We summarize here the way that integrin- and non-integrin- mediated cell-
substrate interactions contribute to different types of cell migration. 
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Classes of adhesion receptors involved in cell adhesion and migration. Important domains of adhesion 
receptors and interstitial ECM ligands collagen, flbronectin and hyaluronan are shown. 
Modes of cell migration and adhesion requirements 
Cell migration is not a uniform event but comprises distinct modes of cell migration 
that are executed by different cell types and contexts. These migration types var·y in cell 
shape, adhesion strength and migration speed and also in whether cell-cell junctions are 
retained (Fig. 2). 
Arguably, the most "simple" migration mode is amoeboid migration (Friedl et al. 2001). 
Cells that move in an amoeboid manner· include primordial germ cells, lymphocytes, 
dendritic cells, lymphoma cells and neutrophils, all of which exhibit low or no integrin-
mediated traction force generation (Entschladen et al. 1997; Friedl et al. 1998; Blaser· 
et al. 2006; Lammermann et al. 2008). These cells form relatively instable adhesion sites 
to a substrate; such sites rapidly turnover and, depending on extracellular context and 
signalling, allow for rapidly adaptive migration (Friedl et al. 2001). Amoeboid movement 
is driven by a roundish to ellipsoid cell shape, non-focalized but rather diffusely organized 
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adhesion sites to the substrate and a strictly cortical actin cytoskeleton that lacks stress 
fib res (Fr ied l and Wolf 2003). Two types of force generation contribute to amoeboid 
movement. 
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Various migrat ion strategies. Depenoent on ce ll-matrix adhesion strength s and ce ll cont ractility, force 
generat ion occurs either via attachment to the ECi\11 subst rate and pulling or by ce ll propu lsion. Dependent 
on the stability of ce ll-ce!! ac!hesio:!, ce ll s n: i- grate either individually or with;n mu!tice!!u !ar strands (red actin 
cytoskeleton). 
Based on relative ly wea k attachment and spread ing on the substrate, a fast "gliding" 
t ype of movement is enabled that supports a w eakly adhesive pulling-type migrat ion 
across two-dimensional (20) and in th ree-dimensional (3D) environments (Friedl and 
Wolf 2009). Al ternatively, in non-adhesive ce lls, polarized dendrite or bleb formation 
coup led to rear-retraction fail t o attach to 20 substrate and lack ad hesion sites and, 
thus, provide an intercalating propu lsive type of migration in 30 ti ssues (Fackler and 
Grosse 2008). The biophysical basis of this blebbing-type migration is incompletely 
underst ood as it shows signs of ad hesion- independent migration. Instead of foca lized 
adhesion complexes, a predominantly cortical actin cytoskeleton drives ce ll polarization 
and physica l translocation by shape change and cytoskeleta l stiffness in complex 
ti ssue environments (Pa luch et al. 2006; Friedl and Wolf 2009). In ce ll s w ith increased 
adhesion and cytoskeletal cont ract ili ty, cell-matrix interactions become focali zed and 
the ce ll adopts an elongated spindle-shaped morphology; this mode of migration is 
termed mesenchymal migration and is used by fibroblasts, myoblast s and many cancer 
ce ll s (Friedl et al. 1998; Friedl 2004), generates substanti al adhesion and traction force 
towards the surrounding tissue and further mediates proteolytic ti ssue remodelling 
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by the function of cell-produced proteases (Wolf and Friedl 2009). Both ligand binding 
and intracellular coupling of cell adhesions are turned over in the range of minutes to 
hours thereby regulating both local adhesion strength and the dynamics of the cell 
(Zamir and Geiger 2001; Ballestrem et al. 2001). During morphogenesis, regeneration 
and cancer invasion, cells that retain cell-cell junctions by means of cadherins and other 
cell-cell adhesion mechanisms migrate collectively either as monolayer sheets or as 30 
strands, sprouts or isolated clusters (Friedl et al. 2004). Two types of for·ce generation 
in collective migration are under discussion at present, depending on the amount of 
anterior adhesion and traction force generation. If one or several front- and mid-row 
cells generate adhesion and tr·action force towards the substrate, collective migration 
results from adhesive "pulling" mediated by adhesion-complexes that connect to the 
actin cytoskeleton, similar to mesenchymal movement (Hegerfeldt et al. 2002; Trepat 
and Wasserman 2009). This type of migration is commonly detected in sprouting vessels, 
epithelial sheets duringwound healing and cancer invasion (Heger·feldt et al. 2002; Friedl 
and Gilmour 2009). A second, less well understood mode of collective force gener·ation 
is multicellular pushing, which is produced by a stable stick-like stalk and a relatively 
roundish terminal bud that protrudes into soft tissue in the absence of apparent 
force-generating adhesion complexes (Ewald et al. 2008). Thus, different cellular and 
molecular requirements for adhesion and force generation govern the different types of 
cell migration. Whereas, until recently, integrins have received ample attention and are 
considered as the main mediators of adhesion force generation during cell migration, the 
promigratory functions of non-integrin adhesion systems remain to be integrated into 
these concepts of cell movement. 
lntegrins 
lntegrins are heterophiliccell adhesion molecules consisting of non-covalently connected 
a and [3 chains that together determine ligand-binding specificity and intracel- lular· 
coupling (Humphries 2000; Hynes 2002). Based on ECM/Iigand recognition, integrins 
mediate binding to laminins (a2[31, a3[31, a6[31, a7[31), fibrillar collagens (a1[31, a2[31, 
a3[31, a10[31, a11[31) and Arg-Giy-Asp (RGD) motifs contained in many ECM proteins 
(a5[31, av[33, av[35, all b[33; Takada et al. 2007). Thereby, integrins are the most important 
cell surface receptors for cell i:lteractions with ECM str-uctures. 
lntegrins control the strength and turnover of cell interactions with ECM scaffolds 
(Hynes 1992). After ligand binding, integrins multimerize in the plasma membrane in a 
focalized manner and connect, via intr·acellular signalling and adaptor proteins, to the 
actin cytoskeleton, termed focal contact or focal adhesion (Burridge and Chrzanowska-
Wodnicka 1996; Zaidei-Bar et al. 2007; Moser et al. 2009). Alternatively, diffuse integrin 
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distribution devoid of microscopically detectable clustering and focalization of adhesion 
site mediates substrate binding and intracellular signalling (Friedl et al. 1998). 
To mediate cell movement, the integrin-mediated cell- substrate interactions and linkages 
to the actin cytoskeleton form and turnover, the dynamics and polarityofwhich determine 
cell speed and directional persistence. The way that integrins govern migration type and 
rates depends upon net adhesion strength per cell, type of cell-matrix interactions and 
type of substrate. On 20 ECM substrates, including collagen, flbronection orvitronectin, 
integrin-mediated adhesions are preferentially mediated by a5[31, av[33 and a2[31, 
respectively (Takada et al. 2007). In integrin-dependent migration models, the highest 
velocities result from an intermediate level of net adhesion strength allowing both rapid 
focal contact formation and the generation of traction forces, which are regulated by 
the small GTPase Rho (OiMilla et al. 1991; Beningo et al. 2006). Accordingly, increasing 
adhesion to the substrate slows cells down and favours cell immobilization and anchoring 
attributable to delayed rear-retraction. Likewise, at low net adhesion, migration rates 
are impaired because of reduced binding strength and force generation at the leading 
edge, resulting in partial or complete loss of migration (Palecek et al. 1997). The impact 
of adhesion- and traction force-dependent integrin functions are commonly established 
in haptokinetic migration across a 20 ligand-coated substrate, so that some degree of 
attachment is indispensible for migration (Huttenlocher et al. 1995). This principle of 
adhesion-driven migration applies to many, if not all, actin-associated integrins, notably 
[31, [32, [33, and [34 integrins (Rabinovitz and Mercurio 1997; Maaser et al. 1999; Vicente-
Manzanares et al. 2009). Consequently, both cell adhesion and migration are impaired by 
adhesion-perturbing anti-integrin antibodies or genetic deletion of integrins so that the 
cells either round up and partly detach or completely lose contact to t he substrate (Friedl 
and Wolf 2003). If, however, cells move through a 30 ECM , distinct physical principles 
apply because cells are entirely surrounded by ECM and, even after loss of adhesion, 
continue to interact passively with the substrate (Friedl and Brocker 2000). 
For cells of high integrin availability moving through a 30 ECM, including fibroblasts 
and certain cancer cells, integrins mediate adhesive pulling at the leading edge so that 
traction force towards the substrate is continually being generated (Fig. 2; Maaser et 
al. 1999; Petrie et al. 2009). Consequently, cell elongation and mesenchymal migration 
are dependent on integrin-mediated adhesion and focalization of the actin cytoskeleton 
to matrix contacts. The integrin engagement leads to the activation of focal adhesion 
kinase, Rho/Rae guanine nucleotide exchange factors and Rho kinase (ROCK), which 
together drive the formation and turnover of adhesions (Iwanicki et al. 2008). Following 
interference with integrin-mediated adhesion, mesenchymal migration is abrogated and 
no alternative adhesion receptors compensate for ablated integrin-dependent force 
generation and mesenchymal migration (Maaser et al. 1999; Grinnell 2008, 2009). 
In mesenchymal migration, integrin [31 or av[33 integrins cooperate with cell surface 
proteases, notably matrix metalloproteinases (M M Ps) leading to the generation of 
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small microtracks bordered by remodelled collagen fibres (Deryugina et al. 1998; Wolf 
et al. 2007). Secondary to traction force generation, mesenchymal migration leads to 
contraction and remodelling oft he ECM in vitro and to wound healing (Cooke et al. 2000; 
Larsen et al. 2006). 
If integrin-mediated traction force is low or negligible, moving cells utilize the amoeboid 
migration mode (Fig. 2; Friedl et al. 2001). Whereas, on 2D surfaces, amoeboid migration 
is still dependent on low adhesion mediated by integrins (Lammermann et al. 2008), 
amoeboid migration in 3D flbr illar collagen or interstitial tissue in vivo persists either 
partly or fully after integrins are blocked by antibody or are genetically ablated (Friedl 
et al. 1998; Lammermann et al. 2008). In integrin-independent amoeboid migration, the 
leading edge produces pseudopodia, dendrites or roundish-shaped blebs, all of which are 
dependent on cortical actin networks but do not form focalized adhesion complexes with 
the ECM substrate (Friedl et al. 1998; Lammermann and Sixt 2009). The mechanisms 
underlying integrin-independent migration are incompletely understood, but are best 
explained by actin forward flow followed by cell intercalation between matrix pores 
and gaps and cell contraction mediated by myosin II to move both the cell rear and 
the nucleus forward (Lammermann et al. 2008). Thus, grossly different magnitudes 
of integrin-mediated adhesion and force generation are associated with the diverse 
migration modes. 
Accor-dingly, in 3D ECM-based models, cells can switch between high and low integrin-
dependence of migration. The lowering of integrin-mediated adhesion by blocking 
with antibodies or by interfer ing with the integrin-effector c-src does not abrogate 
migration of cancer cells in 3D ECM-based models, but is followed by persistent robust 
cell movement (Carragher et al. 2006; Zaman et al. 2006). Whether such plasticity is 
restricted to cancer cells and which alternative adhesion mechanisms compensate for 
impaired integrin function remain unclear. 
Because of their multifunctional nature and ubiquitous expression, integrins contribute 
to most cell-tissue interaction models substantially and impact other adhesion path- ways 
in response to ECM. Thus, as we will discuss below, the study of adhesion mechanisms 
other than i ntegri ns is often compromised by an over Ia p with i ntegri n-mediated substrate 
recognition and function. 
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Syndecans 
Syndecans are a family of transmembrane cell surface heparan sulphate proteoglycans 
(HSPGs) with four members, syndecan 1-4. All vertebrate cells express at least one 
syndecan family member in a cell-type and tissue-specific manner, which is further 
modified during cell activation (Tkachenko et al. 2005). Syndecans bind to ECM ligands 
and further cooperate with other cell surface receptors for ligand-binding and signalling. 
Via their heparin-binding ectodomain, syndecans bind to extracellular glycosamino-
glycans, including heparan sulphate and chondroitin sulphate, and to other ECM 
molecules, including collagen types I, Ill and IV, fibronectin and vitronectin (Beauvais et 
al. 2004). By distinct mechanisms, syndecans further bind via residues within the HSPG 
side chains to cytokines and growth factors, including fibroblast growth factor-2 and 
epidermal growth factor and "present" them laterally to their specific receptors (Wu et 
al. 2003; Tkachenko et al. 2005). 
Syndecans mediate both cell adhesion and co-signalling, often in the same context, 
which renders the distinction between adhesion and co-signalling function difficult, if 
not impossible. In most cell models, overexpression of syndecans enhances cell adhesion 
and haptokinetic migration in normal and neoplastic cells, whereas interference with 
syndecan function decreases cell migration (Table 1). As an example, in endothelial 
cells, binding of syndecan-4 to fibronectin-coated substrate results in syndecan-4 co-
clusteringwith integrin a5~ 1 and the activation of Rac-1 through the intracellular scaffold 
protein synectin (Tkachenko et al. 2006; Morgan et al. 2007). Consequently, syndecans 
enhance cell spreading, polarization and migration in vitro and cell migration and tissue 
remodelling during wound healing and angiogenesis in vivo (Table 1; Echtermeyer et al. 
2001; Stepp et al. 2002; Morgan et al. 2007). 
Syndecans interact with a large number of ligands, which in parallel also bind to other 
cell surface receptors. Thus, a functional synergy between syndecans and integrins leads 
to an overlap in adhesion-dependent signalling pathways (Morgan et al. 2007). Given 
that syndecans functionally synergize with integrins, the extent to which syndecans can 
be understood as true adhesion receptors awaits further clarification by using models 
that isolate the direct contribution of syndecans to adhesion from its co-receptor and 
signalling activities. 
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Discoidin domain receptors (DDR) 
Discoidin domain receptors (DDRs) belong to the discoidin-like domain-containing 
subfamily of receptor tyrosine kinases, with two members in mammalian cells: DDR1, 
expressed as five isoforms (DDR1a-e), and DDR2 with no known isofor-ms (Alves et al. 
2001; Vogel et al. 1997). As main ligands, DDRs bind to all triple-helical fibrillar collagens, 
and DDR1 additionally binds to collagens type IV, VI and VIII (Curat et al. 2001). DDR1 
is expressed in many epithelia (Vogel et al. 1997), and in tissue-infiltrating leukocytes 
(Kamohara et al. 2001), whereas DDR2 is expressed in muscle cells, kidney, lung, brain 
and connective tissue (Vogel1999); both DDRs are upregulated in many cancer cell types 
(Vogel et al. 2006). After ligand binding, DDRs induce various intracellular signalling 
pathways, including the activation of Wiskott-Aidrich syndrome protein and Pyk-2s, the 
SH2-domain-containing-transforming protein and SH2-domain-containing phosphatase 
2, all of which indirectly promote actin dynamics (Buday et al. 2002; Koo et al. 2006; 
Vogel et al. 2006). Accordingly, DDRs enhance cell migration, proliferation, and survival 
(Vogel 1999). In contrast to other receptor tyrosine kinases, initial signalling through 
DDRs occurs within minutes but peaks only several hours later, implicating DDRs in 
sustained and slow rather than acute responses to the ECM (Vogel et al. 1997, 2006). 
Despite their collagen-binding capability, whether DDRs can be considered as classical 
adhesion receptors is unclear. DDRsignallingtypicallyco-engageswith integrins (Shintani 
et al. 2008). DDRs enhance integrin-mediated cell adhesion to collagen (Kamohara et 
al. 2001) and enhance integr-in- mediated signalling (Shintani et al. 2008). In addition, in 
some models, DDR1 overexpression enhances cell attachment to collagen that cannot 
be directly attributed to integrin function, suggesting either a direct adhesion function 
of DDR1 or- the co-engagement of yet another adhesion system (Kamohara et al. 2001). 
DDRs regulate cell migration in an isoform-specific manner. DDR1a-overexpressing 
leukemia and glioma cells show enhanced migration into 3D collagen lattices, whereas 
overexpression of DDR1b reduces migration in both cell types (Kamohara et al. 2001; 
Ram et al. 2006). On the basis that all DDRs bind to collagen by a similar mechanism, the 
signa I ling pathways that underlie such different fine-tuning of migration are unknown. 
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Syndecan type Cell type Experimental model Function Ref. 
Syndecan-1 Breast 20 spreading and Increased spreading, (Burbach et 
cancer cells migration assay; adhesion and migration on al. 2004) 
migration through 30 20 collagen I ;mcreased cell 
matrigel after invasion in 3D-Matrigel 
overexpression 
Myeloma In vivo model of Increased metastasis and (Khotskaya et 
cells experimental metastasis tumor growth al. 2009) 
in mice 
Syndecan-2 Intestinal 2D adhesIon and Increase of adhesio,, (Choi et al. 
epithelial migration after spreading on collagen type I 2009) 
cells overexpression (in cooperation with o2j31 
integrin} 
Colon Migration across type I Increased migration speed 
carcinoma collagen-coated surface (Parketal. 
cells after overexpression 2002), 
(Contreras et 
Migration through Increased migration and al. 2001) 
Melanoma polycarbonate filler invasion 
cells {trans well) after (Lee et al. 
overexpression 2009) 
Syndecan-3 Neuronal Migration through Increased migration (Hienola et aL 
cells polycarbonate filter 2006) 
(trans well) 
Syndecan-4 Melanoma Adhesion and migration Increased adhesion and (Chalkiadaki 
cells across fibrooectin-coated migration et al. 2009) 
2D surface 
Fibroblasts Adhesion and migration Increased adhesion and (Midwoodet 
in 30 fibrln-fibronectin- migration al. 2004; 
matrix Midwood et 
al. 2006) 
Table 1 
Regu lation of cell migration by syndecans (20 two-dimensional, 30 three dimensional) 
DDRs not on ly enhance cytoskeleta l dynamics, but further induce a more complex 
"invasion program". DDRsignalling upregu lates pro-invasive M M Ps 2 and 9, wh ich leads to 
enhanced proteo lytic degradation of ECM (Hou et al. 2002) and invasion and metastasis 
of tumour ce lls in vivo (Vogel et al. 1997). Although experimental over- expression of 
DDR1 acts in a promigratory manner (Ram et al. 2006), whether lower endogenous 
levels mediate the same effect remains unclear. To improve the discrimination between 
adhesive and signa lling funct ions of DDRs, future studies shou ld address DDR adhesion 
and other functions in integr in-independent models. 
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CD44 
CD44 is a highly glycosylated member of the hyaladherin or link protein superfamily of 
adhesion molecules and is either expressed as the standard form (CD44s) or as one of 
12 distinct isoforms (CD44v1-v12; Ponta et al. 2003; Naor et al. 2008). CD44 binds its 
main ligand, HA, via the hya luronan-binding domain (Banerji et al. 2007). Other ligands, 
which instead interact w ith va riable membrane- proximal domains of CD44, include 
heparan sulphate (exon v3), chondroitin sulphate (exon 5) and, via unmapped sites with 
probably weaker binding strength, co llagen types I and VI, fibronect in and laminin and 
ce ll surface receptors, such as E- and L-selectin (Ponta et al. 2003; Bendall et al. 2004; 
Naor et al. 2007). The cytoplasmic domain of CD44 recruits the actin-binding proteins 
ezrin, radixin and moesin (ERM; Legg et al. 2002) and ankyrin and thereby physically 
bt-idges extracellular ligand s to the actin cytoskeleton and induces intracellular signalling 
(Bourgu ignon 2008; Singleton et al. 2004) . In addition to its adhesion function, CD44 
serves as a co-receptor for other signalling receptors, such as the receptor tyrosine 
kinase mesenchymal-epithelial transition factor (c-Met), epidermal growth factor 
receptor and tumour growth factor-~ (Orian-Rousseau et al. 2002). 
CD44s is expressed by all nucleated vertebrate cells, including most cancer cells (Naor et 
al. 1997; Ta nabe et al. 1993). Activated cells and many cancer cells additionally express 
CD44variants, such as CD44v3-v10on ket-atinocytes and CD44v6 on many transformed 
ce ll s ((Brown et al. 1991); Wang et al. 2009). CD44-med iated signalling occurs via 
vat·ious pathways. HA binding leads to the activation of several effectors, including c-Src 
(Ouhtit et al. 2007), Rac1 and RhoA (Bourguignon et al. 2000; Bourgu ignon et al. 2001). 
In turn, active Rho and its effector ROCK promote the recruitment of the cytoskeleton-
protein ankyrin-1 and engage w ith the conserved cytoplasmic domain of CD44 and 
thereby provide a second link between CD44 and the actin cytoske leton (Singleton and 
Bourguignon 2004). 
In add ition to binding to tissue-anchored HA, CD44 immob ilizes HA at the cell surface 
(Rilla eta I. 2008).1 nearly cell adhesion, cell-surface-tethered HAcaptures ECM substrata 
pt·iorto integrin-mediated focal contact formation (Zimmerman et al. 2002). Cell -surface 
HA is constitutively present at the tips of cell protrusions, such as pseudopodia and 
lamellipodia, and engages w ith extracellular ECM substrate before integrin clustering 
and the formation of focal adhesions are detectable (Zimmerman et al. 2002; Rilla et al. 
2008). 
In most 20 haptokinetic migration models, CD44 enhances migration, either directly 
by mediating attachment to the substrate or by enhancing promigratory signalling. In 
normal and neoplastic cells, CD44 supports adhesion and migration across HA-coated 
surfaces (Zhu et al. 2006). Hereby, in contrast to integrins and syndecans, CD44 does 
not cluster at contact sites but 1·ather seems to form uniform intet-action zones to the 
substrate with a trend for redistt·ibution to the cell rear (Jacobson et al. 1984; Goebeler 
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et al. 1996; Friedl et al. 1997). In migrating leukocytes, CD44 is virtually excluded from 
the leading edge and accumulates together with ERM proteins in the posterior uropod, 
albeit that its function here is unclear (Sanchez-Madr-id and del Pozo 1999; Wagner et 
al. 2008). Many cells, irrespective of adhesion strength and the substrate across which 
they migrate, release substantial amounts of CD44, the function of which however is 
unclear, from the rear of the cell (Bazil and Horejsi 1992; Friedl et al.1997).1n addition to 
an adhesion function, the CD44-HA interaction results in the rapid activation of surface 
proteolysis via endopeptidases, including MT1- MMP and ADAMs (a disintegrin and 
metalloproteinase family), which cleave the CD44 ectodomain and thereby limit CD44-
mediated cell attachment (Nagano et al. 2004). Thus, the dual r-ole of CD44 comprises 
cell attachment and the secondar·y release of CD44-mediated adhesion bonds. 
In contrastto in vitro findings with respecttothe contribution of CD44 to cell migration on 
an HA substr·ate, CD44-deficient mice lack obvious defects of development, regeneration 
and immune function, suggesting intact interstitial cell migration (Protin et al. 1999; 
Naor et al. 2008). To what extent other adhesion receptors, including 131 integrins, the 
receptor for hyalumnan-mediated motility (RHAM M) or layilin as alternative receptors 
for HA compensate for· the loss of CD44 remains to be addressed (Pmtin et al. 1999; 
Naor et al. 2007; Chen et al. 2008). 
In cancer models, the interaction of CD44 variants with HA supports lymphoma and 
melanoma progression and metastasis, which is prevented by blocking antibodies 
targeting CD44v4-v10 or by expressing CD44 with an inactive HA-binding domain 
(Wallach-Dayan et al. 2001). Conversely, over-expression of soluble CD44 ectodomain 
in malignant melanoma and mammary carcinoma cells inhibits gr-owth, local invasion and 
metastasis in vivo, suggesting a role for the membrane-anchoring of CD44 (Ahrens et al. 
2001; Peterson et al. 2000). However, given the lack of a phenotype in CD44-deficient 
mice, the in vivo relevance of CD44-mediated adhesion and migration detected in vitro 
remains unclear. Thus, like syndecans, CD44 and its variants pr-ovide multiple adhesion 
and co-signalling functions, the mechanistic contribution of which to cell migration 
remains incompletely understood. 
Concluding remarks 
The various adhesion systems expressed by vertebrate cells serve overlapping functions 
for cell positioning, anchoring and signalling, but simultaneously retain additional 
independent and unique properties for each receptor. Whereas the molecular structure 
and associated signalling machinery of each receptor system have been examined in detail, 
only the r-ole of integrins in cell migration has been conclusively established. Conversely, 
the functions of syndecans, DDRs and CD44 in the different types of cell migration, 
their integration into distinct adhesion and de-adhesion functions of the cell, their 
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functional overlap and their spatiotemporal coordination during cell-matrix interaction 
and migration within multi-ligand environments remain unknown. Syndecans and DDRs 
cooperate with integrins synergistically in mediating cell adhesion and migration; this 
compromises defined experimental control of their functions. In order to experimentally 
overcome the governance of integrins and to gain better conceptual insights into each 
adhesion system independently, future strategies will require models of limited integrin 
availability or integrin deficiency. lntegrin-deficient cell models that still retain their 
cytoskeletal and polarization machinery will be instrumental in addressing specific 
migration modes and mechanisms and their response to physical tissue properties. To this 
end, the discrimination ofthe bona fjde adhesion function of DDRs, syndecans and C044 
from their other co-receptor functions and from intracellular docking to cytoskeletal and 
signalling scaffolds, which contribute to cell adhesion and migration by indirect routes, 
will be of importance. Such approaches will clarify the way that distinct adhesion systems 
spatio-temorally contribute to the complex process of cell dynamics and of anchoring in 
multifaceted tissue environments. 
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Abstract 
A new class of bioorthogonallabeling probes was developed based on Bicyclo[6.1.0] 
non-4-yne (BCN), a strained cycloalkyne that displays excellent reaction kinetics in 
cycloadditions with azides and nitrones. Functionalization with Alexa Fluor 555 or 
biotin facilitated straightforward and highly specific visualization of proteins and 
glycans, and allowed subcellular-resolved imaging of glycan expression in metastatic 
melanoma cells during invasive migration into 3D collagen lattices. 
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The advent of chemical biology tools for imaging and tracking of biomolecules (proteins, 
li pids, glycans) in their nat ive environment is providing unique insights into cellular 
processes that are not achievab le w ith trad it ional biochemica l or molecular biology tool s. 
Ill Bioor·thogonallabeling of biomolecules has proven particularly useful for the detection 
and study of glycans'2 ' and lipids,l3l based on a highly selective reaction between an abiotic 
functional tag and a designed chemica l probe. W ith respect to the abiot ic tag, azide has 
been used extensive ly because of its stra ightforward chemica l introduction, sma ll size, 
and re lat ive inertness.14J The finding that azides react rapidly and clean ly w ith terminal 
acetylenes in the presence of copper(l), the quintessential "c lick" reaction, has found 
tremendous application in life and material sciences.151 However, because up to 20 mol 
%of copper( I) species is typically used , such click chemi stry is not su itable for labeling 
of living systems without compromising ce ll function.16 ' Apart from that, the presence of 
copper· may induce oligonucleotidel71 and polysaccharidei81 degradation. To avoid the use 
of toxic meta ls, severa l metal-free bioorthogonallabeling reaction have been developed. 
'
9
' ln particular, phosphines have been used for cova lent ligation to azides, a procedure 
known as Staudinger ligation.[101 However, owing to the oxygen sensitivity of phosphines, 
recent focus of chemical ligation is shifting t owards strain-promoted cycloaddit ion 
reactions with cyclooctynes (Scheme 1 a).'11l Most prominently, azides were found to 
react with cyclooctynes with high reaction rates in a so-call ed strain-promoted alkyne-
azide cyc loadd ition (SPAAC).' 12i The too lbox of metal-free bioorthogonal reactions was 
most recent ly further expanded by our research grou p1131 and others,'141 by demonstrating 
that cyclooctynes undergo even more rapid strain-promoted cycloaddition with nitrones 
(SPANC), a procedure that was found sui table for dual, irreversible, and site-specific 
N-term ina l modification of proteins.' 13l 
The broad application of meta l-free cyc loadd ition in life sciences is, however, hampered 
by t he limited commercial availabili ty and lengthy synthetic routes for preparation of the 
most common cyclooctynes (Scheme 1 b) . For example, eight synthetic steps are required 
to generate second-generation Dl FO (1),'151 nine steps for Dl BAC (3),1161 and seven 
steps for BARAC (4),1171 whil e yields are usually low (10% for 2,'181 16% for 4). Additional 
modifications, such as dibenzoannu lation (compounds 2-4), increase lipophilicity and 
may, therefore lead to non-specific binding to protei ns-' 171 
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a) 
/ 
0 + N~N-N 0 -SPAAC SPANG 
b)cJ: 
1: DIFO (2nd gen.) 
Scheme 1. 
Reactions and structures of cyclooctyne compounds for strain-promoted cycloaddition. a) Cycloaddition with 
azide (SPAAC) or nitrone (SPAN C). b) Structures of the most commonly employed cyclooctynes. 
Here we report bicycle [6.1.0] nonyne (BCN) as a novel ring-strained alkyne for metal-
free cycloaddition reactions with azides and nitrones. Bicyclononyne derivatives, 
which were obtained in a highly straightforward process through cyclopropanation of 
1,5-cyclooctadiene, are Cs symmetrical and display excellent reaction kinetics in strain-
promoted cycloaddition reactions. Functionalized derivatives of BCN were applied in 
the labeling of proteins and glycans, as well as in the three-dimensional visualization of 
living melanoma cells. Based on the known reactivity enhancement of cyclo-propane 
fusion,1 191 we speculated that analogues of bicycle [6.1.0] nonyne (compound 6, Scheme 
2 a) would form a class of versatile cycloalkynes for bioconjugation by combining relative 
stability with high reactivity. Thus, the synthesis of BCN started by the dropwise addition 
of ethyl diazoacetate to a large excess (8 equiv) of 1,5-cyclooctadiene in the presence of 
rhodium acetate.1201The resulting mixture of diastereomeric compounds exo-5 and endo-
5, formed in a 2:1 ratio, was readily separated by chromatography on silica gel (combined 
yield 76%). Next, as exemplified for endo-5, the individual stereo isomers were converted 
into the corresponding hydroxyalkynes by reduction of the ester group, bromination, 
and elimination-a three-step reaction sequence that was performed within eight hours 
and required only a single purification step. The desired bicycle [6.1.0] non-4-yn-9-ol 
(endo-6) was thus obtained in 61% overall yield after purification (the diastereomeric 
exo-isomer of 6 was prepared in 53% yield form exo-5). Both exo-6 or endo-6 were found 
sufficiently stable for prolonged sto1·age at -20°C and did not undergo structural change 
upon stirring in the presence of 5 mm glutathione for 48 hours in CD3CN/ 020 (1:2).1171 
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Next, we investigated the reaction kinetics of 6 in the prototypical SPAAC reaction with 
benzyl azid e. Ca lculation of second-order reaction kinetics demonstrated t hat the three-
membered ring fusion leads t o a nea t· 100-fold rate enhancement over plain cyclooctyne 
k == 2 x 10·3 lvP s·1 measuring 0. 14 M-1 s·1 for endo-6 and 0.11 M-1 s·1 for exo-6. Reaction 
rates increased, as anticipated ,l131 in a more polar mixture (CD3CN/D20 (1:2)), measuring 
0.29 and 0.19 M-1 s 1 for endo-6 and exo-6, respective ly, va lues similar t o or better 
t han other cyclooctyne systems.l4-211 Strain-promoted acetylene-nitrone cyc loaddition 
(SPANC)I131 w ith nitrone 7 (Scheme 2b) instead of an azide was found to be significant ly 
faster, measuring 1.66 and 1.32 M·1 s·1 fot· endo-6 and exo-6, respective ly. The usefulness 
of BCN fo1· bioorthogonal functionali zation of biomolecules was next investigated in the 
one-pot SPANC functionali zation of a model peptide with anN-terminal serine. Indeed, 
we observed a clean conversion of FRATt ide, a GSK-1 binding peptide that prevents axin 
binding,l221 into the expected isoxazoline conjugates upon SPANC labeling w ith endo-6 
or biot inylated BCN conjugate 9, as judged by mass spectrometr ic analysis and spot-blot 
ana lys is (see the Supporting Information). 
a) 0 @ HQ" 1. LiAlH4 HQ" 0 N2~0Et Et20, o •c + Rh(OAch 2. Br2, CH2Cl2 CH:zC12 3. KOtBu, THF o·c H H 
oAoEt 
0 •c to reflux 
0 OEt (61%) 'oH (76%) 
exo-5 endo-5 endo-6 
b) 0 
HN)lNH 
HQHO Me 0 \~o~N~ +'J 9R= - 0 ' N" N./'-..Ph H H 
7 (O)l_N,R A 
11 R = \~o~N__. s H 2 H 
Scheme2. 
a) Synthesis of 9-hydroxymethylbicyclo [6.1.0] nonyne (endo-6 ). b) St ructures of BCN conjugated t o biot in (9) 
or Alexa Fluor 555 (11). THF = t etrahydrofuran 
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We also became interested in whether BeN-conjugates are suitable for labeling of 
azido-containing proteins. To this end, recombinant virus capsid pr-otein was expressed 
in auxotrophic E. coli in the presence of azidohomoalanine,[231 thus leading to the 
introduction of a single azide in nearly 50% of the isolated protein. Without further 
separation, the mixture of proteins was subjected to strain-promoted functionalization 
with BCN-Aiexa Fluor 555 conjugate 11 by mixing for three hours in a phosphate buffer 
(pH 7.5). After washing and dialysis, incorporation of 11 was confirmed by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE; Figure 1 a) and mass 
spectrometric analysis, which indicated a quantitative mass increase of 1135 Da, that is, 
the molecular weight of 11 (see the Supporting Information). Next, capsid proteins were 
assembled into viral capsids by dialysis to a sodium acetate buffer (pH 5.0, 0.01m CaCI ), 
2 
and subsequently purified by FPLC. A strongly fluorescent peak appeared around 1.2 ml, 
which is the common elution volume of vir-us capsid. Finally, the structure of virus capsids 
was determined by transmission emission spectroscopy (TEM) indicating the structural 
integrity of the protein capsids afterfunctionalization with 11 (Figure 1 b). 
a) b) 
CP-N3 + 11 native CP + 11 
Figure 1. 
BCN modification of azido-containing virus capsid protein and assembly into virus capsids. a) SDS-PAGE 
analysis of reaction of BCN-AFS55 ccnjugate (11) with capsid protein containing azide (left) or without azide 
(right). Top: Coomassie Brilliant Blue staining, bottom: fluorescence image. b) TEM pictures of fluorescent 
capsids (images recorded on a JEOL 1010TEM, the sample was deposited on a hydrophilized Formvar carbon-
coated TEM grid and consequently negatively staitled with 0.2% uranyl acetate). 
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The bioavailability and tolerability of labeling surface glycans on living human melanoma 
[lbl 
MV3 cells was addr-essed using the chemical reporter str-ategy. MV3 melanoma cells 
are highly invasive and metastatic, and their abundant production of surface glycans 
was previously implicated in invasion processes.
1241 
Thus, MV3 cells were incubated 
with peracetylated N-azidoacetyl-d-mannosamine (Ac4ManNAz), labeled with BeN-
biotin conjugate 9, and stained with streptavidin-Aiexa Fluor 488 (Figure 2). To be able 
to compare the efflciency of labeling of 9 to that of dibenzocycylooctyne (DI BO, 2), 
[181 
one of the most reactive cyclooctyne systems known to date, cells were also labeled 
with a DIBO-biotin conjugate. In all cases, cells retained mor-phological integrity and 
cell surface fluorescence, with consistently higher labeling for BCN than for DIBO, as 
detected by confocal microscopy (Figure 2 a) and flow cytometry (Figure 2 b). By using 
flow cytometry, high monophasic intensities and excellent signal-to-noise ratio (SNR) 
were found for both DIBO-biotin (SNR = 116) and BCN-biotin (SNR = 221). No signs 
of label-induced cytotoxicity were detected after propidium iodide staining (see the 
Supporting Information). 
b) 
Figure 2. 
Green fluorescence intensity 
Untreated 
Ac4ManNAz + SA-AF488 
w/o Ac4ManNAz + DIBO + SA-AF488 
Ac4ManNAz + DIBO + SA-AF488 
w/o Ac4ManNAz + BCN + SA-AF488 
Ac4ManNAz + BCN + SA-AF488 
Surface and total fluorescence intensity of MV3melanoma, cultured in the absence or presence of Ac4ManNAz 
(50 [JM), followed by labeling with a cyclooctyne-biotin conjugate and secondary labeling with streptavidin-
Aiexa Fluor 488 (SA-AF488). a) Representative confocal images of unlabeled cells (top) , cells labeled with 
DIBO-biotin (middle) or BCN- biotin 9 (bottom). Bar: 20 [Jill. b) Label intensity assessed by flow cytometry, 
indicated as mean fluorescence intensity (MFI). Numbers denote the average of green fluorescent cells for 
that particular experiment. 
49 
CH/FfE:\ 3 
Functional cell integrity was confirmed after incorporating MV3 cells into three-
dimensional collagen lattices yielding spontaneous and vigorous invasion. Owing to its 
high signal-to-noise ratio, labeling with BCN revealed nne, subcellular details, which 
can discriminate surface glycan distribution states on individual living cells as shown by 
densitometry experiments (see the Supporting Information). Whereas cells in suspension 
retain a near-homogeneous distt-ibution of azido-sialic acids on the cell surface (as 
in Figure 2), invading cells show the redistribution and accumulation of sialic acid at 
actin-rich contact sites with collagen fibers, consistent with their role in cell adhesion 
!25. 26, 271 
and migration (Figure 3). Thereby, submicron resolution reveals nne surface 
distribution of sialic acids at leading edge filopodia, focal clusters at actin-rich contact 
sites to collagen fibers, and substantial glycan-rich deposits into the tissue matt-ix from 
the trailing edge (see the Supporting Information). 
z 
u 
IXl 
Figure3. 
Ac4ManNAz Ac4ManNAz F-actin DAPI Collagen 
Live-cell staining and redistribution of glycans during invasive cell migration through a three-dimensional collagen 
matrix. Focal accumulation of sialic acid on migrating IVIV3 melanoma cell at interaction sites to collagen flbers and 
partial colocalization with F-actin. Insets, trailing edge. Direction of migration was determined from retraction 
flbers (asterisks) and deposited sialic acid-rich material lacking F-actin from the cell rear (gray arrowhead).1' 8! Bar: 
10 ~m. Focalized glycan distribution at cell matrix interactions (black arrowheads). 
In conclusion, in view of the non-toxic labeling procedure, the tunable fluorescent 
properties by choice of dye and the high signal-to-noise ratio, BCN will be useful for 
addressing molecular glycan function studies in live-cell and other systems. A key 
advantage of BCN over earlier cyclooctynes lies in the combination of its exceptionally 
easy preparation with high reactivity. Furthermore, it should be noted that the lack of 
conformational isomerism in bicycle [6.1.0] non-4-ynes1291 leads to sharp peaks in the 
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1HN lVI R spectrum, which is further simplified by the Cs symmetry of BCN. An additional 
advantage of a symmetrical cyclooctyne is the formation of a single regioisomer upon 
cycioaddition, an aspect of particular advantage in areas where the formation of 
homogeneous adducts is mandatory
111
JThus, BCN will allow a broad range of applications 
that require the highly efficient and metal-free conjugation of two separate molecular 
entities, for example in life sciences, materia l science, surface modification, and molecular 
diagnostics. 
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Detailed synthetic preparation and structural analysis of compounds 5-11 and 
cycloadducts. 
General methods and procedures 
1H NMR spectra were recorded in CDCI 3 or CD 3CN!Dp mixtures on Bruker DMX 300 
ot· Varian lnova-400 spectrometers at 300 K. TMS (6H 0.00) or CD 3CN (6H 1.94) was 
used as the internal reference. 13C NMR spectra were recorded in CDCI 3 at 75 MHz on 
a Bruker DMX 300 spectrometer, using the central resonance of CDCI 3 (6c 77.0) as the 
internal reference. Mass spectra were obtained on Applied Biosystems Voyager DE-Pt·o 
MALDI-TOF (no calibration) or J EOL Accu To F. Chemicals wet-e purchased from Aldrich 
and used without further purification. CH 2CI 2, acetonitt·ile, THF, Et20 and toluene were 
obtained dry from a MBRAUN SPS-800 solvent purification system; and CHpH was 
distilled from magnesium and iodine. Aqueous solutions are saturated unless otherwise 
specified. All reactions were performed under anhydrous conditions under argon and 
monitored by TLC on Kieselgel 60 F254 (Merck). Detection was by examination under 
UV light (254 nm) and by charring with 10% sulfuric acid in methanol or with aqueous 
KMn04. Silica gel (Acros 0.035-0.070 mm) was used for chromatography. 
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(1R,8S,9r,Z)-Ethyl bicyclo[6.1.0]non-4-ene-9-carboxylate (exo-5), and (1R,8S,9s,Z)-
ethyl bicyclo[ 6.1.0]non-4-ene-9-carboxylate (endo-5) 
To a so lut ion of 1,5-cyclooctadiene (19.6 ml, 160 mmol) and Rh 2(0Ac)4 (380 mg, 0.86 
mmol) CH 2CI2 (10 ml) was added dropwise in 3 h a solution of ethyl diazoacetate (2.1 
ml, 20 mmol) in CH 2CI 2 (10 ml). This so lution was stirred for 40 h at rt. CH 2CI 2 was 
evaporated and the excess of cyc looctad ieen was removed by filtration over a glass 
filter filled with silica and elution w ith EtOAc:heptane, 1:200 (400 ml). The filtrate was 
concentrated in vacuo and the residue was purified by column ch romatography on silica 
ge l (EtOAc:heptane, 1:20) to afford exo-5 (1.10 g, 28%) and endo-5 (2.24 g, 58%) as 
colorless oils. RF exo-5 0.24, RF endo-5 0.33 (EtOAc:heptane, 1:20). 
exo-5: 1H NMR (COCI3' 400 MHz): d 5.68-5.60 (m, 2H), 4.10 (q, J = 7.2 Hz, 2H), 2.35-
2.27 (m, 2H), 2.24-2.16 (m, 2H), 2.13-2.04 (m, 2H), 1.59-1.53 (m, 2H), 1.53-1.43 (m, 2H), 
1.25 (t, J = 7.2 Hz, 3H), 1.18 (t, J = 4.8 Hz, 1H). 13C NMR (COCI 3, 75 MHz) : d 174.3, 
129.8, 60.1, 28.2, 27.8, 27.6, 26.6, 14.2. HRMS (FAB+) m/z ca lcd for C12H1p 2 (M +H)+: 
195.1385, found: 195.1388. 
endo-5: 1H NMR (COCI3' 400 MHz): d 5.65 -5.57 (m, 2H), 4.12 (q, J = 7.2 Hz, 2H), 2.53-
2.46 (m, 2H), 2.25-2.16 (m, 2H), 2.10-2.01 (m, 2H), 1.87-1.79 (m, 2H), 1.70 (t, J = 8.8 
Hz, 1H), 1.43-1.34 (m, 2H), 1.26 (t, J = 7.2 Hz, 3H). 13C NMR (COCI3, 75 MHz): d 172.2, 
129.4, 59.7, 27.0, 24.1, 22.6, 21.2, 14.4. HRMS (FAB+) m/z ca lcd for C12H1p 2 (M + H)+: 
195.1385, found : 195.1378. 
(1R,8S, 9s)-Bicyclo[ 6.1.0]non-4-yn-9-ylmethanol (endo-6) 
To a suspension of LiAIH 4 (90 mg, 2.34 mmol) in Etp (10 ml) was added 
dropwise at 0 oc a so lut ion of endo-5 (520 mg, 2.68 mmol) in Etp (10 ml). 
This suspension was stirred for- 15 min at RT, then coo led down to 0 °(, and 
water was added carefu lly unti l the grey solid had turned into white. Na 2SO 4 
(2 g) was added, the so lid was filtered off and washed thoroughly with Etp 
(100 mL). The filtrate was concentrated in vacuo. 
W ithout further purification the alcohol was dissolved in CH 2CI2 (20 mL). At 0 oc 
a solut ion of Br2 (151 ml, 2.94 mmol) in CH 2CI2 (2 ml) was added dropwise until the 
ye llow color persisted. The reaction mixture was quenched w ith a 10% Na2S20 3-solution 
(5 ml), and extracted w ith CH2CI2 (2 x 20 mL). The organic layer was dried (Na 2SO 4) and 
concentrated in vacuo to afford the dibromide (833 mg, quant.). 
Without further purification t he dibromide (700 mg, 2.24 mmol) was dissolved in TH F 
(25 mL). A so lution of KOtBu (7.4 ml, 1M in THF, 7.40 mmol) was added dropwise at 
0 oc. Then the solution was refluxed for 2 h. After cooling down to rt the mixture was 
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quenched with saturated NH 4 CI-solution (20 ml), and extracted with CH 2CI 2 (3 x 20 
mL). The organic layer· was dried (Na2S04) and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (EtOAc:pentane, 1:1) to afford endo-6 
(205 mg, 61%) as a white solid. RF 0.22 (EtOAc:pentane, 1:1). 
1H NM R (CDCI 3, 400 MHz): d 3.73 (d, J = 8.0 Hz, 2H), 2.35-2.20 (m, 6H), 1.66-1.56 (m, 
2H), 1.39-1.30 (m, 1H), 1.18 (bs, 1H), 0.99-0.90 (m, 2H). 13C NMR (CDCI 3, 75 MHz): d 
98.4, 59.3, 28.5, 21.0, 20.9, 19.5. 
(1R,85,9r)-Bicyclo[6.1.0]non-4-yn-9-ylmethanol (exo-6) 
Compound exo-6 was prepared by an identical procedure as described for 
endo-6. Final purification by column chromatography on silica gel 
(EtOAc:pentane, 1:1) afforded exo-6 (128 mg, 53%) as a white solid. RF 0.23 
(EtOAc:pentane, 1:1). 
1H NMR (CDCI3' 400 MHz): d 3.54 (d, J = 6.4 Hz, 2H), 2.44-2.40 (m, 2H), 
2.32-2.25 (m, 2H), 2.18-2.14 (m, 2H), 1.88 (bs, 1H), 1.44-1.34 (m, 2H), 0.74-
0.63 (m, 3H).l3C NMR (CDCI 3, 75 MHz): d 98.7, 66.9, 33.3, 27.2, 22.5, 21.4. 
(1R,85,9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl (4-nitrophenyl) carbonate (8) 
To a solution of endo-6 (32 mg, 0.213 mmol) in CH 2CI 2 (5 ml) was 
added pyridine (43 ml, 0.532 mmol) and p-N02PhOC(O)CI (53 mg, 
0.266 mmo!).After stirring for 15 min at RTthe mixture was quenched 
with saturated N H4CI-solution (5 ml) and extracted with CH2CI 2 (3 x 
5 mL). The organic layer was dried (Na2S04) and concentrated in 
vacuo. The residue was purified by column chromatogr·aphy on silica 
gel (EtOAc:pentane, 1:5) to afford 8 (52 mg, 77%) as a white solid. 
RF0.30 (EtOAc:pentane, 1:3). 
1H NMR (CDCI 3, 400 MHz): d 8.28 (d, J = 9.2 Hz, 2H), 7.40 (J = 9.6 Hz, 2H), 4.41 (d, J = 
8.4 Hz, 2H), 2.37-2.22 (m, 6H), 1.67-1.57 (m, 2H), 1.56-1.47 (m, 1H), 1.11-1.02 (m, 2H). 
13C NMR (CDCI3' 75 MHz): d 155.6, 152.5, 145.3, 125.3, 121.7, 98.7, 68.0, 29.0, 21.3, 
20.5, 17.2. 
( 1R,8S, 95)-bicyclo[ 6.1.0]non-4-yn-9-ylmethyl12-( + )-biotinylami no-3,6, 9-trioxa-
dodecyl carbamate (9) 
To a solution of 7 (52 mg, 0.165 mmol) in DMF (5 ml) was added (+)-biotin-(PE0)4-
NH2 (69 mg, 0.165 mmol) and NEt3 (69 ml, 0.495 mmol). After stirring for 2 hat RTthe 
reaction mixture was evaporated to dryness in vacuo. The residue was purified by column 
chromatography on silica gel (acetone:MeOH, 9:1) to afford 9 (68 mg, 69%) as a white 
solid. RF 0.22 (acetone:MeOH, 9:1). 
56 
1H NMR (CDCI 3, 400 MHz): d 6.76-6.69 (m, 1H), 6.61 (bs, 1H), 5.67 (bs, 1H), 5.40-4.34 
(m, 1H), 4.52-4.49 (m, 1H), 4.33-4.30 (m, 1H), 4.15 (d, J =8Hz, 2H), 3.64-3.63 (m, 8H), 
3.59-3.54 (m, 4H), 3.46-3.42 (m, 2H), 3.39-3.35 (m, 2H), 3.17-3.12 (m, 1H), 2.90 (dd, 
J = 12.8, 4.8 Hz, 1H), 2.75 (d, J = 12.8 Hz, 1H), 2.30-2.21 (m, 8H), 1.80-1.53 (m, 6H), 
1.48-1.31 (m, 3H), 0.97-0.92 (m, 2H). HRMS (ESI+) m/z calcd for C29 H47N40 7S (M + H)+: 
595.3165, found: 595.3166. 
( 1R,8S, 9s)-bicyclo[ 6.1.0]non-4-yn-9-ylmethyl 3,6, 9-trioxa-12-azadodecylcarbamate ( 10) 
To a solution of 8 (14 mg, 0.044 mmol) in DMF (1 ml) 
was added 1,8-diamino-3,6-dioxaoctane (38 f.Jl, 0.266 
mmol) and NEt3 (19 f.JL, 0.133 mmol) and the reaction 
mixture was stirred at RT for 15 min. The mixture was 
concentrated under reduced pressur-e, taken up in 
CH 2CI 2 (20 mL) and extracted with 1 N NaOH (2 x 2 mL), 
followed by water (2 ml). The combined aqueous 
phases were extracted once with CH 2CI 2 (10 ml) and 
extracted with water (2 ml). The combined organic 
layers were dried over Na 2S04 and concentrated in vacuo. Silica gel column 
chromatography (CH 2CI 2:MeOH, 20:1---> 10:1---> 5:1, 1% Et3 N) and concentration in 
vacuo gave the title compound 10 (12 mg, 83%) as a slightly yellow oil. 1H NMR (CDCI 3, 
400 M Hz): d 5.34 (bs, 1H), 4.15 (d, 2H, J = 8.0 Hz), 3.62 (s, 4H), 3.58-3.48 (m, 4H), 3.38 
(m, 2H), 2.89 (t, 3H, J = 5.2 Hz), 2.32-2.19 (m, 6H) , 1.64-1.51 (m, 2H), 1.40-1.31 (m, 1H), 
0.96-0.88 (m, 2H). 13C NMR (CDCI 3, 75 MHz): d 98.8, 73.4, 70.3, 70.2, 70.1, 62.7, 41.7, 
40.8, 29.1, 21.4, 20.1, 17.8. HRMS (ESI+) m/z calcd for C17H28Np4 (M +H)+: 325.2122, 
found: 325.2120. 
BCN-Aiexa Fluor 555 conjugate (11) 
To a solution of 10 (0.27 mg, 0.833 f.Jmol) in DM F (1 ml) was added Alexa Fluor 555 
carboxylic acid, succinimidyl ester (1 mg, 0.833 f.Jmol). The reaction mixture was stirred 
for 16 h at RT, and any remaining unreacted Alexa Fluor 555 was quenched with 
ethanolamine (1 f.JL, 17 f.Jmol) for 1 hat RT. The reaction mixture was then concentrated 
in vacuo. The crude product was used without any further purification. 
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((SaR,65,6aS)-1-benzyl-1,4,5,5a,6,6a, 7 ,8-octahydrocyclopropa[ 5,6]cycloocta[ 1,2-d] 
[1,2,3]triazol-6-yl)methanol 
-
"oH 
To a solution of endo-6 (24 mg, 0.16 mmol) in a mixture of CH 3CN/ 
Hp=3/1 (7 mL) was added BnN 3 (19.91-JL, 0.16 mmol). This mixture was 
stirred for 16 hat RT, and then extracted with CH 2CI 2 (3 x 5 ml). The 
organic layer was dried (Na 2504) and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (EtOAc) to afford 
the endo-cycloadduct (44 mg, 97%) as a white solid. RF0.11 (EtOAc). 
1H NMR (COCI 3, 400 MHz): d 7.34-7.26 (m, 3H), 7.11-7.09 (m, 2H), 5.52-5.42 (m, 2H), 
3.68 (ddd, J = 25.7, 11.3, 7.8 Hz, 2H), 3.11 (ddd, J = 15.8, 7.3, 3.8 Hz, 1H), 2.91 (ddd, J 
= 15.8, 9.6, 4.0 Hz, 1H), 2.78 (ddd, J = 16.1, 6.6, 3.5 Hz, 1H), 2.55 (ddd, J = 16.1, 10.3, 
3.7 Hz, 1H), 2.25-2.17 (m, 1H), 2.04-1.97 (m, 2H), 1.59-1.41 (m, 2H), 1.19-1.10 (m, 1H), 
1.03-0.95 (m, 1H), 0.86-0.78 (m, 1H). 13C NMR (COCI3' 75 MHz): d 145.1, 135.2, 133.1, 
128.8, 128.0, 126.8, 59.5, 51.9, 26.0, 23.1, 22.2, 21.5, 20.9, 19.3, 19.0. HRMS (ESI+) m/z 
calcd for C17H22Np (M +H)+: 284.1763, found: 284.1749. 
((SaR,6R,6aS)-1-benzyl-1,4,5,5a,6,6a,7,8-octahydrocyclopropa[S,6]cycloocta[1,2-d] 
[ 1,2,3]triazol-6-yl)methanol 
The exo-product was prepared by the same procedure as described for 
the endo-cycloadduct. The residue was purified by column 
chromatography on silica gel (EtOAc) to afford exo-cycloadduct (43 mg, 
95%) as a white solid. RF0.10 (EtOAc). 
1H NMR (COCI3' 400 MHz): d 7.33-7.28 (m, 3H), 7.11-7.09 (m, 2H), 5.46 (s, 2H), 3.50-
3.40 (m, 2H), 3.09 (ddd, J = 15.9, 7.3, 3.3 Hz, 1H), 2.85 (ddd, J = 15.9, 10.1, 3.5 Hz, 1H), 
2.73 (ddd, J = 16.2, 6.7, 3.0 Hz, 1H), 2.51 (ddd, J = 16.1, 10.5, 3.2 Hz, 1H), 2.41-2.33 (m, 
1H), 2.22-2.15 (m, 2H), 1.39-1.30 (m, 1H), 1.27-1.18 (m, 1H), 0.83-0.76 (m, 1H), 0.70-
0.62 (m, 2H). 13C NMR (COCI3' 75 MHz): d 145.4, 135.2, 133.3, 128.8, 128.0, 126.8, 
66.1, 51.9, 27.6, 27.1, 26.3, 25.8, 22.9, 22.0, 21.9. HRMS (ESI+) m/z calcd for C17H22Np 
(M +H)+: 284.1763, found: 284.1746. 
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(SaS,6S,6aR)-N-benzyl-6-(hydroxymethyl)-2-methyl-3,4,5,5a,6,6a,7,8-octahydro-
2H-cyclopropa[S,6]cycloocta[1,2-d]isoxazole-3-carboxamide 
To a solution of endo-6 (54 mg, 0.36 mmol) in a mixture of CH 3CN/ 
Hp=3/1 (7 mL) was added nitrone 7 (70 mg, 0.36 mmol). This 
mixture was stirred for 16 hat RT, and then extracted with CH 2CI 2 
(3 x 5 mL). The organic layer was dried (Na 2S04) and concentrated 
in vacuo. The residue was purified by column chromatography on 
silica gel (EtOAc:heptane, 2:1) to afford endo-cycloadduct as a 
mixture of isomers (114 mg, 92%). RF0.17 (EtOAc:heptane, 4:1). 
1H NMR (CDCI 3, 400 MHz): d 7.58-7.52 (m, 1H), 7.34-7.22 (m, SH), 4.52-4.46 (m, 1H), 
4.41-4.34 (m, 1H), 3.93 (s, 0.4H), 3.88 (s, 0.6H), 3.74-3.65 (m, 2H), 2.81-2.73 (m, 1H), 
2.69 (2s, 3H), 2.43-2.19 (m, 3H), 2.08-1.94 (m, 3H), 1.65-1.44 (m, 2H), 1.19-1.06 (m, 1H), 
1.03-0.95 (m, 1H), 0.90-0.83 (m, 1H). 13C NMR (CDCI 3, 75 MHz): d 170.4, 146.3, 146.1, 
138.3, 138.2, 128.7, 128.5, 127.5, 127.3, 103.1, 102.8, 79.8, 79.3, 59.7, 46.1, 42.8, 39.1, 
25.9, 25.5, 25.2, 21.6, 20.6, 20.5, 19.8, 19.6, 19.2, 18.6, 18.3, 18.1. HRMS (ESI+) m/z 
calcd for C20 H27Np3 (M +H)+: 343.2022, found: 343.2008. 
(SaS,6R,6aR)-N-benzyl-6-(hydroxymethyl)-2-methyl-3,4,5,5a,6,6a,7,8-octahydro-
2H-cyclopropa[S,6]cycloocta[1,2-d]isoxazole-3-carboxamide 
I o The exo-product was prepared by the same procedure as described 
H~o/NyJlH ~/'-_Ph for endo-cycloadduct. The residue was purified by column chromatography on silica gel (Et0Ac:CH 2CI 2, 5:1) to afford the exo-cycloadduct as a mixture of isomers (28 mg, 88%). RF 0.11 (EtOAc:heptane, 2: 1). 
OH 
1H NMR (CDCI 3, 400 MHz): d 7.55-7.49 (m, 1H), 7.34-7.24 (m, SH), 4.52-4.33 (m, 2H), 
3.91 (s, O.SH), 3.87 (s, O.SH), 3.54-3.40 (m, 2H), 2.78-2.72 (m, O.SH), 2.69 (2s, 3H), 2.61-
2.53 (m, O.SH), 2.40-2.31 (m, 1H), 2.28-2.11 (m, 4H), 1.50-1.26 (m, 3H), 0.79-0.62 (m, 
3H). 13C NM R (CDCI 3, 75 M Hz): d 170.4, 170.3, 146.3, 138.4, 138.3, 128.6, 128.5, 127.6, 
127.4, 127.3, 103.3, 103.0, 80.0, 79.6, 66.6, 46.2, 42.9, 42.7, 26.7, 26.6, 26.4, 25.9, 25.7, 
25.4, 25.1, 24.3, 24.2, 21.4, 21.2, 20.9, 20.8. HRMS (ESI+) m/z calcd for C20H27Np3 (M + 
H)+: 343.2022, found: 343.2010. 
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Rate plots for cycloaddition of endo-6 and exo-6 with benzyl azide 
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Reaction time (s) 
1H-NMR monitoring of cycloaddition of exo-6 or endo-6 with benzyl azide was performed by rapid mixing 
(t~O) of stock solutions A and B 10.3 mL each) in an NMR tube and immediate insertion into a 400 MHz NMR 
spectrometer. NMR spectra were measured at preset time-intervals. Each experiment was performed in 
triplicate. 
Stock solution A: alkyne 6 was dissolved in a mixture of CD 3CN and 0 20 (ratio 3:1 or 1:2, 10 ml) to give a 36 
mM solution. 
Stock solution B: benzyl azide was dissolved in a mixture of CD3CN and op (ratio 3:1 or 1:2, 10 ml) to give a 
32.8 mM solution. 
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All experiments wer-e conducted at 18 mM concentration. 
Kinetics of the reaction of exo-6 or endo-6 with benzyl azide were determined by 
measuring the decrease of the integra l of the signal caused by benzyl azide methylene 
protons, w ith the integral of the acetonitril e or water solvent-peak as internal standard. 
A sta rting value for the integral of the methyl signals was estimated, due to the fact that 
cycloadd ition had already proceeded significantly by the time of the first measurement. 
From the conversion plots thus obta ined, the second order rate plots were calculated 
according to equation: 
kt 1 [A] 0 ([B] 0 -[P]) ---- x n _...;;;...__..:;...._ __ [B]o-[A]o ([A]o-[P])[B]o (1) 
1 
with k = 2nd order rate constant (M-1s-1) , t = reaction time (s), [A]0 = the in it ial concentration 
of substrate A (mmol/ mL), [B]0 = the initial concentration of substrate B (mmol/ml) and 
[P] = the concentration of product (mmol/ml). 
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Rate plots for cycloaddition of endo-6 and exo-6 with nitrone 7 
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Reaction time ( s) 
1H-NMR monitoring of cycloaddition of exo-6 or endo-6 with nitrone 7 was performed by rapid mixing (t=O) 
of stock solutions A and B (0.3 ml each) in an NMR tube and immediate insertion into a 400 MHz NMR 
spectrometer. NM R spectra were measured at preset time-intervals. Each experiment was performed in triplo. 
Stock solution A: alkyne 6 was dissolved in a mixture of C03CN and 020 (ratio 3:1 or 1:2, 10 ml) to give a 36 
mM solution. 
Stock solution B: N-(methyliminoacetyl N-oxide)benzylamine (nitrone 7) was dissolved in a mixture of C03CN 
and 020 (ratio 3:1 or 1:2, 10 ml) to give a 32.8 mM solution. 
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All experiments were conducted at 18 mM concentration in CD3CN:D20=3:1. 
Stock so lut ion B: N-(methyliminoacetyl N-oxide)benzylamine (nitrone 7) was dissolved in 
a mixture of CD 3CN and op (ratio 3:1 or 1:2, 10 ml) to give a 32.8 mM solution. 
Kinetics of the reaction of exo-6 or endo-6 with nitrone 7 were determined by measuring 
the decrease of the integral of the nitrone methyl groups, with the integral of the 
acetonitrile or water solvent peak as interna l standard. A start ing va lue for the integral 
of the methyl signals was estimated, due to the fact that cycloaddition had already 
proceeded significantly by the time of the first measurement. 
From the conversion plots thus obtained, the second order rate plots were calculated 
according to equation: 
kt I [A] 0 ([B]o-[P]) ---- x n _....;;..__~--[s]0-[A]0 ([A]o-[P])[B]o (1) 
1 
with k = 2nd order rate constant (M-1s-1), t = react ion time (s), [A]0 =the initial concentration 
of substrate A (mmol/ml), [B]0 =the initial concentration of substrate B (mmol/ml) and 
[P] =the concentration of product (mmol/ml). 
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Mass spectrometric analysis of SPANC labeling of FRATtide with endo-6 and biotin-
conjugate 9. 
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SPANC labeling of FRATtide with endo-6 (A) 
FRATtide (15.6 ~g, 3A nmol, 34 ~M) was dissolved in 0.1 M NH 40Ac buffer pH 6.9 (100 fJLl and Na104 (UfJg, 
5.5 nmol, 48 fJM) was added. The reaction was allowed to take place at room temperature for 40 min and 
p-methoxybenzenethiol (9.2 ~g, 66.0 nmol, 565 fJM) was added. The mixture was shaken for 2h at 25 oc and 
p-anisidine (13.5 fJg, 109.3 nmol, 845 ~M), N-methylhydroxylamine hydrochloride (18.2 fJg, 218.6 nmol , 1.5 
mM), and endo-6 (41.1 fJg, 273.3 nmol, L8mM) were added. Finally, the reaction mixture was shaken at 25 oc 
for 24 h to give the desir-ed conjugate. MS (Accu-TOF) measurement gave 4681.4 Da as the main peak after 
deconvolution. 
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SPANC labeling of FRATtide with BCN-biotin conjugate (B) 
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FRATtide (9.3 1-Jg, 2.1 nmol, 35 iJM) was dissolved in 0.1 M NH~OAc buffer pH 6.9 (60 iJLl and Nal04 (0.71-Jg, 
3.4 nmol, 52 iJM) was added. The reaction was allowed to take place at room temperature for 40 min and 
p-methoxybenzenethiol (5.7 1-Jg, 40.7 nmol, 581 iJM) was added. The mixture was shaken for 2 hat 25 oc and 
p-anisidine (8.3 1-Jg, 6 7.2 nmol, 864 1-JM), N-methylhydroxylamine hydrochloride (11.3 1-Jg, 134.8 nmol, 1.6 mM), 
and 9 (100.3 1-Jg, 168.6nmol, 1.7 mM) were added. Finally, the reaction mixture was shaken at 25 oc for 24 h to 
give the desired conjugate. The residue was purined using an YM-3 millipore microcon centrifugal niter device 
by centrifuging three times for 30 min at 13,000 xg with 300 iJL 0.1 M NH 40Ac buffer pH 6.9. MS (Accu-TOF) 
measurement gave 5126.8 Da as the main peak after deconvolution. 
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Spot-blot analysis of biotinylated FRATtide 
ponceau S 
streptavidin-
rhodamine red 
A B 
1 fJL of native FRATtide (A) or pur:ned FRATtide-BCN-biotin conjugate (B) were spotted on Whatman 
nitrocellulose membrane. Non-speciflc sites were blocked using 5% BSA in TBS-T (20 min). Top: proteins were 
stained using ponceau S. Bottom: proteins were stained with TBS-T solution containing 1% BSA and 0.01% 
rhodamine red-labeled streptavidin (l rwitrogen) for 5 min. 
After absorption of the peptide to the membrane, it can be reversibly stained with ponceau 
S, which stains all peptides and proteins present, showing that there are equal amounts 
of protein in each spot. Incubation with labeled streptavidin, followed by washing, shows 
that only the FRATtide-BCN-biotin conjugate (B) binds to the streptavidin, but there is 
no staining for FRATtide alone (A). This indicates that the conjugation of biotin to the 
FRATtide was successful and that there is no aspeciflc absorption taking place at non-
functionalized FRATtide. 
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MS analysis of fluorescence labeling of capsid protein with BCN-Aiexa Fluor 555 
conjugate 11. 
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Mass (m/z) 
ESI -TOF mass spectrum of capsid protein reacted with 10. Peak B corresponds to the mass of unreacted CP, 
wh ile peak A em-responds to t he react ion product. The mass diffe rence between the pea ks is 1135.1 (expected 
1135) . 
The capsid protein (CP) of Cowpea Chlorotic Mottle Virus (CCMV) was expressed 
recombinantly in methionine auxotroph E. coli. The gene encoding the CP was 
obtained as described by Minten et al1 The wild -type CP contains two methionines, 
Met1 and Met137, and due to the cloning procedure a third methionine was added at 
the N-term inus of the protein. Site-directed mutagenesis was used to mutate two of 
these methioni nes into alanines. First Met137---+Aia was mutated with the primer set 
CGAAAGATGTTGTCGCTGCTG_CGTACCCCGAGGCG (mutation site underlined) and 
its reverse complement using the following PCR program: [95 °C, 1'; 16 cyc les of (95 
°C, 30" ; 55 oe, 1'; 68 oe, 15'); 68 °C, 5']. Consequently Metl---+Aia was mutated using 
the primer-set CGCGGCAGCCATATGGCGTCTACAGTCGGAACAG (mutation site 
underlined) and its reverse complement using the same PCR program. Both mutations 
were confirmed by sequence analysis. 
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Recombinant expression 
For recombinant expression, the plasmid containing the CP-gene was transformed to a 
strain of methionine-auxotroph f.coli bacteria (8834 (DE3) plysS cells, Novagen). The 
auxotroph expression was performed following the general procedur-e described by Link 
et ai.2 with some modifications. The bacteria were cultured in LB medium supplemented 
with ampicillin (100 mg/L) and chloramphenicol (50 mg/L) until an optical density of 
0.4- 0.6 was reached, at which point IPTG (final concentration 1 mM) was added to 
allow synthesis of T7 polymerase in presence of methionine. After 15 minutes the 
culture was washed twice by centrifugation and resuspension in 0.9% NaCI, followed by 
resuspension in M9 minimal medium supplemented with all natural amino acids (40 mg/L 
each) except methionine, glucose (0.4%), MgS04 (1 mM), thiamine (0.0005%), ampicillin 
(100 mg/L) and chloramphenicol (50 mg/L). The bacteria were cultured at 37 oc for 15 
minutes before azidohomoalanine (40 mg/L) and I PTG (1 mM) wer-e added to start the 
production of azido-conta in i ng C P. After cu ltu ring the bacteria for 18 hours at 30 oc the 
bacteria were harvested by centrifugation. 
The CP was purifled by Ni 2+ NTA afflnity chromatography under native conditions 
(Qiagen, Hilden, Germany). After puriflcation the protein was analyzed by SDS-PAGE 
and mass spectroscopy, the latter indicating that approximately 50% of the proteins 
contains an azidohomoalanine instead of a methionine (data not shown). TheN-terminal 
location of this this azide group ensures its positioning on the inside surface of the virus 
capsid after assembly from theca psid proteins. 
Protein functionalization 
The mixture of singly functionalized proteins and non-functionalized proteins (1 mg/ 
ml in 0.1M phosphate buffer pH 7.5, 1M NaCI) was mixed with 4 equivalents of Alexa 
Fluor-BCN conjugate 11, which was dissolved in a minute amount of water. After mixing 
for 3 hours at RT, the reaction pr-oduct was analyzed on a 12% SDS PAGE gel, of which 
a f1uorescence image was obtained before staining it with Coomassie Blue stain. As 
control reaction Alexa Fluor-BCN conjugate 11 was mixed with non-functionalized CP 
protein in exactly the same conditions as the reaction. The absence of f1uorescence in 
the f1uorescence image shows that there is neither a side reaction nor any non-covalent 
adhesion of the dye to the protein. 
To obtain a mass spectrum of the reaction product, the product was dialyzed to 0.1% 
formic acid in water (using Microcon® centrifugal niter units, 10 kDa, Millipore) before 
injecting it into the ESI-TOF (JEOL AccuTOF) mass spectrometer. Deconvolution of the 
raw data resulted in the spectrum displayed in Figure 5. 
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FPLC trace of the reaction mixture after assembly of fluorescent caps ids by dialysis 
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FPLC trace of the reaction mixture after assembly of the caps ids by dialysis. The peak at 1.2 ml corresponds 
to 28 nm capsids, the 555 nm-absorbance shows that the capsid protein-AF555 conjugate is present in the 
capsids. 
Capsid assembly 
Self-assembly of the functionalized capsid protein was performed by 18 hour dialysis of 
the crude reaction mixture to a slightly acidic buffer (pH 5.0, 50 mM NaOAc; 1 M NaCI; 
10 mM CaCI 2), which induces the formation of 28 nm sized spherical particles.34 FPLC 
size exclusion analysis on a Superose 6 column showed an absorption peak at 280 nm 
at an elution volume of 1.2 ml, indicating the formation of 28 nm-sized capsids. The 
overlapping absorbance at 555 nm indicated the presence of Alexa dye in the capsids. 
Transmission electron microscopy 
An FPLC sample of the 1.2 ml peak was loaded on a TEM-grid, which was subsequently 
stained with 0.2% uranyl acetate in water. Analysis oft he grid clearly shows the presence 
of spherical particles with a size of approximately 28 nm, the expected size for virus 
capsids. 
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Flow cytometry of glycan labeling 
Cell culture procedure 
Invasive and metastatic human melanoma cells (IV1V3) 5 were maintained in culture 
medium RPIV111640, containing 10% fetal calf serum, penicillin/streptomycin (each SOU/ 
ml) in a 5% C0 2 water-saturat ed atmosphere. 
Cell surface azide labeling 
IV1V3 ce lls were cultured for 6 days in the absence or presence of Ac41VlanNAz (50 [1M). 
Medium and compound change was performed after 3 days. For live-cell labeling, cel ls 
were detached using EDTA (1 miVl), washed and centrifuged three times (PBS, 300 x G, 5 
min, 4 °C), resuspended in PBS and incubated in BCN-biotin 8 (60 1JIV1), Dl BO-biotin (60 
iJIVl), or buffer (1 h, 20 °C), washed three times (PBS, 300 X G, 2 min, 4 °C), resuspended 
in ice-cold PBS containing Alexa Fluor 488-conjugated streptavidin (5 IJg/ml, Invitrogen; 
final vo lume 200 IJil After incubation (30 min, 4 °C), cells were washed three times, 
resuspended in PBS (200 iJI , 4 °C) for further cell-function studies. 
Flow cytometry 
Flow cytometrywas performed on a BD Biosciences FACS-Ca libur f1ow cytometer using 
the 488 nm argon laser and data were analyzed with FCS Express version 3 research 
edition (De Novo Software, Los Angeles, CA). Per sample, 2x104 morphologically intact 
ce lls were analyzed in the presence of propidium idodide (2.5 IJg/ml). 
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Fluorescence intensities and cell viability after celllabelingwith Ac4 ManNAz and detection with Dl BO-or BeN-
biotin and secondary Alexa Fluor 488-conjugated streptavidin. (A) Mean intensities for green fluorescence 
(Alexa Fluor 488) and standard deviations (SD) from four independent experiments. (B) Intact cell viability 
after glycan labeling. Green fluorescence (Alexa Fluor 488) and propidium iodide (0 1) label. Numbers indicate 
the percentage of PI-negative, viable cells. 
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Procedure for confocal microscopy and 3D imaging of glycan redistribution during 
invasive cell migrations 
For confocal microscopy, azido-labeled cells were t-esuspended in normal culture 
medium, transferred to a 6 well plate and incubated for 30 min at 37 oc. Life cell imaging 
of MV3 cells was performed on a Olympus FV1000 confocal laser scanning microscope 
using excitation at 488 nm and emission detection of 520/50 nm. 
Distt-ibution studies of azido sialic acids were performed in 30 cell migration assays. 
Labeled MV3 cells were incorporated into 30 collagen I lattices and incubated for 90 min 
at 3JCC, subsequently ftxed w ith paraformaldehyde (4% in 0.1 M phosphate buffet-) for 
30 min at 37 oc and washed three times (PBS). Finally F-actin was stained with phalloidin 
Alexa Fluor 568 (Invitrogen, 2 U/ml) and nucleus with DAPI (Roche Diagnostics, 2,5 ~g/ 
ml). 
Imaging of MV3 cells was performed as described above, using an additional excitation 
at 559 nm and emission detection of 647 nm and excitation at 405 nm and emission 
detection of 422 nm. 
Pixel densitometry 
a) b)255 ~;:::'.::.NA' J ~j ~ 
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' · Cell 
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c) 
Intensity measurements of sialic acid and F-actin distribution at the cell surface. a) Region of interest for 
densitometric analysis. Bar 2 ~Ill. b) Fluorescence intensity for sialic acid and F-actin from the leading to trailing 
edge. c) Two-channel detail of the lead ing pseudopod, revealing partial colocalization (yellow) in the sub-micron 
range. Asterisk, sialic acid containing deposited cell surface material. Bar 2 ~Ill. 
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Abstract 
Tumor development is marked by alterations in glycosylation patterns but the 
functional significance of glycosylation in biological processes including cell 
adhesion and migration is not well understood. Over the last decades technologies 
have been developed to perturb glycan biosynthesis and address their functional 
role. However, tools like natural inhibitors are often limited in their utility due to 
their impact on intracellular glycosylation and their strong off-target effects. There 
is a strong need for tools that allow the study of the dynamics in glycan functions 
that can be met in complex biological systems. We here introduce a protocol for 
the efficient enzymatic digestion of cell surface glycosylation using a two-step 
procedure that allows a separate digestion of distinct glycan epitopes using high-
purity glycosidases while maintaining cell viability and integrity. Furthermore, we 
describe procedures for detecting the successful digestion of enzyme-selected 
glycan chains and moieties using antibodies, lectins and bioorthogonal labeling. 
Excellent cellular viability was maintained after applying the approach to the cells, 
which allows the subsequent functional analyses of targeted glycans and their roles 
in dynamic biological contexts such as cell adhesion and migration. 
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Introduction 
Glycosylation of proteins is one of the most important posttranslational modifications, 
with more than half of all human proteins estimated to be glycosylated.111 Cell surface 
glycans are components of glycoproteins, glycolipids, and proteoglycans, forming an outer 
layer of a phylogenetically old and molecularly complex scaffold, the so-called glycocalyx. 
These biopolymers play key roles in numerous biological processesl21 such as cell-cell 
and cell-matrix interactions involved in embryonic developmentl3 1, leukocyte homing141, 
adhesion, migration and invasion.151 Furthermor-e, glycans serve additional functions 
including modulation of protein structure, sorting and targeting of proteins within the 
cell and modulation of enzyme activity. 161 An increasing number of studies attempt to 
determine the molecular glycan-mediated mechanisms that underlie these processes, 
but the wide range of functions and contrasting results make a comparative evaluation 
often a challenge. For example high expression of some glycosyl epitopes promotes 
invasion and metastasis, leading to shorter 5-10 year survival rates of patients, whereas 
expr-ession of some other glycosyl epitopes suppresses tumor progression, leading to 
higher postoperative survival rates_l71 In recent decades increasing progress has been 
made in the development of analytical tools for the study of cellular glycosylation and 
corresponding defects, including high performance anion-exchange chromatography 
of glycans after deglycosylation and purificationl81 or mass spectrometry.19J Using these 
techniques it has become possible to screen patient material from complex cell lysates 
or bodily fluids and detect potential glycosylation anomalies and thereby identify new 
clinical biomarkers. Regrettably, analyzing glycans in living systems is a challenge for 
which these experimental approaches are not suited, as they provide only a snapshot of 
glycosylation at a certain state. Tumor development including invasion and metastasis 
is an extremely complex and dynamic process, that requires a steadily adaptation of 
cells in response to environmental determinants, including availability of nutrients and 
accessibility of ligands within the tissue. Thus, it is difficult if not even impossible to study 
the context dependent functions of glycosylation dur-ing tumor progression in isolation. 
Rather a means is required to study these biopolymers both as individual glycans and 
glycan ensembles in physiologically relevant context to relate this impact. Consequently, 
efforts have been made to investigate potential functions of glycosylation in living 
systems, such as perturbing glycan strategies using small molecule inhibitors of glycan 
biosynthesis that target glycosyltransferases. Natural inhibitors including tunicamycin 
block the biosynthesis of N-linked glycan precursors11cr and serve as useful tool for 
efficient inhibition of glycosylation in biological systems as it is selective for its target 
and active in living cells. Tunicamycin has been widely employed to study the effects 
of glycosylation on protein function.1111 However, the use of tunicamycin is limited as it 
interferes also with intracellular glycosylation and feature strong off-target effects.llla·c 
121 Thus, an induced impact on cellular function cannot be correlated to missing glycan 
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residues on the cell surface but might result from an affected intracellular mechanism 
that depends on accessible N-glycosylation. Recently, new inhibitors and approaches 
including modifled sugars known as "primers of glycosylation" have been developed 
that are supposed to disrupt glycosy lation in a more reflned fashion than tunicamycin. 
1131 However, there are more than 100 glycosyltransfer·ase families predicted in 
mammalians1141 w ith structura l homology and functiona l overlap wh ich makes inhibition 
of individual glycosyltransferases still a challenge. Approaches that use enzymes, 
including exo- and endoglycosidases to interfere w ith ce ll surface glycosylation have 
r·eceived more attention during the last years. However, in most of the enzymes often 
require reaction milieus with pH values and buffer conditions that are inappropriate for 
functional studies in live ce ll s.l 15 1 Nevertheless, in case one could optimize that appmach 
for· an application in living syst ems, the spatial orientation of glycosidase treatment to 
the ce ll surface through externally administered enzymes, makes such an approach the 
most promising tool to study the funct ion of cell surface glycans while largely maintaining 
intracellular glycosylation and accompan ied mechanisms such as protein conformation 
and stability.1161 We developed an approach for enzymatic digestion of the main part of 
cell surface glycan chains and moieties while retaining cell viability. Aim was to generate 
a protocol that combines opt imal enzyme efflcacy with a mild treatment of cells under 
physiological conditions to maintain cellular integrity. We achieved optimal enzyme 
cond itions by decreasing the serum concentration in the incubation medium, that 
contains amongst growth factors also proteolytically active enzymes and inhibitors1171 
to a level that compromi ses it s potential impact on enzyme activity1181 while providing 
crucial ingredients requ ired for ce ll survival. Using high-purity glycosidases enables a 
targeted enzymatic treatment and thereby allows the incubation under conditions that 
can be tolerated by cells. Furthermore, incubation w ith high purity enzymes in a two-step 
procedure allows a separate digestion of distinct glycan epitopes that is prerequisite for 
a selective analysis of their functions. We developed this approach with the purpose 
to provide evidences for a direct relation between the glycoca lyx polarity and integrin 
independent cell adhesion to co llagen I flbers. To perform these studies, cells need an 
exce llent viability to deflne a functional i mpair·ment as a result of a degraded glycan chain 
or moiety and not of the treatment. We contmlled the cell viabil ity using propidium 
iod ide (PI). When applying the digestion protocol, the targeted glycan classes and 
moieties were efflciently removed from the cell surface with more than 95 %decrease 
in signa l as approved by staining procedures using glycan targeting antibodies, lectins 
and bioorthogonal labeling. The epitope speciflcity of the glycosidases was approved 
using lectins recognizing glycan residues that were not addressed by the used enzymes. 
Finally, this protocol could be implemented into functional assays to study the mle of the 
glycoca lyx in cell adhesion and migration in vitro and in vivo. The here presented strategy 
pmvides an innovative tool to interfere spatially with ce ll surface glycosylation using 
high-purity glycosidases for an efficient and selective digestion of individual and multiple 
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glycans. Furthermore, it facilitates subsequent functional analyses of targeted glycans in 
dynamic biological contexts such as cell adhesion and migration. 
Materials 
Reagents 
• Fetal bovine serum (FBS, PAA Laboratories, Cat. No. A15-101) 
RPMI1640 (1x, liquid, GlutaMAX, 2,000 mg/L 0-glucose, Gibco, Cat. No. 
21875-034) 
• L-glutamine (4 mM, 100x; PAN, Cat. No. P04-80100) 
• Penicillin (10,000 U/ml)- streptomycin (10,000 1-Jg/ml) (100x, Gibco, Cat. No. 
15140-122) 
• Sodium pyruvate (1 mM, Invitrogen, Cat. No. 11360) 
Phosphate-buffered saline containing Ca2 +and Mg2 + (PBS) (1x, Gibco, Cat. 
No. 14040-117) 
• EOTA (1M; PAN Biotech, Cat. No. P10-026500) 
• 3,8-0iamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium-
diiodide (PI) (50 mg/ml, Sigma Aldrich, Cat. No. P4170) 
• Hyaluronidase from bovine testes, Type 1-S (275-550 U/ml, Sigma-Aldr-ich, Cat. 
No. H9910) hydrolyzes 1,4-linkages between N-acetyl-~-0-glucosamine and 
0-glucuronate residues in hyaluronate. 
Heparitinase I from Flavobacterium heparinum (10 mU/ml, Seikagaku, Cat. 
No. 100704) hydrolyses a-N-acetyl /-sulfo-0-glucosaminidic linkage in 
heparansulfate and reacts with chondroitin sulphate A ( 0.1 %), B ( 1.0 %), C (0.1 
%), Hyaluronic acid ( 0.1 %) and Heparin ( 1.0 %). 
Chondroitinase ABC from Proteus vulgaris (100 mU/ml, Sigma-Aldrich, Cat. 
No. C3667) acts on chondroitin 4-sulfate, chondroitin 6-sulfate, and dermatan 
sulfate and acts slowly on hyaluronate. 
• Neuraminidase from Clostridium perfringens (C. welchii), Type V (100 mU/ 
ml, Sigma-Aldrich, Cat. No. N2876) cleaves terminal sialic acid residues which 
are a-2,3- a-2,6- or a-2,8-linked to Gal, GlcNac, GaiNAc, AcNeu, GlcNeu, 
oligosaccharides, glycolipids or glycoproteins. 
• ~-1,4 galactosidase (150 mU/ml, QA-Bio, Cat. No. E-BG07), recognizes 
specifically non-reduced terminal ~-1,4-galactose. According to the 
manufacturer, the production host strain has been extensively tested and does 
not produce any other detectable glycosidases. 
• Anti-heparan sulfate (HS) single chain Fv fragment-vsv-g-tag antibodies 
(HS4C3)1 20 1 
Anti-dermatan sulfate (OS) single chain Fv fragment-vsv-g-tag antibodies 
(LKN 1)12ob, 211 
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• Anti-chondroitin sulfate (CS) single chain Fv fragment-vdv-g-tag antibody 
(103H 10)I20b22l 
• Monoclonal mouse anti-vsv-g (clone P5D4) lgG (Sigma-Aldrich, Cat. No. V5507) 
• Goat-anti-mouse lgG Alexa Fluor 488-conjugated antibody (2 mg/ml, Invitrogen, 
Cat. No. A-11029) 
Peracetylated N-azidoacethylmannosamine (Ac4ManNAz, 50 mM stock in 
DMSO, Sigma-Aldrich, Cat. No. A-7605) CRITICAL Store at -20 oc or -80°C 
Biotin-conjugated Bicyclo [6.1.0] nonyne (BCN-POE3-NH-biotin, 10 mM stock 
in MilliQ, SynAfflx, Oss, The Netherlands) CRITICAL Stor-e at -20°C. 
• Alexa Fluor488-conjugated Streptavidin (2 mg/ml, Invitrogen, Life Technologies, 
Carlsbad, USA, Cat. No. S32354) CRITICAL Store at-20°C. 
• Biotin-conjugated Maackia amurensis agglutinin (MAA) (1 mg/ml, EY 
Laboratories, INC., Cat. No. BA-7801-5) CRITICAL Store at -20°C. 
• FITC-conjugated Arachis hypogaea (peanut) Agglutinin (PNA) (5 mg/ml, Sigma 
Aldrich, Cat. No. L7381) CRITICAL Store at-20°C. 
Human MV3 melanoma (provided by G. van Muijen, Dept. of Pathology, 
RadboudUMC Nijmegen, The Netherlands) 
• Human T-leukemia cell-line Molt-4 (ACC362; DSMZ Braunschweig, Germany) 
• Human MV3 melanoma (provided by G. van Muijen, Dept. of Pathology, 
RadboudUMC Nijmegen, The Netherlands)i231 
• Human T-leukemia cell-line Molt-4 (ACC362; DSMZ Braunschweig, Germany) 
Equipment 
• FACS-Calibur (BD Biosciences, Erembodegem, Belgium) flow cytometer, 488 nm 
line argon ion laser, emission 530/40 (Alexa Fluor 488), 620/50 (PI) 
e FACS tubes (Micronic, Lelystad, The Netherlands, Cat. No. M32000) 
• Greiner CELLSTAR 96 round bottom well plates (Sigma Aldrich, Cat. No. M9311) 
• Flow cytometry analysis De Novo FCS 5.0 (De Novo Software, Glendale, USA) 
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Reagent Setup 
Cell detachment buffer (2 mM EDTN1xPBS, pH 7.4) Add 200 ~I EDTA to 98 ml PBS 
CRITICAL To prevent cleavage of protein cores and bound glycan chains of proteoglycans 
and glycoprote ins in an uncontrol led manner that may affect cell functions do not use 
trypsine for ce ll detachment. 
MV3 and Molt4 cell culture medium Add 50 ml FBS, 5 ml sodium pyruvate, 5 ml 
L-glutamine and 5 ml penicillin-streptomycin to 435 ml RPM 11640. The medium can be 
stored for several weeks at 4 oc. 
MV3 and Molt-4 low serum medium Add 5 ml FBS, 5 ml sod ium pyruvate, 5 ml 
L-glutamine and 5 ml penicillin-streptomycin to 435 ml RPMI 1640. The medium can be 
stored for several weeks at 4 oc CRITICAL To prevent proteolytic degradation of used 
glycosidases through serum-containing proteases, it is essential to administer serum 
only at low concentrations. 
Hyaluronidase digestion medium Weigh 2.75 mg hyaluronidase and add 5 ml low 
se rum medium yielding 275-550 U/ml CRITICAL Hyaluronidase digestion medium 
needs to be prepared freshly prior t o th e digestion experiment. 
Pre-cocktail digestion master-mix Add 4 ~I heparitinase (20 mU/ml), 2 ~I chondroitinase 
ABC (200 mU/ml) and 1.8 ~I neuraminidase (200 mU/ml) to 92,2 ~I hya luronidase 
digestion medium (100 ~I master-mix) 
Maxi-cocktail digestion master-mix Add 4 ~I heparitinase (20 mU/m l), 2 ~ I 
chondroitinase ABC (200 mU/ml), 1.8 ~I neuraminidase (200 mU/ml) and 10 ~I ~ - 1,4 
ga lactosidase (300 mU/ml) to 83,2 ~I hyaluronidase digestion medium (100 ~I master-
mix). 
CRITICAL Used enzyme volumes are two-fo ld administe red in the master-mix and will 
be finally di luted 1:2 with hya luronidase digestion medium including ce ll s to ach ieve 200 
~I digestion vo lume. To ensure that experiments are performed in a near-physiologica l 
environment, it is essent ial to maintain ce lls at 37 oc and physiologica l pH cond itions 
(7.4). Cont rol t he approximate pH prior to each treatment using indicator paper. 
Digestion control medium Add MilliQ at equal volumes to low seru m medium instead 
of master-mix enzymes. 
Heparan sulfate (HS) staining solutions Add 5 ~I HS4C3 to ~I PBS. 
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Dermatan sulphate (DS) staining solutions Add 20 fJ I LKN 1 to 80 fJ I PBS. 
Chondroitin sulphate (CS) staining solutions Add 20 fJII03H 10 to 80 fJI PBS. 
CRITICAL Keep all antibody solutions on ice. 
PSD41gG staining solution Add 10 fJI P5D41gG to 90 fJI PBS. 
Goat anti mouse- Alexa Fluor 4881gG staining solution Add 0.5 fJ I to 99.5 fJI PBS (10 
fJg/ml working solution). 
Ac4ManNAz incubation medium Add 1 fJI Ac4ManNAz to 999 fJI cell culture medium 
(50 fJM working solution). CRITICAL Medium needs to be prepared freshly on the day of 
administration and kept at 37 oc. 
BCN-biotin solution Add 6 fJI BCN-biotin to 994 fJI PBS (60 fJM working solution) 
CRITICAL Keep the solution at room temperature. 
Streptavidin- Alexa Fluor 488 staining solution Add 0.5 fJI Streptavidin- Alexa Fluor 
488 to 99.5 fJI PBS (10 fJg/ml working solution) CRITICAL Keep the solution temperature 
at 4 oc. 
MAA-biotin staining solution Add 10 fJI MAA-biotin to 90 fJI PBS (100 fJg/ml working 
solution) CRITICAL To minimize uptake of MAA by cells during the incubation period, it 
is essential to keep the solution temperature at 4 oc. 
PNA-FITC staining solution Pre-dilute the PNA-FITC stock solution in PBS to achieve a 
concentration of 1 mg/ml prior to the incubation expet-iment. Add 10 fJI MAA-biotin to 90 
fJI PBS (100 fJg/ml working solution) CRITICAL To minimize uptake of MAA and PNA by 
cells during the incubation period, it is essential to keep the solution temperature at 4 OC. 
Staining control solution Add MilliQ in equal volumes to PBS instead of antibodies, 
probes or lectins 
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Procedure 
Cell culture TIMING -1 h 
1 Culture MV3 and Molt-4 cells in cell culture medium (see REAGENT SETUP) in T75 
flasks at 37 °C, 5% C02" 
2 Passage cells 1:10 every third day at about 70% confluence, for MV3 cells according 
to the following protocol (Steps 3-6). For Molt-4 cells transfer 1 ml to a flask pre-
filled with 10 ml cell cultut-e medium. CRITICAL STEP Split the cells before they 
reach 70% confluency to prevent contact inhibition in adherent cells. 
3 Aspirate the cell culture medium, wash the cells with 10 ml PBS and aspirate to 
remove traces of old media. 
4 Harvest MV3 cells by incubation with 3 ml2 mM EDT A/PBS for about 2 min. 
5 Add 7 ml cell culture medium and transfer the cells into a 15-ml conical tube. 
6 Add 1 ml of the cell suspension into a new T75 flask pr-e-filled with 10 ml Hela cell 
culture medium. 
7 For metabolic labelling experiments, inoculate 2 x 105 cells in Ac4 ManNAz incubation 
medium (see REAGENT SETUP) in T25 flasks 72 h before the glycosidase digestion 
experiment PAUSE POINT Culture cells for 72 hat 37 oe, 5% C02' 
Preparation of cells for enzymatic digestion with glycosidase cocktails TIMING -1h 
8 At 1 h before the glycosidase digestion experiments, aspirate the MV3 cell culture 
medium from the T25 flasks (prepared in Step 6 and 7). Thereafter, briefly wash 
the cells with 5 ml PBS and aspirate to remove traces of old media. For Molt-4 cells 
transfer cells into a 15 ml conical tube and continue with step 11. 
9 Harvest MV3 cells by incubation with 3 ml 2 mM EDT A/PBS for about 2 min. 
10 Add 3 ml cell digestion medium (see REAGENT SETUP) in T75 and T25 flasks and 
transfer the cells into a 15 ml conical tube. 
11 Spin down the cells by centrifugation at 400g for 5 min, room temperature. 
12 Carefully remove the supernatant and resuspend the cells in digestion medium (for 
control cells) or Hyaluronidase digestion medium (for digestion cells) 
13 Repeat steps 11 and 12 once CRITICAL STEP Wash cells carefully to dispose 
residual compounds from the cell culture medium including 10% FBS. 
14 Resuspend cells in digestion medium (for control cells) or Hyaluronidase digestion 
medium (for digestion cells) (see REAGENT SETUP), count them using a Neubauer 
counting chamber and adjust the cel l number to 5 x 105 cells/ml in 15 ml conical 
tubes. 
83 
C: HAPTER.4 
Enzymatic digestion with glycosidase cocktails TIMING -6 1/ 2 h 
15 Transfe r 100 f.JI Pre-cocktail und Maxi-cocktail master-mix (see REAGENT SETUP) 
into each conical Eppendorf tube. For Control cell s transfer 100 f.JI digestion control 
medium (see REAGENT SETUP) into each conical Eppendorf tube. 
16 Add 100 f.JI cell suspension (Step 14) to each conical Eppendorf tube. 
17 Cover the upper side of the Eppendorf tubes w ith parafilm and prick in a tiny hole 
w ith a needle or a ye llow pipette tip CRITICAL STEP The perforated parafilm allows 
sufficient gas exchange for oxygenation, thus avoid closing the tubes w ith the plastic 
lid. 
18 Incubate the cells for 6 hat 37 °C, 5% COT Mix the ce ll suspension every 2 h gently 
with a pipette and place them immediately back in the incubator. Prevent air-bubbl es 
CRITICAL STEP Every 2 h t ransfer a drop of cell suspension from each tube on an 
object slide and mount it on a light microscope. Monitor ce ll s in digestion medium 
and compare them carefully with the control cells regard ing ce ll morphology. 
Preparation of cells for immuno-stainings and confocal microscopy TIMING -40 min 
19 Transfer the cell suspensions into 96 well plates wit h round bottom. 
20 Spin down the ce ll s by centt-ifugation at 400g for 5 min, room temperature. 
21 Carefully remove the supernatant and resuspend the ce lls in PBS. 
22 Repeat steps 20 and 21 three times CRITICAL STEP Wash ce ll s carefully to dispose 
residual compounds from the glycosidase cocktail med iu m. 
23 After the last centrifugation step remove the supernatant and continue with 24, 40 
or 51. 
Immuno-fluorescence with GAG recognizing antibodies TIMING -21f2 h 
24 Transfer the 1st ant ibody HS, DS and CS staining solutions (see REAG ENT SETUP) 
to the appropriate wells on the 96 well plate (prepared in steps 19-23). Fo r Control 
ce ll s transfer the staining contro l solution with appropriate vo lume (see REAGENT 
SETUP). 
25 Incubate the cells for 45 min at 20°C. 
26 Spin down the cells by centrifugation at 400g for 5 min, room temperature. 
27 Carefu lly remove the supernatant and resuspend the ce lls in PBS. 
28 Repeat steps 26 and 27 tw ice CRITICAL STEP Repeating the steps is essent ial to 
dispose antibody residuals. 
29 Transfer the 2nd ant ibody P5D4 1gG sta ining solution (see REAGENT SETUP) to the 
appropriate wells on the 96 we ll plate. 
30 Incubate the cells for 30 min at 4°C on ice. 
31 Spin down the cells by centrifugat ion at 400gfor 5 min, 4°C. 
32 Carefully remove the supernatant and resuspend the ce ll s in PBS. 
33 Repeat steps 31 and 32 twice. 
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34 Transfer the 3rd antibody Goat anti mouse- Alexa Fluor 488 lgG staining solution 
(see REAG ENT SETU P) to t he appropriate wells on th e 96 we ll plate. 
35 Incubate the cells for 30 min at 4°C on ice CRITICAL STEP Cover the tubes with 
aluminiu m fo il to keep them dark and prevent photo-bleaching. 
36 Spin down the cells by centrifugation at 400g for 5 min, 4°C. 
37 Carefully remove the supernatant and resuspend the ce lls in PBS. 
38 Repeat steps 36 and 37 tw ice. 
39 After the last centrifugation step, resuspend the ce lls in cold PBS, transfer the ce ll s 
into coni ca l FACS tubes, put t hem on ice and continue with step 62 CRITICAL STEP 
Cover the tubes with aluminium foil to keep them dal-k and prevent photo-bleaching. 
Bioothogonallabelling of SiaNAz using strain-promoted alkyne-azide cycle-
addition (SPAAC)l24l TIMING -2 h 
40 Transfer the BCN-biotin solution (see REAG ENT SETUP) to the appropriate we lls 
on t he 96 we ll plate (prepared in steps 19-23). For Control ce lls transfer t he staining 
contro l solut ion w ith appropriate vo lume (see REAG ENT SETUP). 
41 Incubate the ce ll s for 1 h at room temperature. 
42 Spin down the ce ll s by centrifugation at 400g for 5 min, room tempel-ature. 
43 Carefully re move the supernatant and resu spend the cells in PBS. 
44 Repeat steps 42 and 43 twice CRITICAL STEP Repeating the steps is essential t o 
dispose ant ibody resid ua ls. 
45 Transfer the St reptavid in- Alexa Fluor 488 stai ning solution (see REAGE NT SETUP) 
to the appropriate wells on the 96 well plate. 
46 Incubate t he ce ll s for 30 min at 4°C on ice CRITICAL STEP Cover t he tubes w it h 
aluminium foil to keep them dark and prevent photo-bleaching. 
47 Spin down the cell s by centr ifugat ion at 400 g for 5 min, 4°C. 
48 Carefully remove the supernatant and resuspend the cells in PBS. 
49 Repeat steps 42 and 43 twice. 
50 After the last centrifugation step, resuspend the cells in co ld PBS, t ra nsfer the cell s 
into con ica l FACS tubes, put them on ice and continue w ith step 62 CRITICAL STEP 
Cover the t ubes with aluminium foi l to keep them dark and prevent photo-b leaching. 
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Fluorescence with Galj3-1,4 recognizing Maackia amurensis agglutinin and Gall3-1,3 
GaiNAc recognizing Arachis hypogaea (peanut) agglutinin TIMING- 2 h 
51 Transfer the MAA-biot in and PNA-FITC staining solution (see REAGENT SETUP) to 
the appropr-iate wells on the 96 well plate (prepared in steps 19-23). For Control 
cells transfer the staining control solution w ith appropriate volume (see REAG ENT 
SETUP). 
52 Incubate the cells for 20 min at 4°C on ice. 
53 Spin down the cells by cent rifugation at 400 g for 5 min, 4 oc. 
54 Carefully remove the supernatant and resuspend the ce lls in PBS. 
55 Repeat steps 52 and 53 twice CRITICAL STEP Repeating the steps is essential to 
dispose antibody residuals. 
56 Transfer the Streptavidin- Alexa Fluor 488 staining so lution (see REAGENT SETUP) 
to the appropriate wells on the 96 well plate. 
57 Incubate the cells for 30 min at 4°C on ice CRITICAL STEP Cover the tubes with 
aluminium foil to keep them dark and prevent photo-bleaching. 
58 Spin down the cells by centrifugation at 400 g for 5 min, 4°C. 
59 Carefu lly remove the supernatant and resuspend the ce lls in PBS. 
60 Repeat steps 57 and 58 twice. 
61 After the last centrifugati on step, resuspend the cells in cold PBS, transfer the cells 
into conical FACS tubes, put them on ice and continue with step 62 CRITICAL STEP 
Cover the tubes with aluminum foil and keep them dark to prevent photo-bleaching. 
Flow cytometry TIMING -1 h 
62 Add propidium iodide (PI) to each FACS tube shortly before the measurement w ith a 
ftnal concentration of 2.5 iJg/ml. Mix cell suspension gently CRITICAL STEP PI needs 
to be added to each tube independently, because it is potentially toxic by intercalating 
into the DNA in small amounts and harming replicating I dividing cells. 
63 Perfor-m measurements with the appropriate parameters (488 nm line argon ion 
lase r, emission 530/40 (Alexa Fluor 488), 620/50 (PI)). 
64 At the end export the datasets for data analysis. 
Data analysis of flow cytometry experiments TIMING -2 h 
65 Import datasets, usually as fsc format, in analysis software, e.g. FCS Express and 
perform data analysis. 
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Timing 
Steps 1-7, Ce ll culture: 1 h 
Step 8-14, Preparation of ce ll s for enzymatic digestion wit h glycosidase cocktails: 1 h 
Step 15-18, Enzymatic digestion with glycosidase cocktai ls: - 6 1/ 2 h 
Step 19-23, Preparation of ce ll s for immuno-sta inings:- 40 min 
Step 24-39, lmmuno-sta inings with GAG recognizing antibod ies:- 2 1/ 2 h 
Step 40-50, Bioorthogonallabelling of SiaNAz using SPAAC:- 2 h 
Step 51-61, lmmuno-stainings with Ga l ~-1,4 recognizing Maackia amurensis agglutinin 
and Arachis hypogaea (peanut) agglutinin recognizing Gal ~-1,3 GaiNAc:- 2 h 
Step 62-64, Flow cytometry: - 1 h 
Step 65, Data analysis of flow cytometry experiments:- 2 h 
T rou bleshooti ng 
Troubleshooting advice can be found in Table 1. 
Step • Problem ' Possible reason 
18 • Cell s do ' Cells are sensitive t o the 
• not appear ' treatment (low serum, 
• hea lthy during ' long incubat ion, enzyme 
• the incubation . cocktail s) 
~1 - • Glycan 
61 removal 
' incomplete 
Cell s express different or 
addit ional glycan residues 
- e.g. in response to cell 
culture environmental 
cues·)a 
· Solution 
• Prepare a t ime se ries, e.g. 2 h, 4 h, 6 hand monitor 
• the cells careful ly at each time point. Alternatively, 
' reduce the glycosidase concentration fo r a certain 
• enzyme or for the co mplete enzyme collection or 
increase the serum concentration. Primary cells 
· such as activated T ce ll s or primary nbroblasts but 
• also cell lines that experienced add itional stress e.g. 
in a transfection procedure prior to the glycosidase 
· treatment may react to t he slightest changes in 
' culture conditions. 
' Prepare a separate staining procedure using an 
appropriate lect in or modified sugar for metabolic 
label ing. Some glycosidases do not digest the t arget 
. sugar at all or not effic iently. ~-1,4 Galactosidase wi ll 
• not digest ~- 1,4 coupled ga lactose if t he adjacent 
. sugar, N-acetyl-glycosam ine (GicNAc) comprises an 
· 1-3 glycosidic bond to L-Fucose, commonly found 
in sialyl Lewis' or Lewis' .1 251 We recommend to stain 
- either with sia lyl Lewis' recognizing A/euria aurantia 
agglutinin (AAA) or Lotus tetragono/obus agglutinin 
(LTL-A) which recognises Lewis'•26' Alternatively 
- perform a bioorthogonal labell ing assay using 
6-azido-Fucose to determine the fucosylat ion 
' status of the used cell s_l271 
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Anticipated Results 
One should note that the glycocalyx composition is not uniform among cell types and 
hence expression levels of certain glycan chains show enormous variations. This was 
shown particularly for the glycosaminoglycans (GAGs) on MV3 and Molt-4 cells (Fig. 
1a, b). When measuring the expression patterns of surface glycans on cells to approve 
the digestion of cell surface glycan chains and moieties, fluorescence signals measured 
by flow cytometry showed an efficient decrease in intensity. The digestion efficiency 
exceeded 90% for the applied glycosidases in most cases (Fig. 1, 2, blue and green curves/ 
bars) while maintaining excellent cell viability as approved by staining with propidium 
iodide (PI) (Fig. 2b). The successfui digestion of glycosaminoglycans and sialic acids (Fig. 
1a, b) could be additionally validated by MAA and PNA (Fig. 2a, c, blue curves and bars). 
The increase of fluorescent signals is due to exposed non-reduced epitopes below the 
GAG layer and downstream of sialic acids that are accessible for the lectins. Furthermore, 
using PNA lectin, which recognizes an epitope different from the target sequences of the 
applied glycosidases approved the high purity of enzymes. As depicted in Fig. 2c, the PNA 
epitope Gal ~-1,3 GaiNAc was not digested, but rather more accessible for the lectins. 
This was even more pronounced after digestion with the ~-1,4 galactosidase (blue and 
green curves/bars). 
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Figures 
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Figure 1 
Enzymatic digestion and proflling of GAGs and sialic acids in MV3 and Molt-4 cells by flow cytometry. Cells were 
digested (step 15-18), stained with GAG recognizing antibodies (step 24-39) or bioorthogonallabeled using BCN 
for sialic acids (step 40-50) and measured by flow cytometry. (a) Flow cytometry histograms of one representative 
experiment; (b) Average intensities and standard errors (SEM) of three (MV3) and two (Molt-4) independent 
experiments. Statistical analysis was obtained by the non-paired, nonparametric Mann-Whitneyt-test. 
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Figure 2 
Enzymatic digestion and proflling of Gal ~-1,4, Gal ~-1,3 GaiNAc and viability in MV3 and Molt-4 cells by flow 
cytometry. Cells were digested (step 15-18), stained with MAA or PNA lectin (step 51-61) or and measured by 
flow cytometry. (a) MAA flow cytometry histograms of one representative experiment and corresponding bar 
diagrams for average intensities and standard errors (SEM) of three independent experiments; (b) Scatterplot 
presenting the distribution of alive and dead cells after enzyme treatment and administration of propidium 
iodide (PI). Mean percentage of cell viability and standard deviations (SO) of three independent experiments. 
(c) PNA flow cytometry histograms of one representative experiment and corresponding bar diagrams 
for average intensities and standard errors (SEM) of two independent experiments. Statistical analysis was 
obtained by the non-paired, nonparametric Mann-Whitneyt-test. 
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Abstract 
The migration of cells through the extracellular matrix (ECM) of tissues and organs 
critically contributes to morphogenesis, tissue repair and, in its deregulated form, 
cancer invasion and metastasis. Adhesion molecules of the integrin family are the 
dominant cell system to bind extracellular matrix proteins and generate force for 
migration1•2• In addition, experimental models which disable integrin function have 
revealed alternative low-adhesive types of mechanotransduction that can sustain 
cell movement3-6, however the organization of integrin-independent adhesion sites 
and their mechanisms for force coupling remain unclear. Using multi-enzymatic 
digestion of sugar moieties on the surface of mesenchymal cells after interference 
with integrin function as well as on leukocytes that intrinsically migrate integrin-
independently, we show that the surface glycocalyx generates cell attachment 
to ECM ligands in the 100-500 pN force range and mediates amoeboid migration 
in 30 ECM-based models in vitro and in vivo. By combining glycan removal with 
30 confocal and electron microscopy, identified glycan-based adhesions consist 
of actin-rich complex-shaped imprint-like membrane appositions along ECM 
topologies associated with filopods and bleb-like interactions. The data suggest 
that, by shape-adaptive scaffolding combined with generic stickiness, the glycocalyx 
mediates multivalent nanotopologies between the cell surface and ECM to enable 
mechanocoupling and cell migration. Because integrin- and glycan-mediated 
mechanotransduction occur in parallel modulation of each adhesion system may 
adjust cell-matrix interaction and migration programs, including the mesenchymal-
to-amoeboid transition. 
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To mediate cell migration across surfaces, integrins form transient focalized actin-
containing adhesion and signalling complexes that provide mechanotransduction as 
well as intracellular signals that control cytoskeletal organization, cell shape, and gene 
expression 1·2710. In cancer metastasis, integrins mediate cell invasion and represent 
candidate targets for pharmacological interference81113. In contrast to 2D migration 
models, interference with ~1 integrin function in 3D models, where cells migrate through 
substrate of complex geometry and confinement, provides only incomplete inhibition of 
migration, depending on the cell model.6·1417 We thus aimed to identify the cellular and 
molecular mechanisms of integrin-independent cell-matrix interaction, force generation, 
and migration within interstitial tissue in vitro and in vivo. 
Fibrillar collagen is the predominant scaffold in mammalian tissues recognized with high 
affinity by integrins a1~1, a2~1, and a11~1, and weakly by aV~3 10· 18 . Invasive MV3 
melanoma cells express ~1 and aV but lack all other integrin ~-chains (Extended Data Fig. 
1a, h). MV3 cells utilize a2~1 integrins for efficient migration within 3D collagen lattices9 
and for collagen matrix remodeling19·20. The majority of MV3 cells is elongated and 
spindle-shaped dur-ing migration at speeds similar to in vivo movement of mesenchymal 
cells 20, yet a fraction (10-20 %) fails to elongate during migration (Extended Data Fig. 
1b, dashed box). Graded interference with ~1 integr-ins either by adhesion-perturbing 
mAb 484 at concentrations saturating the epitope up to 90% (Extended Data Fig. 1c-e) 
or by stable ~1/~3 integrin downregulation with an efficiency between 93% (Extended 
Data Fig. 1f, westernblot) and 99% demonstrated by antibody competition followed 
by flow cytometry (Extended Data Fig. 1g) reduced migration rates but failed to cause 
immobilization, so that most cells continued to move at lower speed and partially 
reduced directional persistence (Fig. 1a, Extended Data Fig. 2a, b). Interference with ~1 
integrins further caused changes in how the cells were moving. First, the spindle-shaped, 
elongated morphology was abandoned and an ellipsoid shape with multiple dynamic 
blebs and few filopodia at the surface was gained (Fig. 1b). Second, focalized ~1 integrin 
and filamentous actin at sites of interaction with collagen fibres converted towards 
cortical diffuse distribution when ~1 integrins wer-e inhibited using mAb 484 (Fig. 1b, 
arrowheads). Third, interference with ~1 integrin impaired the ability to contract free-
floating collagen lattices, which is a measure for tr-action force in 3D ECM (Extended Data 
Fig. 2c). Abrogated matrix contraction and cell elongation were concurrent, suggesting 
that impaired traction force and cell rounding during migration were coupled. 
These findings support concepts that mammalian cells maintain different molecular 
motility programs 12·21. Mesenchymal migration of fibroblasts and some cancer cell types 
results from elongated spindle-shaped morphology, focalized adhesion sites, and high 
traction force towards the ECM 7912. Conversely, amoeboid migration displayed by 
leukocytes and other cells generates weak mechanotransduction by means of poorly 
focalized adhesion sites and actin cytoskeleton6·142123. 
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Fig. 1 Conversion to amoeboid migration in mesenchymal tumor cells and fibroblasts after interference 
with integrins. 
(a-c) Mesenchymal-amoeboid transition in MV3 melanoma cells after interference with ~1 integrin function 
using anti-~1 integrin mAb 4B4. (a) Speed change with increasing doses of mAb 4B4. Data show the population 
speed obtained by single cell tracking for an 18h observation period (120 cells, 3 independent experiments). (b) 
Cell morphology, F-actin and ~1 integrin distribution (arrowheads )for control and mAb4B4 treatment condition. 
Arrows, direction of migration, based on retraction fibres from the cell rear (asterisks). (c-d) Mesenchymal-
amoeboid transition in murine embryonic iibroblasts after interference with ~1 integrin function. Amoeboid 
migration in ~1-deiicient embryonic murir,e iibroblasts. (c) Migration speed and (d) morphology of wild-type 
and ~1-/- MEFs. Bars (b), 10 ~m. F-act in (red, grey insets), collagen iibres (green; reflection), and constriction 
rings (arrowheads). Bars (d), 100 ~m. (e-f) Constitutive amoeboid migration in human Molt-41eukemia cells in 
control cells and after interference with ~1 and ~3 integrin function using mAb 4B4 and cyclic RGD (eRGO). 
Migration speed (e) and morphology (f) of Molt-4 control cells and in the presence of ~1 and eRGO. F-act in (red, 
grey insets), collagen iibres (green; reflection) and direction of migration (arrows). Bars, 20 ~rn. 
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~1-/- MEFs employed a rounded amoeboid migration type with increased speed, 
compared with ~1 +/+(f1/f1) M EFs (Fig. 1c, d), slightly diminished directional persistence 
(Extended Data Fig. 2d, e) and impaired ability to generate traction force in 3D ECM 
(Extended Data Fig. 2f). This amoeboid phenotype in ~1-/- M EFs was reversible 
after reintroduction of ~1 integrin (Extended Data Fig. 2g, h), suggesting amoeboid-
mesenchymal transitions as a direct function of ~11evels. 
As confirmatory model, integrin-independent migration of human T-leukemia cells 
(Molt-4) was equally amoeboid with rounded shape and an elongated uropod in both, 
control cells and interfering with ~1 and aV integrins using mAb 484 and cRGD (Fig. 1f, 
Extended Data Fig. 2i,j) with similar migration speeds (Fig. 1e). 
These results confirm for 3D fibrillar collagen that eukaryotic cells posses largely 
integrin-independent interaction mechanisms to maintain migration. The expression of 
a set of alternative collagen receptors 24.29 , that might compensate the loss of integrin-
mediated adhesion and migration was measured in MV3, including syndecan-4 (SDC-
4), discoidin domain receptors (DDR) 1 and 2 and proteoglycan CD44. DDR-1 and 
-2 or SDC-4 were not expressed by MV3 cells (Extended data Fig.3a) and CD44 was 
expressed, however CD44 perturbing antibody did not affect the migration of MV3 cells 
in 3D fibrillar collagen 9 (Extended data Fig.3b), excluding these known collagen receptors 
as to mediate amoeboid movement in these cells. 
In contrast to mammalian cells which express integrins together with ECM proteins, 
the lower eukaryote Dictyostelium discoideum is an amoeba without known collagen 
receptor-30.33, which interacts with surr-ounding substrates via a ce llulose-based surface 
coat (,s lime") 34. As a 'natural' model of collagen receptor-independent movement, D. 
discoideum efficiently migrates into and within 30 collagen lattices (Extended data 
Fig.3c,d). We thus hypothesized that non-specific low-affinity interaction with collagen 
fibres could result from surface glycans 35·37 or even non-adhesive cell extensions and 
shape change38. 
In mammalian cells, the glycocalyx forms a thick, polar layer39·40 , which is composed of 
var ious classes of glycoconjugates, including glycosaminoglycan (GAG) chains of the 
proteoglycans heparan sulfate, chondroitin sulfate, dermatan sulfate as well as N-and 
0- linked glycans of the glycoproteins and glycolipids coupled to the cell membrane 
(Extended data Fig. Sa). Highly sulfated glycoconjugate side chains of proteoglycans 
are known to interact with EC M components, including fibrillar collagen 35·36.4 1. MV3 
cells expressed an about 200 nm th ick glycan layer at the cell surface (Fig. 2a, b) but 
depending on the cell type the glycocalyx may reach hundreds of nanometers up to 
several micrometers in thickness4 2·45. 
To address the role of surface glycans in cell migration, protein- and lipid-linked 
glycoconjugates were enzymatically removed from the surface of live cells by using a 
cocktail of glycosidases, including GAG digesting enzymes hyaluronidase, heparitinase, 
chondoritinase, neuraminidase and galactosidase recognizing ~-1,4 coupled galactose 
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residues in N- and 0-linked glycans and glycolipids. The enzymatic digestion of GAG 
chains lowered heparan- and chondr-oitin sulfate by ~98% and dermatan sulfate by 
~95% (Extended data Fig. 5g), which together with sialic acid removal by neuraminidase 
resulted in an exposure of subjacent [3-1,4 coupled galactose residues (Fig. 2d, Extended 
data Fig. 5 d, PIN). Additional treatment with [3 1-4 galactosidase removed [3 1-4 coupled 
galactose by >90% in MV3 [31/[33KD, >98% MEF [31-/- and >94% Molt-4 cells without 
negative impact on cell viability (Extended data Fig. 5 d). The loss of cell surface [3-1,4 
galactose was maintained for at least 6-9h (MV3), 24-92 h (M EF [31-/-) and 5-6 h (Molt-
4) followed by a stepwise r-ecovery (Extended data Fig. 5 e, f). 
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(a) Transmission electron microscopy and quantitative image densitometry (b) of the glycocalyx thickness. 
MV3 ~1~3KD cells before and after glycan removal with P/N/G glycosidase cocktail. Detection of surface 
glycans with Ruthenium red. Bars, 1 f.JIIl (left), 1 !Jill (middle). 200 mn (right). (a) Blue dot, position of the plasma 
membrane. Dashed lines, cross-sections perpendicular to the plasma membrane used for image analysis 
from 10 cells of 2 independent experiments (see densitometry proflles in Extended data Fig. 5b). P values, 
non-paired Mann-Whitney test for independent means. (c) Population-based analysis of digestion efficacy of 
glycans moities on the surface of living MV3, ~1-/- Mef and Molt-4 cells. ~-1.4 galactose was detected with 
Maackia amurensis agglutinin and fluorescence intensity was assessed by flow cytometry (means and SD from 
3 independent experiments). (d) Live-cell atomic force microscopy and spectroscopy. Interaction forces of 
MV3 control cells and cell after ~1/~3 KD and additional treatment with P/N/G glycosidase treatment to a 
fibrillar collagen I surface after 0.5 s or 20 s interaction time. Pooled median values of maximum retraction 
forces shown as Log F,"for 21 (Collagen I) and 15 cells (BSA) from3 independent experiments. Data sets were 
compared usingANOVA followed by post-hoc Bonferroni correction. Bar, 20!Jm. 
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To ver-ify that the digestion procedure was non-toxic and further did not compromise 
the basic cell function and migration ability, ~11~3 integrin-expressing MV3 control cells 
treated with GAG, sialic acid and ~-1,4 galactose digesting enzymes (PINIG) together 
with isotype and cRAD showed normal baseline migr-ation, mesenchymal phenotype, 
and focalized cell-matrix interactions (Fig. 3a-d, Fig. 4 a, b, Extended data Fig. Sa, S I, 
II). Likewise, ~1-1- but ~3 integrin-expressing MEFs developed similar morphological 
phenotypes and migration speeds after treatment with glycosidases when compared 
with ~1 +l+(fllf1) M EFs (Fig. 1c, Fig. 3d, Fig. 4a, b). These data exclude even subtle cell 
perturbation by the glycosidase treatment and further show that the glycocalyx has no 
detectable contribution to mesenchymal migration. 
However, when glycan removal was combined with interference of integrin expression 
and function, cell migration and persistence were severely compromised across the 
studied cell models. Cells were immobilized and completely rounded, despite ongoing 
cytoskeletal activity ("running on the spot"), for time periods of 6-9h in MV3 (Fig. 3a-c, 
Extended data Fig. Sa, b, e), at least 24h in ~1-1- M EFs (Fig. 3d, Extended data Fig. Sa, c) 
and for 5-6 h in Molt-4cells (Fig. 3e, Extended Data Fig. 7a, d, f). The subsequent stepwise 
recovery of migration was consistent with the re-onset of ~-1,4 galactose expression 
(Extended data Fig. 5 e, f). Strikingly, the enzymatic removal of GAGs and neuraminic 
acids alone (PIN) did not influence migration of MV3 ~11~3KD cells significantly (Fig. 3c), 
whereas the migration of Molt-4 cells were partly compromised (Fig. 3e, PIN), indicating 
a more pronounced impact of changes in the glycosylation of T cells46, e.g. in sialylation 
on cell migration47 compared with MV3 cells. 
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Fig. 3. Surface-glycan dependent cell migration in vitro and in vivo. 
(a-e) MV3 melanoma cells, murine ~1 -/- embryon ic fibroblasts and Molt-4 T lymphoma cells were subjected 
to f'nzymat ic surface-glycan remova l using P/N/G followed by analysis of migration rates in 30 collagen 
latt ices in vit ro. (a) Time-lapse sequences (bright-field microscopy), (b) migration paths and (c) single-cell speed 
distri butions of MV3 vector control and ~ 1m3KD ce lls in the presence of mAb 484 and eRGO for control 
cond it ions or after glycan remova l by P/N or P/N/G. Glycan-dependent migration of (d) ~1 -/- M EF (e) Molt-4 
cells. (f ) Workflow of orthotopic inject ion into the collagen-rich deep mouse dermis followed by intravita l time-
lapse microscopy of LiveAct-expressing MV3 vector cont rol and MV3 ~1/~3KD cel ls w it hout or after glycan 
removal. (g) Zooms showing example cells w it h typica l morphology. White lines represent migrat ion paths after 
8-9h. Arrows, direction of migrat ion. Grey arrowhead, micropart icle released from the ce ll rear (Aster isk). (g, I) 
Bar, 20 f.irn, (g, II- III ) Bar, 10[.1m. (h) M igration speed of MV3 ~ 1/~3KD cells addit ionally treat ed w it h mAb 484 
and 17E6. Data represent 30 cells from 3 independent experiments. 
As in 3D collagen in vitro, MV3 ~1/~3KD cells that were add iti ona lly pretreated with 
integrin-blockingmAbs4B4and 17E6 injected into the deep mousedermisand monitored 
by intravital multiphoton microscopy deve loped blebbing amoeboid movement (Fig. 
3f, g; Extended data Fig. 9 Ill , IV) , whereas MV3 vector control cell s reta ined spindle-
shaped morphology (Fig. 3g, Extended data Fig. 9 1, II). This shows that lowering adhesion 
in otherwise mesenchyma l ce lls y ields similar amoeboid movement in different 3D 
environments, including fabri cated microfluidic channels48 or ce ll confiner5, 3D fibrillar 
co llagen and complex connective tissue. After glycan-removal, cell s underwent complete 
rounding with near-complete migration arrest despite oscillatory shape change (Fig. 3g, 
h, Extended data Fig. 9 V, VI). Thus, an intact surface glycocalyx is required to maintain 
amoeboid migration in collagen-ri ch tissue when integrin fu nctions are perturbed. 
To direct ly add ress whether the glycoca lyx might support ceii -EC M adhesion, atomic 
force microscopy (AFM) was used to probe the binding of synthetic glycans as well as of 
intact ce lls to fibrillar collagen. The t ip of the cantilever was funct ional ized w ith simple-
structured amylose and cellulose polymers that lack modifications such as su lfation or 
acetylation and the forces to break the bonds upon ca ntilever retraction were recorded 
(Extended data Fig. 7a). With increas ing amylose density on the cantilever, the binding 
to co ll agen was dose-dependently strengthened (Extended data Fig. 7b). Besides the 
majority of background-level, weak bonds (40-120 pN), amylose or ce llulose prompted 
subsets of stronger bonds with unbinding forces in the high pN range (Extended data 
Fig.4c-e) . Simi lar concentration dependent increase in binding affiniti es between glycan 
and co llagen fibers was detected when amylose polymer binding t o immobilized co llagen 
was probed by surface plasmon resonance (SPR) (Extended data Fig. 7f). After binding, 
affinity bonds were stable for > 15 min at any amylose concentration that were disrupted 
by the wash-out during the regeneration phase (Extended data Fig. 7g, h). Thus, 
mu ltivalent polysaccharides in the absence of additional positive or negative side chain 
charges provide significant interaction strength to fibrillar co ll agen. 
To determine binding forces between t he glycocalyx and coll agen I, AFM-based single-
cell for·ce spectrocopy (SCFS) was exploited. A living MV3 cell was mou nted to the tip of a 
cantilever and binding forces between ce ll and substrate were recorded upon cantilever 
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retraction (Extended data Fig. 6a). To determine the appropriate interaction times that 
would discriminate fast receptor-independent from slow receptor--dependent bond 
formation, interaction times from 0.5 s up to 20 s with a co ll agen I matrix were used. 
In contro l cells with integrins expressed, short interaction times (0.5 s) enabled variable 
interaction forces from 400 pN up to 2 nN (Fig. 2d, Extended data Fig. 6e), indicating the 
coexistence of low (400 pN- 800 pN) and high-avidity interactions (above 800 pN) when 
adhesion is initiated49·50 Multiple single rupture events (jump events), i.e. the sma llest 
detectable force units, reached 200 pN which represent multiple-bond ruptures 
already after short contact times in the presence of integrins (Extended data Fig. 6c, d). 
After 20s contact time, binding forces were strongly increased and retraction curves 
showed a sharp peak, that can be assigned to multiple single-integr in binding events51.52 
to co ll agen I at the extracellular bind ing sites and to actin at the cytoplasmatic tail as 
well as early cooperative integrin engagement. Weak interactions (<1 nN) were largely 
abandoned (Fig. 2d, Extended data Fig. 6e), indicating time-dependent cooperation and 
reinforcement of adhesion50 . After interference w ith integrins ce lls lacked strong binding 
events but retained peak forces that reached 500 pN and included sma ll jump events 
(<50 pN) (Fig. 2c,d, Extended data Fig. 6d-f). The broadened retraction profile after 20s 
of contact (Fig. 2d, Extended data Fig. 6e, f) might result from time-dependent adhesion 
events, such as intercalation of collagen fibers between plasma membrane blebs or 
engagement of slower but weak adhesion systems. Additional glycosidase treatment 
resu lted in a substantial reduction of both peak force and a shift to single-bond rupture 
events of <30 pN (Fig. 2c, d, Extended data Fig. 6d-f). To rule out intermittent parameters, 
such as receptor activation, cytoskeleta l reinforcement or epitope saturat ion due to 
receptor shedd ing, repeated probing conditions were ver ified. The results clearly show 
similar magnitudes of generated forces at each binding event and equal force distribution 
between a cell and collagen (Extended data Fig. 6b, e lower panel). The loss of binding 
forces after glycosidase treatment was reverted by increasing the contact time (Fig. 2d, 
Extended data Fig. 6e, f), suggesting maturation-dependent additional binding events. 
The glycocalyx is thus suited to support very fast binding to co llagen in the pN range 
when integrin function is marginalized. 
To test, whether besides collagen, any substrate would be bound by the glycocalyx, 
protein-inert BSA was used as non-specific counterpart ligand. The results clearly show 
that integrin binding was lost but glycan binding retained, w ith sim ilar forces compared 
to collagen binding (Fig. 2d, Extended data Fig. 6e, g). Glycosidase treatment of integr in 
knockdown cells resulted in a similar loss of unspecific adhesion to BSA as it was shown 
for collagen I for short contact times (Fig. 2d, Extended data Fig. 6e, g), which assigns the 
residual forces to glycans. 
Thus, the data indicate that the glycocalyx functions as an independent low-leve l 
adhesion system to a broad range of substrates. 
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To map the transitions after limiting integrin availability, as a basis for identifying the 
E0v1-binding contact structures enabled/mediated by surface glycans towards collagen 
fibrils, cell morphologies were classified as mesenchymal (type 1), amoeboid-moving 
with actin-rich protrusions and well-developed filopodia (lla), polarized surface blebs 
(lib), or an elongated uropod (lie), or non-polarized, concentric with microruffles (lila) 
or microblebs (I lib) (Fig, 4a). MV3 cells and MEFs developed a mesenchymal migrating 
phenotype, which converted to bleb-like (MV3 and Molt-4 cells) or filopodal (~1-/- ME Fs) 
amoeboid movement with integt-in function impaired but surface glycans available. 
After interference with both integrins and surface glycans only small subsets of bleb-
like (MV3 cells) and a mix of filopodal and blebbing amoeboid movement (MEF cells) 
were retained. Molt-4 cells were constitutively amoeboid, dominated by an elongated 
uropod with occasional blebs (Fig. 4b) and interference with integrin and surface glycans 
resulted in only a small subset of filopodal, blebbing and uropodal amoeboid migt-ation 
phenotype (Fig. 4b, asterisks indicate amoeboid subsets). Thus, when integrin-mediated 
fot-ce generation is disabled, filopod-like protrusions and blebs are retained to engage 
with extracellular structures. 
105 
CH/\PTER 5 
a 
c 
c 
.Q 
~ 
Ol 
'0 
0 
~ 
f 
106 
-------------------------------------------------------
Migrating Non- b 
migrating 100 
~ 80 
6 60 
~ 40 
tt 
20 
0 
--------- MV3 f31/[33 KD 484/ eRGO 
MAA DAPI F-actin Refl 
-MV3- -MEF- -Mo!t4-
1 ·1 i * * Type 1!]( ella cllb I!IIIC !!IIIIa [](lib 
• P/N/G - P/N/G - P/NIG - P/N/G P/N/G 
--- --- --- ---
lso p1/j33 KO p1+/+ p1-/- lso 484 
/cRAD 464/cRGO /eRAD /eRGO /eRAD /eRGO 
d • .... 1391.. ••• 
60· 
£40 Refl 
!!! f\ F-actin 
.l!l 20 .s ---~-----·-· ·\ ----.... 
-· '-.. 
0 
0 0.5 1 
Length (~m) 
e p < 0.0001 
.s "~''I ~:I . 0 '§.§. . &1:~ "' ~i -0.~ ~~ ~~~ LL
u.. ~ -0.4 
c:f~ 
q_" 
---------------MV3 [31/f33 KD 484 I cRGD-------------- g p = 0.0017 
w/o digestion P/NIG 0.4 
'E 
,........, 
2: 0.3 ~~ m 0.2 io t; 0.1 ~ 
u 0 
- P/N/G 
JiJfc3kd 
eRGO 
h p = 0.0002 
,--, 
'E 0.3 .~ 2: ro 0.2 ~ 1:: 0.1 "§. 
.§ 0 
- P/N/G 
llJfc3kd 
eRGO 
Ciy c: oca iyx-rnec; i:::ted lntcgrin- indepe11den t ;-\rnoeboid Ce ll M igrat ion 
Fig 4. Organization of glycan-dependent cell-matrix interactions. 
(a) Morphologica l phenotypes in migrating and non-migrating cells accord ing to shape and polarity. MV3 
ce lls were fixed after 2h of culture in 3D co ll agen lattices. (b) Phenotype frequencies in MV3, MEF and Molt-
4 ce lls after interference with integrins and surface glycans (97 (MV3), 100 (M EF), 92 (Molt-4) cells from 
3 independent experiments). Asteri sks, amoeboid migrating subsets. Bars, 20~m. (c) Maackia amurensis 
agglutin in (MAA) staining of cell surface ~- 1,4 gal actose res idues (red signal), F-act in (green signal), co llagen I 
(refl ection) and (c: B, E) F-actin (red signal), co llagen I (green refl ection) in MV3 ~ 1/~3KD cont rol cell (c, A-C) 
and after P/N/G digestion (c, D-F). Cells were embedded in 3D collagen and fixed after 90 min. Because of the 
resolut ion limit of-200 nm, these confocal reconstruct ions do not resolve the nanometer-scale exclusion of 
F-act in by imprint ing fibers . (c,A.D) XY and (c, B,E) XZ projections ofF-actin and confoca l reflect ion (fi ber) signal 
f rom seria l posi tions indicated in (c, B,E; dashed lines). (c, C,F) Schematic representation of the YZ project ions 
shown in I- II I and IV-VI. Arrow s, co llagen fi bers located with overlap to glycan-en ri ched blebs. Dashed ar rows, 
collagen fibers late rally intercalating between blebs. Numbers indicate co ll agen fibers engaged w it h the ce ll 
surface. (d) Averaged densitometry curves of a bleb cross section with F-actin res idues (red, 35 curves) and 
collagen I (green, 26 curves) and (e) ca lculation of the fiber imprint depth based on 17 bl eb cross sections from 
3 independent experiments. (f) Scanning electron microscopy and quantification of the area of membrane-
co ll agen fiber contact (g) and imprint area (h) of MV3 B1/B3KD cells before and after treatement with P/N/G 
glycos id ase cocktail. MV3 cells were fixed afte r 2h of cu lture in 3D collagen latti ces. (f: A, B) Regions of interest 
(numbered dashed boxes) depicted as representat ive zooms of the contact area between ce ll membrane 
(green area) and collagen fibers (red), used for ca lculat ing the 3D cell-surface/collagen fiber cont act (g) and 
peri-imprint area (h). Bars, 10 ~m (c: A, D), 2 ~m (c: B, E), 1 ~m (f: A, B), 0.5 ~m (f: A, B RO is). Statistica l analysis 
was obtained using t he non-paired Mann-W hitney test. 
To define the adhesion topologies when engaging with collagen fibers, we performed 3D 
confocal microscopy in fixed and live cells after integrin targeting and simultaneously 
detected the surface glycocalyx by sta ining with fluorescent lectins ConA and MAA. 
MV3 i31/ 133KD (Fig. 4c, Extended data Fig. 10a) and Molt-4 cells (Extended data Fig. 
10e) formed actin-rich filopodal or bleb- like protrusions engaging w ith collagen fibers 
w hich both retained a linear glycan-collagen fiber interface. Whereas filopodia of MEF 
ce lls formed a defined longitudinal interface with col lagen fibers w hich is resolved by 
diffraction-limited microscopy (Extended Data Fig. 10.2a-c), bleb-co llagen fiber contacts 
were topologically complex and more varied. In MV3 cells individual blebs contained 
filamentous actin and uniform, non-foca lized galactosyl-rich surface overlapped with the 
reflection signal from collagen fibers in xyz direction (Fig. 4c,d, Extended data Fig. 10a, 
b, e-g) w it h stretches from sequential sections located near-inside the bleb and depth 
over lap ranging from few to 200 nm or more (Fig. 4e, Extended data Fig. 10c, d, h). Both, 
ga lactosyl-residues and overlap between bleb and fiber were lost after glycan removal 
(Fig. 4c, e, Extended data Fig. 10e, h), implica ting the glycocalyx in providing particularly 
tight apposition between surface blebs and fibrils with "imprint- like" topology. Bleb-rich 
contact types persisted as abortive, non-polarized structures in immobilized cells, which 
differs from apoptotic cell detachment by an intact nuclear morphology (Fig. 4c, Extended 
data Fig. 10a, e) and uncompromised viability after cell retrieval from the collagen lattice. 
To resolve the 3D organization of glycan-mediated contacts, sca nning electron 
microscopy was used for cells located inside the collagen after exposure by mechanically 
ripping the gels apart at mid -level . Blebs located towards the polar front of MV3 i31/ i33KD 
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cells underwent a complex-shaped, indentation in direct contact with a collagen fiber, 
forming a "grip-like" tight interphase of complex geometry with typical half-cylindrical 
shape and a variable contact area ranging from 0.05 up to 0.4 ~m 2 as a function of bleb 
size, fiber calibre and indentation depth (Fig. 4f, A, Extended data Fig. 11a, A, B 4-6). These 
interactions typically withstood mechanical disruption of the collagen lattice during 
sample pr-eparation, but occasional disruptions of the bond with displaced collagen fibril 
uncovered the half-cylindrical grove inside the bleb matching the calibre of the collagen 
fibre (Extended data Fig. 11a, B, C). This indicates very tight "grip-like" apposition of the 
cell surface and collagen fibre. Possibly, the minimal 50 pN adhesion unit detected by 
AFM in MV3 ~1/~3KD cells (Extended data Fig. 6c, inset) corresponds to the disruption 
of individual bleb-based contacts to collagen fibrils (Fig. 4e, Extended data Fig. 10d, h, 
11d). 
Enzymatic digestion of cell surface glycans disabled the tight surface apposition 
between bleb and fibril, resulting in near-ablated direct contacts but largely increased 
peri-imprint area adjacent to t he fiber contact (Fig. 4f-h, Extended data Fig. 11a, D, b 
3-5, d). This identifies the glycocalyx as glue-like scaffold mediating complex-shaped 
membrane topologies in close apposition with irregular-shaped extracellular topologies. 
Additional interaction types detected by SEM irrespective of glycan availability included 
intercalation of collagen fibers between blebs and other protrusions (Fig. 4c, Extended 
data Fig. 10a, e, 11c, dashed arrows). Together these data implicate the glycocalyx 
in supporting fast, low- to moderate-adhesive facilitation of membrane apposition 
along extracellular- interfaces allowing the cell-surface to adopt complex nanotopology 
(Extended data Fig. 12a). Thus, by mediating adhesion through adaptive interfaces, we 
here identify a complementary adhesion principle which typically acts in parallel to 
integrin-mediated mechanocoupling but also may occur independently, when integrin 
functions are disabled. Thus, the glycocalyx provides generic low-affinity but high avidity 
adhesion through adaptive interfaces to mediate integrin-independent mechanocoupling 
and cell migration in 3D tissue environments. 
High- and low-adhesive interactions coexist, overlap and substitute for each other 
(Extended data Fig. 12b). Focalized integrin-mediated cell-matrix adhesions transmit 
dedicated mechanotransduction, mesenchymal migration and further support the 
ability to reor-ganize ECM 7919 When integrins are downregulated or disabled, glycan-
based adhesions depend upon actin-rich filopodal or bleb-like protrusions which support 
tight membrane apposition towards extracellular topologies and shape the cell surface 
accordingly (Extended data Fig. 12a, b). 
Albeit the interaction of blebs with collagen fibers is largely sensitive to glycan removal, 
surface blebs provide a degree of roughness anchoring the cell surface into ECM 
discontinuities in an intercalating manner and provide residual non-adhesive cell 
migration via the stiff yet dynamic cell cortex53. Thus, even more weakly adhesive or non-
adhesive cell-matrix interactions likely sustain a basal migration level by propulsive shape 
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change 22·38 Because integrin- and glycan-dependent adhesion and migration strategies 
overlap, increasing or lowering integrin engagement towards the 30 ECM scaffold 
resu lts in gradual transitions fr-om mesenchymal to amoeboid migration. Consequently, 
complete immobilization in 30 collagen lattices requires the simultaneous interference 
with integrin- and glycan-mediated matrix binding, yet neither· interference strategy 
alone is sufficient to abr-ogate cell movement in 30 ECM. 
The role of the glycocalyx in amoeboid movement indicates an evolutionary ancient 
physiochemical mechanism for substrate binding which may be retained in mammalian 
ce ll s, in reminiscence of ce llulose-based substrate binding by Dictyostelium31·34. 
Mesenchymal-to-amoeboid transition might thus reflect an experimentally induced 'step 
backwards in evolution time' towards less specific mechanisms of ce ll -tissue interaction. 
Glycans provide promiscuous cell-substrate interactions to nearly any substrate of the 
living and non-living nature. In addition, as revealed here, the lattice-like bonds support 
the shape adaptation of the plasma membrane to collagen fibers and complex-shaped 
topologies. Combining the generic st ick iness with shape alignment of the membrane and 
the underlying cortical actin cytoskeleton, extremely flexibly and mechanically robust 
adhesions are being generated. In conclusion, the transition between integrin- and 
glycan-mediated as well as 'physical' cell -tissue interaction may underlie phenotypic and 
functional transitions of cell migration during differentiation and invasion. 
Methods 
Reagents. The following primary antibodies were used: mouse anti-human 131 
integrin 4B4 and K20 (Beckman Coulter); rat anti-mouse 131 integrin mAb KMI6 
(BD-Pharmingen); mouse anti-human 133 integrin mAb Y2/5 1 (AbO Serotec); mouse 
anti-human aV mAb 272-17E6 (Abeam), anti-GAG single-chain antibodies carrying 
a VSV-tag for recognition by a secondary antibody (kind gift from Toin van Kuppevelt, 
Radboudumc Nijmegen), including anti -heparan sulphate (HS) antibody (HS4C3) 54·55 , 
anti-dermatan sulphate (OS) antibody (LKN1) 56 and the ant i-chondroitin sulphate 
(CS) antibody (103H 10)57 ; rabbit anti -human discoid in domain receptor (DDR1) pAb 
lgG C-20 (Santa Cruz BioTech); rabbit anti -human discoidin domain receptor (DDR2) 
pAb lgG H-108 (Santa Cruz BioTech}; mouse anti-human CD44 blocking mAb (5 F1 2) 
(ThermoFischer Scientific). The following isotype control was used: mouse lgG 1 Ab-1 
(c lone: NCG0 1) isotype (Neomarkers). The following secondary and tertia ry antibodies 
were used: mouse anti-VSV mAb P5D4 from hybridoma culture supernatant (ATCC), 
goat ant i rabbit lgG (H+L) (Molecular Probes), AlexaFiuor 488-conjugated goat-anti-
mouse lgG antibody (Invitrogen). The following lectins and secondary probes were 
used: Rhodamine-RedX-conjugated concanavalin A (Invitrogen), Biotin-labeled Maackia 
amurensis agglutinin (EY Laboratories), Alexa Fluor 488 or 647-conjugated streptavidin 
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(Invitrogen); cyclic tripeptide arginine-glycine-aspartic acid (eRGO; Arg-Giy-Asp-0-Phe-
Val) and cRAD control peptide (Arg-Aia-Asp-0-Phe-Val) (Bachem; purity >95 %). DAPI 
(Roche) was used for nucleus staining. 
Cells. Metastatic human MV3 melanoma cells stem from a spontaneous lung 
metastasis after subcutaneous implantation in nude mice 20. For generation of 
[31/[33 integrin double knockdown cells shRNA sequences targeting ITGB1 
([31 integrin; AGCCACAGACATTTACATTAAA) and ITGB3 ([33 integrin; 
AAGTCACTTTCTTCTTCTTAAA)forgenesilencingby RNAinterferencewerecloned into 
the lentiviral vector pLBM either containing a puromycin (p-puro) or a neomycin (p-neo) 
cassette. Lentiviral particles were produced and concentrated by ultracentrifugation, 
as described58. MV3 parental cells were infected with p-puro and p-neo viruses (vector 
controls), or with ITGB1 (on p-puro) and additionally ITGB3-targeting (on p-neo) pLBM 
viruses. Stable MV3 [31/[33 knockdown cells were maintained in medium supplemented 
with puromycin (51Jg/ml) and G418 sulfate (400 mg/ml). Stable LifeAct-eYFP expressing 
MV3 melanoma cells were obtained as follows. A fragment spanning the pMSCV-hygro 
(Addgene) Hygromycin B resistance cassette was PCR-amplified (primer sequences 
available upon request) and inserted into Kpnl-digested plenti6.2/V5-DEST (Invitrogen), 
replacing the Blasticidin resistance cassette and rendering plenti6.2_Hygro!V5-DEST. A 
Bgiii-Notl fragment, containing the LifeAct-eYFP open reading frame, was then isolated 
from plasmid pEYFP-N1-£1,ATG-Lifeact59 and cloned into BamHI/Notl-digested pENTR4 
(Addgene). Using Gateway recombinase-mediated transfer the pENTR4-LifeAct-eYFP 
insert was subsequently introduced in plenti6.2_Hygro!V5-DEST. Stable LifeAct-eYFP 
expressing MV3 cells were obtained following lipofectamine 2000 tr-ansfection of the 
r-esulting plasmid, subsequent hygromycin B (Invitrogen) selection (200 !Jg/ml) and final 
fiuorescence-activated cell sorting. 
Immortalised [31-/- murine embryonic fibroblasts (MEFs) were obtained by crossing 
lmmorto mice (Charles River Laboratories, Wilmington, USA) carrying the thermolabile 
large T antigen H-2KtsA5860 with mice, in which exon 1 of the [31 integrin gene was 
fianked by loxP sites61 and genotyped by tail-tip PCR. Mice that were homozygous for the 
[31 wild-type or fioxed allele and carried at least one lmmorto allele were interbred and 
E13.5 embryos dissected for MEF preparation. Isolated MEFs were cultured at 33°C 
in the presence of IFNg for ftve passages until all non-immortalized cells had senesced. 
Adenovirus-ere (AdCreM 1; Microbix Inc) (MOI40) was added overnight to subconfiuent 
cultures of a random subset of cells derived of [31 (fi/fi)/lmmorto embryos. Deletion 
of [31 expression was monitored by fiow cytometry with mAb KM 16 and confirmed by 
PC Rand Western blot (Extended data Fig.4a,b). Clones from both the parental fioxed 
[31 ([31(f1/fi)) and [31-/- cells were derived by limited dilution, and expression levels of [31 
integrins were detected by fiow cytometry using mAb KM 16 (Extended data Fig.4c, d). In 
control cultures using non-f1oxed immortalised MEFs, Adeno-Cre caused no alteration 
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of migration rates and mesenchymal phenotype (data not shown). For rescue of 131 in 
131-/- MEFs, full-length 131/GFP fusion protein was stably reintroduced at moderate 
expression level, as described 62 The human T-leukemia cell line Molt-4 was kindly 
provided by Blanca Scheijen, Laboratory of pediatric oncology, Radboud Institute for 
Molecular Life Sciences, Nijmegen). 
Unless stated otherwise, cells were maintained in RMPI 1640 (Gibco) (MV3, Molt-4) 
or DMEM (Gibco) (MEF) containing 10% fetal calf serum (Sigma-Aldrich), penicillin/ 
streptomycin 100 U/ml penicillin and 100 [Jg/ml streptomycin (PAA), !-glutamine (2mM), 
sodium pyruvate (1mM) (both Invitrogen) and detached from the culture plate by EDTA 
(2mM) (Invitrogen). Molt-4 cells were cultured in RPMI 1640 (PAN Biotech GmbH) 
supplemented with 10% fetal calf serum (Aurion), penicillin and streptomycin (both 100 
[Jg/ml; PAN) at 37 oc in a humidified 5% C02 atmosphere. 
Flow cytometry. Cells were washed three times with PBS by centrifugation (MV3 M EF 
and Molt cells, 180gfor 5 min). For cell viability analysis, cells were enzymatically digested 
out of 3D collagen I using collagenase I and washing steps were omitted to prevent the 
loss of dead cells by centrifugation. After resuspension the cell-associated fluorescence 
was measured using a FACSCalibur_flow cytometer (BD Biosciences, Erembodegem, 
Belgium). Data were analyzed using FCS Express (Version 5 Research Edition; De Novo 
Software, Los Angeles, CA). Per sample, 10.000 morphologically intact and alive cells 
were gated based on forward and sideward scatter and propidium-iodide negativity. 
Cell sorting.MV3 cells were detached by EDT A, washed, stained with FITC-conjugated 
anti-131 integrin mAb K20 and subjected to cell sorting for high and low surface label (cut-
offs: sth and 95th percentile; FACS DiVa, BectonDickinson). After up to three passages 
and complete loss of residua l FITC-fluorescence, sorted cells were used for migration 
and confocal analysis. 
Westernblot.l31 knockdown efficiency determined by Western blot (detection Ab 18; 
BectonDickinson) from whole cell lysates (>90 %) or flow cytometric analysis of 131 
integt-in surface levels(> 80 %). 
Cell migration in 3D collagen lattices, cell tracking and persistence measurements. 
Integration of cells into 3D pepsin-digested bovine dermis collagen lattices containing 
98% type I and 2.8% type Ill (Vitrogen; Nutracon), time-lapse microscopy and computer-
assisted cell tracking963 and morphometric analysis of mesenchymal and amoeboid 
phenotypes21 were performed as described. The collagen was native, based on its 
sensitivity to cleavage by MMP-14 and resistance to degradation by trypsin64. Cell 
migration experiments were performed at 3JCC (MV3, Molt-4, M EF parental) and 33°C 
(Mef 131 -/-cells) for up to 108h. Multicellular spheroids were generated by overnight 
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culture of lVI E Fs on dishes coated with poly-2-hydroxyethyl methacrylate (0.33 %; Sigma), 
individually transferred by the tip of a pipette and incorporated into collagen solution 
prior to polymerization. The population speed was derived from the individual tracks 
of randomly selected cells for 24 h observation periods. Persistence was calculated as 
mean for each cell from the continuous-time quotient of direct distance between the 
end-points divided by the actual track length over a 6 hand 9 h period, excluding phases 
of immobilization. Box and whisker plots show the median population speed, 25-75 
percentiles (box) and minimum and maximum values (whiskers). Statistical analysis was 
obtained by the non-paired Kruskai-Wallis test for independent samples including post-
hoc Bonferoni adjustment. For interfet-ence with integrin-mediated adhesion, mAb 4B4 
was used at maximum concentration of 10 and 40 f.ig/ml and eRGO peptide (2 or 10 f.IIVI) 
in addition to stable ~1/~3 integt-in knockdown. 
Collagen contraction assay. Cells were incorporated into 3D collagen lattices in non-
adhesive 24-well plates pre-coated with poly-2-hydroxyethyl methacrylate (0.33 %). 
Contraction was quantifled as pixel count representing the matrix area after 24 h. 
Confocal microscopy. Confocal fiuorescence and refiection microscopy were 
performed as described 921. Cells in 3D collagen lattices were flxed in de-polymerized 4 
%para-formaldehyde at 37 °C, washed, and stained with biotinylated IVIaackia amurensis 
agglutinin (IVIAA) and secondary Aiexa Fluor 647 conjugated streptavidin and combined 
with Alexa Fluor 488 conjugated phalloidin and DAPI. Confocal z-reconstruction was 
performed on a TCS SP8 confocal microscope (Leica IVIicrosystems, IVIannheim, Germany) 
equipped with an HCX PL APO 63x 1.2 N.A. water immersion lens and on a Leica SP2 
scanner for each emission separately and displayed by maximum intensity projection of 
selected slices. I mage ana lysis was performed using the Fiji I mageJ software from native 
slices (V1.51d V1.67 and 2.0 NIH, Bethesda). 
Imprint depth. Confocal microscopy cross sections were used to determine the impt-int 
depth ofthe collagen flbers into the glycocalyx layer (IVIAA) and cortical actin (phalloidin) 
of cell membrane blebs. Two measuring lines of constant length (8 f.im) and width (5 
pixels) were set adjacent to both lateral sides of a collagen flber and two additional 
lines were set within the collagen flbet-. Intensities of the IVIAA, phalloidin and collagen 
I signal were determined along these lines by densitometry and exported as table of 
values. Subsequently, values of both lines were averaged and plotted as overlay. The half-
maximum intensities (Max112) of IVIAA, phalloidin and collagen and the corresponding 
x-values were read off the curves followed by the subtraction of the x-values of the 
collagen I from the values of IVIAA and the F-actin. The imprint depth (I D) was calculated 
based on the equation: 
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lD(nm)= 
PSF 
For this the differential values of MAA or F-actin fluorescence and collagen reflection 
were divided by the YZ point spread function (PSF, 3.64). 
Glycan removal. Cells from subconfluent cultures were first detached using 2 mM 
EDTA (MV3, M EF), transfered into 2 ml Eppendorf tubes and washed twice with culture 
medium containing 1% FCS. Molt-4 cells were directly transfered into 2 ml Eppendorf 
tubes and washed equally to MV3 and MEF. Subsequently cells were simultaneously 
incubated with glycosidase cocktail (P/N), containing hyaluronidase at 275-500 U/ml 
(Sigma Aldrich), heparitinase I at 10 mU/ml (Seikagaku), chondroitinase ABC at 100 mU/ 
ml (Sigma Aldrich) and neuraminidase type Vat 100 mU/ml (Sigma Aldrich) targeting 
both distal glycosaminoglycan chains of proteoglycans (P) and terminal sialic acids I 
neuraminic acid (N) of glycoproteins and glycolipids and a cocktail (P/N/G) containing 
additionally S-1,4 galactosidase at 150 mU/ml (Sigma Aldrich) cleaving proximal S-1,4 
galactose (G) of glycopmteins and glycolipids (37 oc, pH 7.0-7.4, 6 h). Afterwar-ds, cells 
were washed three times and further studied. Because latent cytotoxicity negatively 
impacts migration rates, non-damaging conditions were monitored by different 
approaches. After glycan removal, cells were collected, stained by propidium iodide, 
and analyzed by flow cytometry. Unaffected cell viability was routinely confirmed by 
propidium iodide staining and flow cytometry before and after time-lapse microscopy 
and cell retrieval by collagen digestion (type I collagenase, Sigma; 100 U/ml, 15 min, 37 
oc) as well as unaltered intact nuclear morphology after fixation in situ and DAPI staining. 
Transmission electron microscopy (TEM). Detection of the surface glycocalyx using 
TEM was performed largely based on Cox et al 65 . MV3 cells were detached from the 
culture plate by EDTA, pelleted and fixed with Ruthenium Red containing fixatives for 
transmission electron micmscopy. Cells were washed twice with DMEM (without FCS). 
Supernatant was removed and fixative 1 [0.1 M PHEM Buffer (PIPES, HEPES, EGTA, 
MgCI2), 0.075% ruthenium red, 3% glutaraldehyde] was applied to the cell pellet. The 
samples were wrapped with par-afilm and incubated on a shaker at RT for 1 h. After 
incubation, cells were centrifuged (1200 rpm; 5 min and washed with washing buffer 
[0.1 M PHEM Buffer (PIPES, HE PES, EGTA, MgCI2) 0.075% ruthenium red three times 
for 15 minutes. After postfixation with fixative 2 [0.1 M PHEM Buffer (PIPES, HEPES, 
EGTA, MgCI2), 0.075% Ruthenium Red, 1% Osmium Tetroxide (Os04)] for 2h at RT 
(2h at RT) cells were washed three times with 0.1 M PHEM buffer, resuspended in 0.1 
M PB and centrifuged (13.000 rpm; 30 seconds). Supernatant was removed and 4% 
agar (pre-warmed, boiled first in advance) was applied. Samples were then incubated for 
2-5 minutes at 45 oc. Afterwards, cells were immediately centrifuged (before the agar 
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solidified) at 13.000 rpm for 30 seconds and put in an ice bucket. After 2-5 minutes, the 
cell pellet was cut out of the eppendorf tube and carefully chopped up into very small 
slices using a razor blade. The slices were put in to 2% par-aformaldehyde I 0,1 M PB 
and left at RT for 2 h. After washing 3 times in 0,1 M PB the samples were dehydrated 
through a gr-aded ethanol serie (50%, 70 %, 80 %, and 96% respectively for 5 min each 
and 2x 15 min in ethanol100% P.A.). Afterwards, samples were washed with propylene 
oxide for 2 x 20 minutes at room temperature. Propylene oxide was then discarded and 
replaced by a mixture of 1:1 epon:propylene oxide and left in this mixture for at least 2 
hat room temperature. Epon:propylene oxide mixture was replaced by pure epon and 
left for- at least 2 h (preferably over-night) at room temperature. An embedding mold was 
prepared and the samples were carefully placed in the embedding mold (1 slice per hole). 
Fresh epon was added until the hole was slightly overfilled (because of shrinkage of epon 
during polymer-ization). The mold was placed in an incubator at 37 oc. After at least 2 
h, temperature was raised to 60 octo polymerize the epon (epon polymerization is an 
irreversible reaction, once epon has polymerized, it cannot be depolymerized). After 
polymerization, the samples were removed from the embedding mold and semi-thin 
sections (1 iJm thick) were cut on an ultramicrotome, stained with a 1 % Toluidin blue 
solution and examined under a light microscope to selectthe area of interest. Excess epon/ 
tissue was trimmed off by hand with a razor blade and ultrathin sections (50 - 80 nm) 
were cut with a diamond knife and collected on formvar coated copper grids. Sections 
were stained with 4% uranyl acetate for 20 minutes at room temperature, washed 3 
times with M I LL-Q water and stained with lead citrate solution (2.66% lead nitrate and 
3.52% sodium citrate) for 10 minutes at room temperature. Afterwards sections were 
washed 3 times with M I LL-Q water, dried and examined on a Jeol1010 TEM. 
Scanning electron microscopy (SEM). Following the treatment with glycosidases or 
solvent, MV3 cells were embedded into 3D bovine fibrillar collagen I lattice for 90 min. 
Subsequently, the collagen lattices were fixed in 2% glutaraldehyde in 0.1M Cacodylate-
buffer for 1 hat 37 °C, washed, post-fixed for 1 h in 1% Os04 in 0.1M Cacodylate-
buffer, followed by dehydration in a graded ethanol series and Critical Point Dried. Dried 
samples were mounted on stubs and then coated with 5nm Chromium in a Quorum 
Q150TS (Quorum Technologies Ltd, East Sussex, UK). Images were made with a Zeiss 
(Carl Zeiss AG, Jena Germany) Sigma 300 Scanning Electron Microscope operating at 
3kV. 
Imprint area and contact area. Scanning electr-on microscopy pictures were used to 
determine the imprint area. First, the area between the convex maxima of the bleb-
membr-ane, defined as total area AreaTotal and the area covered by the collagen fiber 
defined as AreaFibe' was determined using Fiji/lmageJ (http://pacific.mpi-cbg.de/wiki/ 
index.php/Fijil. Subsequently the imprint area was calculated by subtracting the Area Fiber 
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from the AreaTota:· To determine the contact area, the lateral surface area of the fiber was 
calculated and the bleb-free fiber area subtracted. 
Atomic force microscopy (AFM). The forces between carbohydrate polymers and 
collagen fibres were determined by atomic force microscopy (AFM). Flat collagen 
lattices (1.6 mg/ml, 40 iJm thick) mounted on a 1.5 mm thick glass cover slip (PLANO) 
were probed using a NanoWizard AFM (JPK Instruments, Berlin, Germany) mounted 
on an Axiovert 200 inverted microscope (Carl Zeiss, Jena, Germany). The cantilever was 
functionalized with either bovine serum albumin (3 %, 2 h, 20 °C), Bis-NHS-polyethylen 
glycol (5% w/w, 200000 g/mol, Nektar, Huntsvi lie, AL), amylose (carboxymethyl amylose, 
Sigma) or cellulose (carboxymethylcellulose, Sigma) at the indicated weight percentage. 
After UV-irradiation (10 min), silicon nitride cantilevers (MLCT, Veeco Probes) with a 
spt-ing constant of 60 pN/nm were functionalised by N 1-[3-(trimethoxysilyl)propyl] 
diethylenetriamine (Aldrich; 30 min, RT) followed by heating (30 min, 80 °C), incubation 
in sodium borate buffer (60 min; RT), and either Bis-NHS-PEG solution, amylase, or 
cellulose solution in N-hydroxysuccinimide (NHS; Aldrich; 100 mM) and 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide (EDC, Sigma; 100 mM, 90 min, RT) 66. System 
position and sensitivity were calibrated before each measurement, as described by 
Puech et al 67. The spring constants ranged from 50 to 80 (median 60) pN/nm (thermal 
noise method). All interaction measurements were performed in PBS/BSA (0.4 %) at RT 
(set point of 200 pN for approach curve; dwell time 0.1 s). For each measurement, 1600 
to 10000 force curves were obtained for a retract velocity of 10 iJm/s from different 
spots within a 40 x 40 1-1m collagen surface area. The force curves were analyzed with 
a customized software and statistical analysis was obtained by the software packageR, 
version 1.22 (R Foundation for Statistical Computing). After UV itTadiation (10 min), the 
silicon nitride cantilevers were functionalized with (3-Giycidoxypropyltrimethoxysilane 
(98 %, Sigma Aldrich) at 80 oc for 30 min, incubated in sodium-borate buffer for one hour 
at RT, functionalized with NH2-PEG(3000)-COOH (Rapp Polymers) in 50 mM sodium 
borate buffer for one hour at RT. Then 1% (w/w) BSA was coupled to the PEG for one 
hour at RT with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, Sigma Aldrich, 
100 mM) and N-hydroxy-succinimide (NHS; Sigma Aldrich; 100 mM). The measurement 
was performed without BSA in solution. 
Single cell force microscopy and spectroscopy (SCFM/SCFS). The interaction strength 
between cell surface glycans and 3D collagen I fibers was determined by single-cell force 
spectroscopy (SCFS), using a combined Catalyst AFM (Bruker) and inverted 3-channel 
Leica TCS SP5 II confocal laser-scanning microscope equipped with 10 x 0.4 NA, 20 
x 0.70 NA, and 40 x 0.85 NA air objectives and Hamamatsu (ORCA-05G) brightfield 
camera. Unlabeled or TAMRA-Iabeled 3D Collagen I (1.6 mg/ml, 40 iJm thick) and BSA 
coating (2% in TSM solution, containing 20 mM Tris-HCI, 150 mM NaCI, 1 mM CaCI 2, 
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2 mM MgCI 2 at pH 8.0, incubated 24 h at 4 oc) were made on glass-bottomed dishes 
(55-mm Willco dish), using a 150-mm thick four-segment polydimethylsilane (POMS) 
mask that was fused to the glass directly after treating the glass and mask for 30 s in 
a plasma cleaner/sterilizer (POC- 32G, Harrick Plasma) 68 Ce ll s were attached to a 
tippless AFM cantilevers N P-0 (type 0; nominal spring constant of 0.06 Nm 1 (Bruker) 
coated w ith concanavalin A (ConA) (S igma)69 . ConA-coated canti levers were prepared 
as follows: cantilevers were cleaned by immersion in pure 18 M sulphuric acid (S igma) 
for 1 hand then thoroughly rinsed w ith Milli-Q water followed by ethanol and, after a 
final rinse in Milli-Q water, left to dry. Following an overnight incubation at 4 oc in ConA 
(2 mg/ml in PBS), the cantilevers were rinsed and stored in PBS for no more than 1 day. 
The spring constant of each cantilever was calibrated befot-e ce ll attachment using the 
thermal noise method 70 To adhere a single cell to the AFM cantilever, cells were seeded 
from suspension in the perfusion cham bet- in culture medium without FBS but with 0.5 
%antibiotic-antimycotic at pH 7.4 (+10 mM HE PES). The ConA-coated cantilever was 
pushed softly ( < 3 nN) onto the ce ll for < 10 s. Upon retraction of the cantilever, the 
detachment of the cell was monitored by using brightfield microscopy. Thereafter, the 
ce ll was allowed to adhere strongly to the cantilever for 5-10 min. When cells (part ly) 
detached from the cantilevers during experiments, cantilevers and data were discarded. 
Possib le sink function of cell surface glyca ns towards the ConA coated cantilever, the 
contact area of the cells (133 fJm 2) realtive to the total ce ll su rface (1.385 fJm 2) was 
determined with a ratio of 9.6% and thus could be ruled out. Adhes ion of the cantilever-
bound cell to different substt-ates was measured after pushing the cell into contact with 
the substrate, applying 2 nN contact aquisition for predefined time interva ls (0.5, 5 and 
20 s) . Subsequently, the ce ll was retracted at 5 fJm/s and allowed to recover for a time 
period equal to that of the contact time w ith the substrate69•71 Since the number of 
matrix contacts, w hich can be done by SCFS w ith a single ce ll depends on the contact 
time52, acquisi tion of binding forces was limited to maximal15 measurements per cell to 
prevent cell deformation. The sequence of contact time measurements was varied and 
performed in different areas of the substrate. Repeated pmbing on one spot was limited 
to a maximum of 5 times in a row. The maximum detachmentforce F [max] was calculated 
from the peak of the retraction curves to background level (Extended data Fig. 6c, f, g). 
Surface plasmon resonance (SPR). The binding affinities between amylose polymers and 
co llagen fibres were monitored by surface plasmon resonance (SPR) using a Biacore 
T100 instrument (GE Healthcare). A ll materials were purchased from GE Healthcare 
whereas not specified. For the preparation of the analyte, amylose type Ill (Sigmal 
Aldrich) was dissolved using 200 mM NaOH and subsequently neutralization with 200 
mM HCI. The resulting Amylose - NaCI solution was diluted in Biacore running buffer 
(HBSN, 10 mM Hepes, 150 mM NaCI, pH 7.4). For the preparation of the ligand collagen 
was immobilized via amino groups on the dextran surface of a CM5 sensor chip The 
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amylose solution at concentration ranging from 300 ~g/ml to 12 ~g/ml was injected 
over the immobilized collagen or a control fiow cell at the fiow rate of 50 ~1/min, 25 oc. 
Regeneration was achieved with a short pulse of 100 mM NaOH. No binding is observed 
with PEG dissolved in HBSN and injected in the same way. The negligible non-specific 
binding on the empty fiow cell was substracted from measured specific binding affinity. 
Kinetics were analyzed throught Biacore T100 evaluation 1.1.1 software using Langmuir 
model1:1 for fitting curves. For the global fitting, we chose the the theoretical molecular 
weight of 8000 for amylose. We also calculated the sole dissociation rates, that is only 
time-dependent and not infiuenced by the the analyte molecular weight. 
Intravital multiphoton microscopy. All intravital imaging experiments were approved 
by the Ethical Committee on Animal Experiments and performed in the Central Animal 
Laboratory of the Radboud University, Nijmegen (RU-DEC 2009-174, 2011-298), in 
accordance with the Dutch Animal Experimentation Act and the European FELASA 
protocol (www.felasa.eu/guidelines.php). 
LifeAct-YFP expressing MV3 control and ~1/~3 integrin knockdown cells were incubated 
with anti-~1 integrin mAb 4B4 (10 ~g/ml) and anti-aVintegrin mAb 272-17E6 (10 ~g/ml) 
and glycans were digested. The cells were then injected as single cell suspension (2*104 
cells I mouse) into the deep der-mis of Balb/c nu/nu mice (Charles River) carrying a dorsal 
skin-fold chamber. To ensure complete integrin blocking, mice received i.p. injections of 
4B4 (5 ~g/g) and 17E6 (5 ~g/g) 2 h before cell injection. 
Intravital multiphoton microscopy was performed 1-2 h after cell injection on 
anesthetized mice (1-3 % isofiurane in oxygen) on a temperature-controlled stage 
(37°C). Blood vessels were labeled by intravenous injection of AlexaFiuor750-labeled 
70kD dextran (2 mg/mouse; Invitrogen). 
Imaging was performed on a customized near-infrared/infrared multi photon microscope 
(TriMScope-11, LaVision BioTec, Bielefeld, Germany), equipped with three tunable Ti:Sa 
(Coherent Ultra II Titanium:Sapphire) lasers and an Optical Parametric Oscillator (OPO). 
4D time-lapse recordings were acquired by sequential scanning with 960 nm (YFP, 10-
20 mW) and 1090 nm (AI750 and SHG, 30-60 mW) with a sampling rate of 1 frame I 10 
min over periods of up to 8 h. 
I mage processing and quantification. I mages were processed using Fiji/ I mageJ (http:!/ 
pacific.mpi-cbg.de/wiki/index.php/Fiji). Drifts in time-lapse recordings were corrected 
using the Stack Reg plugin 72. To avoid tissue regions perturbed by the injection procedure, 
migration analysis was performed in intact collagen-rich loose connective tissue 
identified by second harmonic generation. Quantitative analysis of tumor cell migration 
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was performed using the FIJI manual tracking plugin (Fabrice P. Cordelieres, rsb.info. 
nih.gov/ij/plugins/track/track.html). To control for small local tissue drifts, particularly 
important for analyzing the residual migr-ation after glycan removal, movements of 3 
tissue structures in close proximity to each analyzed cell were recorded and used to 
correct individual cell migration tracks. 
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Figure 51. 
a) lntegrin surface levels on MV3 cells after detachment from subconfluent cultures by EDTA prior to the 
migration experiment Red line, anti-integrin mAb; black line, isotypic control antibody" (b) Amoeboid phenotype 
after interference with integrins in tumor cells" Mesenchymal-amoeboid transition in MV3 melanoma cells 
after interference with ~1 integrin function" Spindle-shaped morphology in MV3 control cells and conversion 
to a rounded phenotype induced by anti-~1 mAb 484" Influence of increasing doses of mAb 484 on cell 
morphology" Elongation was determined as length/width for moving cells only" Red lines, medians" Dashed box, 
moving subset in control cells that lacks spindle-shaped elongation" (c-e) Epitope saturation by anti-~1 integrin 
mAb 484" Titration of mAb 484 results in up to 95% binding inhibition of fluorescent detection antibody" 
(c) Principle of the detection assay" MV3 cells were incubated for 30 min with non-fluorescent mAb 484 at 
different concentrations, washed, stained with FITC-conjugated detection mAb 484 (10 ~g/ml), and analyzed 
by flow cytometri (d) Fluorescence intensities (mFI) of FITC-conjugated detection mAb after pretreatment 
with non labeled mAb 484 (red line) or isotypic control antibody (black line)" (e) Mean fluorescence intensities 
+/- standard deviation with increasing doses of mAb 484 (n~3)" Dashed line in (e), isotypic control level" (f) 
Knockdown ~1 integrin efficiency detected by Western blot (> 90 %) and (f) flow cytometry (> 80 %)"The 
~1 integrin of vector control cells ran at approximately 110 kD (black arrowhead) and pre-~1 at 90 kD (gray 
arrowhead)" (g) Residual epitopes were saturated by additional incubation with anti-~1 integrin mAb 484 
leading to a total ~1 integrin interference of 97% shown by flow cytometry" (h) lntegrin 133 surface levels on 
MV3 vector control cells and on MV3 ~1 and ~3 integrin knockdown cells from subconfluent cultures prior 
to the migration experiment Red line, anti-integrin ~3 mAb Y2/51; black line, isotypic control antibody" In 
experiments residual epitopes were saturated by additional incubation with cyclic RGD peptide" 
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Figure 52. 
(a) Amoeboid phenotype after interference with integrins in tumor cells and fib rob lasts. (a -c) Mesenchymal -
amoeboid t rans ition in MV3 melanoma ce ll s afte r interference with ~ 1 integrin funct ion. Influence of 
increasing doses of mAb 4B4 on (a) migratory act ivity shown by reduced ce ll paths and (b) directiona l 
persistence. (a) Data show a representative sampl e of path lengths obtained by 40 single cells for an 18 h 
observat ion per iod and (b) for 120 ce lls f rom 3 independent experiments. (c) Impa ired contraction of free-
floating collagen lattices by mAb 484 associated with impaired cell elongation (e longation fraction > 2). Bars, 
10 ~m. (d-h) Mesenchymal-amoeboid transit ion in murine embryon ic fibroblasts after interference with ~1 
integrin funct ion. Amoeboid migration in ~ 1 -deficient embryonic murine fibroblasts (d) Migration of ~1 +/+(fl/ 
fl) and ~1 -/- M EFs from mult icellular spheroids into t he adjacent 3D collagen lattice (left) and ind ividual cell 
paths (right) (e) Persistence of ~ 1 -expressing and ~1 -/- MEFs. (e) Bars, 10 IJm (f) Collagen cont raction assay 
wit h ~1-/- MEFs cells, compared to ~ 1-positive ce lls. Area of the collagen lattice after 24 h was quantified from 
digita l images (r ight). The f raction of amoeboid ce lls (e longat ion< 2) within 3D co llagen lattices was obta ined 
f rom sti ll images, thus containing mobile and nonmobile subsets. (g) Rescue of mesenchymal phenotype and 
(h) reduced migration speed at moderately increased elongation after re-expression of ~1/GFP, compared to 
parenta l ~1 -/- MEFs. (i) Morphology, (j) persistence and elongation of Molt 4 ce ll s with ~1/~3 integrin blocked 
cel ls (4B4), compa red with isotype control ce ll s. Ul Bars, 20 ~1m. 
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Figure 53. 
(a,b) Detect ion and Analys is of putat ive compensation receptors. (a) Indicated ce lls were incubated with 
integrin-blocking 4B4 and integrin-masking cRGD for 30 min and subsequently cu ltured in 3D bovine collagen 
I in presence of 484 and cRGD for 9 h. Cells were enzymat ically digested out of 3D collagen I using collagenase 
I and incubated with antibodies DDR 1 and DDR2 or Sdc followed by incubation with 2nd fluorescent ly labelled 
ant ibodies and flow cytometry. (b) Cell s were pre-t reated with integr in blocking 4B4 and cRGD and lsotype or 
ant i- CD44 blocking ant ibody for 30 min and embedded in 3D collagen I. Cell migration was recorded ove r 24 
h. (c,d) Migration of Dictyostelium discoideum into 3D collagen lattices. Cell s were over laid onto a 3D coll agen 
matrix and all owed to spontaneously immigrat e. (c) Stil l images after 3 and 4 h of culture and migration tracks 
recorded within th is time period are shown. (d) Speed distribution and median, obtained by single cell tracki ng. 
Bar, 10 ~m. 
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Figure 54. 
Characterization of ~1 integrin null M EFs and rescue after reintroduction of~ 1. (a) PCRanalysis of~1(fl/fl), ~1-/­
and wild-type M EFs (cell line 7929) for ~1 integrin and I mmorto alleles.~ 1·1· cells had no detectable ~1 integrin, 
while the floxed and the wildtype ~1 integrin locus resulted in bands of 320 and 285 bp, respectively (left panel). 
All cell lines carried the lmmorto allele (right panel). Primers for ~1 were GCCGCCACAGCTTTCTGCTGTAGG 
(sense) and CTGATCAATCCAATCCAGGAAACC (antisense). (b) Lysates of ~1(fl/fl) and ~1-/- MEFs were 
probed with anti-~1 antibody KMI6 or rat lgG. ~1-/- cells had no detectable ~1 integrin. The floxed ~1 integrin 
of the parental MEF 7929 cell line ran at approximately 110 kD (black arrowhead) and pre-~1 at 90 kD (gray 
arrowhead) (c) ~1 integrin surface expression in MEFs cells analyzed by flow cytometry. Re-expression of 
~1/GFP in ~1-/- MEFs, resulting in moderate expression level. (d) Surface expression of integrins on ~1(fl/fl) 
and ~1-/- MEFs after detachment from subconfluent 20 culture by EDTA. Except minor upregulation of ~3 
integrins, no difference was detected. (e) lntegrin surface levels on Molt-4 cells from subconfluent cultures 
prior to the migration experiment. (f) Residual ~1 integrin epitopes on Molt-4 cells were saturated by additional 
incubation with anti-~1 integrin mAb 484 leading to a total ~1 integrin interference of 97% shown by flow 
cytometry. Red line, anti-integrin mAb; black line, isotypic control antibody. 
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Figure 55. 
(a-d) Enzymatic removal of glycan moities on the cell surface of living cells using glycosidases for 6 hat 37 
0
( and 5% CO,The expression of cell surface glycan structures and the efficient removal were analyzed by 
flow cytometry (FACS) and transmission electron microscopy (TEM). The impact of the enzymatic treatment of 
living cells on adhesive strength to llbrillar collagen was studied by atomic force microscopy and spectroscopy 
(AFM/AFS) and single cell migration in vitro and in vivo using automatic cell tracking. (b) Cumulative density 
of Ruthenium red staining before and after glycan removal resulting from 10 analyzed cells of 2 independent 
experiments (shaded areas, SO). Blue dot, position of the plasma membrane. Dashed line, cross-sections 
perpendicular to the plasma membrane used for image analysis. Asterisk, interpolated gradient between 
intracellular and extracellular background signal used for calculating the integral. (c) Data show intensities 
normalized to the control cells including standard deviation, calculated from the position-controlled integral 
to represent outer and membrane-proximal, inner zones oft he glycocalyx. P values, non-paired Mann-Whitney 
t test for independent means. (d) Detection of glycan removal using fluorescently-labeled Maackia amurensis 
agglutinin and propidium iodide (PI) for cell viability in flow cytometry of MV3 integrin expressing and ~1m3 
integrin knockdown and 4B4- and eRGO blocked cells, MEF ~1-/- and Molt-4 cells. (e+f) Analysis of retention 
of the deglycosylated status of enzyme treated cells over a time span of 6-9 h (MV3) , more than 90 h (MEF) 
and 5-6 h (Molt-4) and the step-wise recovery of ~-1,4 galactose expression. Mean fluorescence intensities of 
Maackia amurensis agglutinin (MAA) with standard deviations of 3 independent experiments. (g) Efficiency 
of the glycan removal using P/N/G analyzed by FACS and presented as reduction of the epitopes heparan-, 
dermatan- and chondroitin sulfate (HS, OS, CS) and ~-1,4 Galactose (~-1,4 Gal) after treatment compared to 
untreated control cells. Results are based on 3 independent experiments. 
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Figure 56. 
(a-d) Force spectroscopy of cell-surface glycan-binding to collagen fibres using atomic force life cell microscopy. 
Cell surface glycan-mediated interaction forces to collagen fibres. (a) Coupling of a single cell to a Concanavalin 
A coated AFM cantilever to probe the force required for cell detachment F [max] from a 30 fibrillar collagen 
surface. (b) Confocal microscopy of a single force measurement cycle between MV3 vector control and KD 
cells and collagen I surface, including start position, contact acquisition to the fibre and retraction. Life cell AFM 
single-cell force spectroscopy for 0.5 sand 20 s interaction time between MV3 cells and collagen I. Repeated 
cell- matrix interaction on the same collagen spot (47 cells, 3 independent experiments). (c) Force-distance 
curve of a single force measurement cycle between MV3 cell and collagen surface, including start position (I), 
retraction (II), and detachment phase (Ill). The maximum detachment force exerted on the cantilever F was 
calculated from the peak to background level. (c, inset) Representation of unbinding events and determi~~tion 
of the step sizes (single rupture I jump events) occuring during the detachment phase (Ill). (d) Histograms of 
jump event forces at short contact times (0.5 s contact time). (e) Life cell atomicforce spectroscopy for 0.5 sand 
20 s interaction time between MV3 cells and collagen I and BSA. Pooled values ofF'"" for all cells (upper panel) 
and merged values to a mean value for each cell (lower panel) from 3 independent experiments. (f) Averaged 
retraction curves of MV3 vector control cells (grey, 22 curves), 131/133 integrin knockdown cells (red, 49 curves) 
and 131/133 integrin knockdown cells with glycan removal (green, 50 curves) of 3 independent experiments. (g) 
Averaged control values for cell to bovine serum albumin (BSA) coated surface. MV3 vector control (0.5 s, 2nN: 
grey, 28 curves; 20 s, 2nN: grey, 42 curves), 131/133 integrin knockdown cells (0.5 s, 2nN: red, 45 curves; 20 s, 
2nN: red, 33 curves) and cells additionally treated with enzyme cocktail (P/N/G) (0.5 s, 2nN: green, 34curves; 
20 s, 2nN: green, 33 curves). Data sets were compared usingANOVA followed by a Bonferroni test. 
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Figure 57. 
Force spect roscopy of glycan-binding to co ll agen nbers using atomic force microscopy. (a) Covalent coupling 
of mu ltimeric polysaccharide chains to the surface of the cantilever tip t o probe t he force (F) required 
for cantilever detachment from a 3D nbrill ar co ll agen surface. (b) Determinat ion ofF [max] with increased 
amylose coating of the cantilever, compa red to background binding (BSA). P < 0.0001 for amylose coating 0.2 
% and higher, compared t o BSA (unpaired two-tai led Mann W hitney test). (c) Representation of 'high-force' 
interactions above 250 pN w ith increased coat ing concentration of amylose. (d-e) Force dist ribution for 
low- and high-concent rat ion of cellulose (p < 0.0001 compared to BSA cont rol, unpaired two-tailed T test ). 
(f -h) Glycan-med iated binding affinit ies to collagen nbres monitored by surface plasmon resonance (SPR). (f) 
Immobilization of bovine collagen I (orange layer) to a carboxymet hyldextran-modined gold su rface (yellow 
layer) of a CM S sensor ch ip (grey layer) for biospecinc interact ion analysis in a surface plasmon resonance 
sensor. Amylose (orange squares) solut ion is inject ed as an analyte (51) and binds to the st at ionary collagen 
I ligand during t he association phase (AP) fol lowed by t he dissociation phase (DP) susta ined by buffer flow 
and nna lly regeneration phase (RP). (g) Ove rl ay of amylose-collagen I afnnity sensorgrams obtained by 
measurements of changes in the SPR response of increased amylose concentrations. (h) Representation of 
amylose binding to collagen I after the regenerat ion phase (RP) obtained w ith a short pulse of 100mM NaOH 
at the End ofthe experiment (wash-out), shown fo r t he sample with the highest amylose concentration (300~g/ 
ml). 
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(a-d) Impact of glycan removal on mig~ation of (a) MV3, MEF and Molt-4 cells and (b-d) migration persistence 
over 24 h. Black line, average speed of cells without integrin and glycan interference, (blue line) with glycan 
interference, (red line) after ~1/3 integrin knockdown and treatment with mAb 4B4 and eRGO and (green line) 
with additional glycan removal. Mean average speeds with SEM of 3 independent experiments. (e, f) Impact of 
glycan removal on morphology of (e) MV3 and (f) Molt-4 cells. Elongation was determined as length/width of 
cells embedded in 30 collagen I in 3 different experiments. Statistical analysis was obtained by the non-paired 
Kruskal-Wallis test for independent samples including Bonferoni adjustment (b-d) or including Dunn's multiple 
comparison test (e, f). 
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Figure 59. 
Re-onset of elongated phenotype of lifeact-expressing MV3 vector contro l ce ll s and amoeboid migration 
of MV3 ~1/~3 integrin knockdown ce ll s without and with surface glycan removal (P/N/G) after intradermal 
inject ion in vivo. ROis of the imaging fie ld oft he dorsal skinfold chamber showing ce ll s w ith typical morphological 
phenotypes with in 30 collagen of the mouse deep dermis. White lines represent migration paths. Blue dots, 
startpoints. Arrows, direction of migration, based on retraction fibres and microparticles (1-lli, grey-fl lied 
arrowheads) released from the cell rear (asterisks). Black-filled arrowheads, focal cell-collagen interact ion sites 
(1, II ), polar ized (Il l, IV) and difused (V, VI) distribution of act in-Il l led membrane blebs. Asterisks, ce ll rear. (I-ll ) 
Bar, 20 l.lln, (il l-VI) Bar, 10J.Jm. 
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Figure510. 
(a: A, D: e: A, D) Maackia amurensis agglutinin (MAA) staining of cell surface ~1-4 galactose residues (red signal), 
F-actin (green signal), collagen I (reflection) and nucleus (DAPI), (a: B; e: B) MAA (red signal), collagen I (green 
reflection) and (a: E, G; e: C, E) F-actin (red signal), collagen I (green reflection). (a) In 3D collagen I embedded 
and fixed amoeboid ellipsoid-shaped MV3 cells with ~1/~3 integrin interference. Schematic representation of 
the YZ projections shown in 1-111 (a: C) and 1-V (a: F, H).Arrows, collagen fibers, dipped into the glycan-enriched 
blebs. Dashed arrows, collagen fibers lateral intercalating in blebs. Numbers indicate collagen nbers. (b) Mean 
densitometry curves with standard deviation of bleb cross sections (21 curves) with ~1-4 galactose residues 
(red) and collagen I (green). (c) Determination of the imprint depth of Collagen fibers into membrane blebs 
of MV3 KD cells. (c: A, B) YZ projectiorl of a MAA (red) and F-actin (cyan) positive membrane bleb. Dashed 
box, region of interest showing MAA signal for ~1-4 galactose (c: B, red) and Phalloidin signal for F-act in (c: B, 
cyan) next to the reflection for collagen I (c: A, B green) signal. White traces indicate the measuring lines with 
a constant length of 8 ~m and a width of 5 pixels. (c: C) Overlay of averaged intensity curves for MAA (red), 
F-actin (cyan) and collagen I (green) including points of maximal (Max) and half-maximal (Max112) intensities. (d) Calculation of the nber imprint depth based on 21 bleb cross sections of MV3 KD cells without glycan removal 
from 3 independent experiments. (e: A, D) Fixed polarized Molt-4 cell in 3D collagen I with amoeboid shape (e, 
A) which is completely abrogated after glycan removal (e: D)_ Cross sections of the ROI (e: B, C, D) shown as 
YZ projections (I-IV). Arrows, position of collagen I nbers (green). Numbers indicate collagen nbers. (f) Mean 
densitometry curves of a bleb cross section with ~1-4 galactose residues (red, 32 curves) and collagen I (green, 
32 curves) and (g) with F-actin (red, 15 curves) and collagen I (green, 15 curves). (h) Calculation of the nber 
imprint depth for collagen I n bers in MAA based on 11 cross sections and in F-acti n based on 10 cross sections 
of cell blebs without and 17 bleb cross sections of cells with glycan removal from 3 independent experiments. 
Molt-4 Bars, 10 [Jill (a: A, D; e: A, D), 21-1m (a: B, E, G; c: A; e: B, C, E). Statistical analysis was obtained for MV3 
cells by the non-paired, nonparametric Mann-Whitney t-test. 
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Structure and molecular composition of ce' lular interactions with collagen fibres. Reconstructions from b1-/-
M EF after fixation after 6-h-culture in collagen lattices. (a-c) Non-focalized distribution of heparan sulfate (HS) 
and glycans (stained by concanavalin A) at the surface of actin-rich filopodia extending along collagen fibres. (d) 
Length and calculated area of the interface between filopodia and collagen nbres and (e) cumulative contact 
area of all fllopodia originating from the same protrusion (11 cells). The area of contacts was calculated by 
multiplying contact length by the mean nbre diameter (300 nm). Arrowheads, location of collagen flbres, based 
on the single-channel reflection images. Arrows, direction of migration, based on retraction nbres or small 
particles released from the cell rear (asterisks). Bars, 5 ~m. 
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G!ycocalyx-mccliatcd lntegr· in-independent Arnoeboicl Lrcll M igrat ion 
MV3 ~1/~3 KD 484/ eRGO 
Solvent 
100 run 
C Coexistence a different 
contact nanotopologies 
P/NIG 
{a-c) Scann ing electron microscopy of MV3 KD cells before and after glycan removal w ith P/N/G glycosidase 
cocktail. MV3 ce lls were fixed after 2h of cu lture in 3D collagen latt ices. RO is showing collagen fibers which 
form deep imprints into membrane blebs of MV3 KD ce lls (a: A-C, b: 4-6) which are absent in cells after P/ N/G 
glycosidase digestion (a : D, b: 3-5). (c) Representat ive ROI showing coexistence of imprints and inte rca lat ions 
in MV3 KD ce lls without glycan removal. (d) Schematic representation of the imprint formation between a 
membrane bleb and a collagen fiber for ce ll s w ithout glycan removal and its loss after interference with ce ll 
surface glycosylation. Bars, 0.51-Jm (a, b), 1 !Jill (c). Stat istical analysis was obtained for MV3 cells by the non-
paired, nonparametric Mann-Whitneyt-t est. 
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Figure512. 
Glycans serve as multivalent and universal adhesion scaffold. (a) Glycocalyx- mediated adhesion strategies 
developed by cells after interference with ~1/~3 integrin expression and function. (b) Distinct cell-matrix 
interactions govern transitions in cell migration strategy. Mesenchymal movement can interconvert into two 
types of amoeboid migration. The filopodal migration mode is strictly glycocalyx-dependent and reminiscent of 
Rac/Cdc42 phenotypes, whereas blebby migration is only in part glycan-dependent and mimics the Rho/ROCK 
phenotype. With decreasing adhesion strength, integrins, surface glycans and blebs provide overlapping cell-
matrix interaction systems with decreasing adhesion strength and, concomitantly, reduced migration rates 
until reaching near-complete cell detachment, loss of polarity, and immobilization. 
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Summary 
This thesis provides a first evidence for a direct relation between glycocalyx polarity 
and integrin-independent cell adhesion and migration. To prove this relationship, 
novel approaches were established, including glycan detection and glycan digestion, or 
adapted to study glycan-mediated adhesion, force generation and cell migration in vitro 
and in vivo. The new insights and further molecular characterization will contribute to a 
better understanding of the glycocalyx in distinct modes of cell migration and invasion 
and may have predictive value in targeting tumor progression and metastasis. 
Cancer is one of the leading causes of death worldwide with 14m illion new cases and 8.2 
million cancer-related deaths in 2012 (World Health Organization 2016). During and 
after their transformation into neoplasm cancer cells make use of the intrinsic capacity 
of normally resident tissue cells to migrate upon activation, a process typically employed 
by cells during morphogenesis, immune response and wound healing. 
Important steps to initiate tumor dissemination and metastasis formation are the 
penetration and degradation cf the basement membrane, the detachment of tumor- cells 
from the primary tumor, and invasion into the extracellular matrix (ECM)- rich connective 
tissue for fur-ther dissemination.11r The common process underlying cell migration 
through ECM is polarized actin polymerization-mediated protrusion, actomyosin-driven 
contraction, and resulting shape change and forward locomotion of the cell bodyi 2r. To 
establish contact with and transmit actomyosin-driven forces to the surrounding ECM, 
the cell either develops protrusions that form adhesion sites to the tissue through 
adhesion receptor-s, e.g. integrins or alternative receptorsl31; or on the other hand, 
cells may use poorly adhesive intercalation or propulsion into ECM-free clefts, or-
friction against confining ECM fibers[4J The role of integrins in cell migration has been 
conclusively described over the last decades, but how alternative adhesion-systems ar-e 
involved in adhesion and de-adhesion processes is still challenging and remains largely 
unclear-. 
The motivation to study the contribution of the glycocalyx to tumor cell adhesion and 
migration was due to the fact that cells, despite inhibition of [31 integrin, the dominant 
adhesion receptor to fibrillar collagen I, maintained the ability to migrate in three-
dimensional fibrillar collagen.tst Following integrin inhibition, MV3 human melanoma cells 
and murine embryonic fibroblasts (MEFs) underwent a morphological and migratory 
transition from a mesenchymal to an amoeboid fi lopoda I or amoeboid blebbing phenotype 
and maintained substrate contact and migration with lower speeds (Chapter 5). Human 
T-leukemia cells, on the opposite, maintained adhesion and migration at constant speeds 
after integr-in interference in 3D fibrillar collagen, corresponding to a natur-al amoeboid 
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morphology and migration mode by integrin-independent mechanisms 16Ad.sb.?l_ Based on 
these findings, the alternative mechanisms used by cells to compensate for their loss of 
integrin -mediated adhesion and migration were the focus of t his thesis. 
Alternative adhesion mechanisms in cell adhesion and migration 
As summarized in Chapter 2, next to the integrin superfamily of ad hesion receptors, 
a co llect ion of alternative ce ll surface receptors was attr ibuted to contri bute to ce ll 
anchoring and migration. The express ion of a set of putative co llagen receptors was 
measured in MV3 melanoma ce ll s, including proteoglycans CD44, syndecan-4 (SDC-4), 
and receptor tyrosine kinase discoid in domain receptors (DDR) 1 and 2. Whereas CD44 
was co nsistently expressed, no expression of DDR-1 and -2 or· SDC-4 was detected 
(Chapter 5). CD44 perturbing antibody did not affect the migration of MV3 cells in 3D 
fibrillar co llagen.181 This was confirmed independently here for ce ll s after interference 
with ~1 and ~3 integrins as CD44 blockage showed no effect on the residual amoeboid 
ce ll migration. Consequently no indicati on for CD44 as a potential compensation 
receptor in these cells was obtained . Because every cell carries a strongly polar outer 
layer, the glycocalyx, the work in this thesis focused on the role of the glycocalyx in 
mediating residual adhesion and migration of cells. The here presented new insights 
identify t he sticky property of the glycoca lyx as adhesion mechanism through which 
ce ll s can generate adhesion forces to co llagen in the piconewton range and support 
integrin-independent adhesion and migration in vitro and in vivo. In summary, a novel 
adhesion mechanism is identified which mediates cell substrate interaction to solid-state 
ligands, which may be relevant when integrin-mediated attachment is restricted or even 
impossible, e.g. due to integrin receptor downregulation and I or limited accessibility of 
ligands. 
Detection and enzymatic degradation of the glycocalyx on live cells 
In Chapter 3, Bicyclo [6.1.0] nonyne (BC N) was introduced as a novel probe for 
biorthogonal labeling, which provides an appropriate sta ining tool for visualization 
of glycans including sialic acids in living ce ll s. There is a strong need for staining tools 
that allow the detection of glycan moieties in living ce lls since reporter techniques, e.g. 
GFP fluorescent fusion proteins are not applica ble for glycan imaging. Further, glycan-
binding proteins (lectins) influence ce ll fu nction by crosslinking su rface receptors, and 
antibod ies recognizing small glycan structures are r·are. Ce ll s incubated with BCN 
retained morphological integrity and viability allowing subsequent funct ional studies, 
e.g. ce ll migration assays. 
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In Chapter 4, to investigate the inf1uence of the glycocalyx as polar layer in cell adhesion, 
a protocol was developed that allows a gradual enzymatic degradation of carbohydrate 
chains while maintaining optimal viability. The efficient digestion of the bulk glycocalyx 
was shown using conventiona i staining with antibodies for glycosaminoglycans (GAGs) 
and lectin for [3-1,4 galactose (Gal), but also bioorthogonallabeling of sialic acids (SAs). 
Lectins recognize their epitopes with a certain carbohydrate binding specificity. In 
contrast, bioorthogonallabeling enables the detection of "global" sialic acid residues and 
their enzymatic degradation in one step regardless of the orientation of the glycosidic 
bonds. The results identify differences in the composition of the glycocalyx between 
the analyzed cell types. IVIV3 human melanoma cells and murine embryonic fibroblasts 
(IVIEFs) showed high expression patterns for- glycosaminoglycans (GAGs), sialic acids 
(SAs) and galactoses (Gal), whereas Molt-4 immune cells expressed only small amounts 
of GAGs, but similar- amounts of SAs and Gal. 
In order to retain identical glycan digestion conditions for all cells and enable dir-ect 
cell-to-cell comparison, Molt-4 cells were treated equally to IVIV3 cells and IVIEFs. The 
digestion procedure combines a yet unprecedented number and type of high-purity 
glycosidases in a two-step procedure to remove first the outer layer of the glycocalyx 
followed by quantitative removal of the bulk of mostglycocalyx layers, while- importantly 
- retaining cell viability. This digestion strategy was instrumental to probe cell functions, 
including adhesion, migration and formation of contact structures to complex-shaped 
interaction with fibrillar collagen and identify specific functions of the glycocalyx in cell-
matrix interactions. 
Digestion of the glycocalyx to study its role in migration in vitro and in vivo 
To study the inf1uence of the glycocalyx on cell migration, the glycan digestion pr-otocol 
(Chapter 4) was combined with integrin interference strategies in Chapter 5 to 
perform cell migration analysis in vitro and in vivo. The results show that digestion of 
the glycosaminoglycans (GAGs), including hepar-an sulfate (HS), chondroitin sulfate 
(CS), dermatan sulfate (OS), and sialic acids (SAs) were insufficient to impair migration. 
Additional removal of [3-1,4 galactose (Gal) caused a transient loss of migration in integrin 
inhibited cells, that were either embedded in 30 collagen I gel in vitro or in the collagen-
rich mouse dermis in vivo. This was accompanied by a transition from the amoeboid-
polarized to a complete roundish phenotype. The disabled migration and round 
morphology lasted for 7 to 10 hours, depending on the used cell line, and was followed by 
a step-wise recovery oft he amoeboid migration phenotype, which occurred concurrently 
with re-expression of endogenous surface glycans. These results indicate that glycan-
matrix interactions are not exclusively reserved for negatively charged glycan chains or 
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residuesl91, but rather require additional contribution of less complex carbohydrates such 
as 13 1-4 galactoses. Thus, besides negative cell surface charge mediated by GAGs and 
sialic acids, bipolar interactions mediated by 13-1,4 galactose are essential to facilitate 
contact to collagen I fibers and thereby enable integt-in-independent adhesion and 
migration. The ability of cells to generate non-specific weak molecular interactions to 
ECM, independent of predicted epitopes, facilitates a more rapid adaptation to steadily 
changing environments that are abundant in biological systems and would usually 
require a realignment of receptor expression. 
Adhesion forces mediated by the glycocalyx in vitro 
To explore whether the glycocalyx functions as direct adhesion scaffold that mediates 
integrin-independent migration, glycan-mediated adhesion strength was quantified 
in Chapter 5. Single-cell force spectroscopy (SCFS) was used to study the dynamic 
formation of cellular adhesion to a fibrillar collagen surface. SCFS allows for controlled 
and accurate screening of cell-substrate interactions even for short contact times, a 
prerequisite for early measurements of glycan-mediated integrin-independent adhesion 
eventsllot with piconewton accuracy.llll The results summarized in Chapter 5 show 
substantial interaction forces between the glycocalyx of MV3 human melanoma cells and 
collagen after integrin interference. This interaction force was lost after enzymatic glycan 
removal. Measured binding forces rapidly exceeded 500 pN at short interaction times 
(0.5 sec). This indicates that integrin- and glycan-mediated adhesion occur concurrently, 
however interference with integrins was required to accurately detect the mediated 
adhesion by the glycocalyx. Future work will be required to identify the mechanisms of 
glycan-collagen binding, such as electrostatic bonds, hydrogen bonds and van der Waals 
fot-ces.1121 
Glycocalyx-mediated adhesion develops different contact nanotopologies 
to fibrillar collagen 
As summarized in Chapter 5, diffraction-limited 30 confocal microscopy combined with 
30 scanning electron microscopy of MV3 melanoma control and enzyme-treated cells 
revealed that glycan-dependent cell interactions to collagen fibers consisted of actin-rich 
cell filopodal or bleb-like protrusions engaging with collagen fibers. In dependence on 
glycan availability, these cell protrusions form morphologically diverse interfaces. They 
contain focalized galactosyl residues, include single blebs forming grip-like structures 
that genet-ate a complex-shaped, "grasp-like" interphase to collagen fibers. Additional 
interaction types, which appeared independent of glycan availability, included collagen 
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fiber intercalation lateral to blebs with deep imprints across the cell body in high-density 
ECM regions. This identifi es the glycoca lyx as mediator for comp lex-shaped membrane 
topo logies that provide 3D interact ions to complex-shaped extrace llular topologi es. By 
mediating adhesion through adapt ive interfaces, novel adhesion mechanisms beyond 
integrin-mediated mechanocoupling were identified. These findings will contribute to a 
better understanding of t he broad range of adaptations ce lls might acqu ire to facilitate 
and maintain adhesion and migration in response to the heterogeneous environmental 
demands found in the body. 
Conclusion and future directions 
Over the past decades, insight has been gained into t he role of the glycocalyx in 
various biological pr-ocesses, including tumor cell adhesion, migration and invasion. 
Transformation of normal ce ll s into cancer ce lls results in signifi cant changes in 
glycosylationr 1· 13l, indicating a role of t he glycocalyx in tumor formation and metastasis.'141 
As consensus strategy, previous research focussed on proteoglycans and glycoproteins 
as specific glycan chains presented by corresponding protein cores that bridge the ce ll 
membrane and induce intrace llular signal transduction . In this thes is, an alternative 
concept on glycan chains fo rming a st icky coatfor cell -substrate interaction and amoeboid 
migration was established. The results indicate that the glycoca lyx is indispensab le 
for cell adhesion and migration when integrin functions are disabled. The introduced 
find ings present the sticky glycocalyx as an act ive med iator for integrin- independent ce ll 
adhesion and migration and provide a strong potential for further stud ies that investigate 
the cytoske letal steps underlie the revealed complex topology. It would be interest ing 
to find out whether ce lls can adopt diverse t opologies or whether specific shapes are 
pr-eferred. Can glycocalyx-interfered cells recover membrane topo logies under certain 
circu mstances or conditions such as higher compression found e.g. in more confined 
tissues? Are these glycan adhesions relevant to all cells under all circumstances or on ly 
during specific, low-adhesion conditions? 
In terms of glycan mediated adhesion there is a strong need for the understanding, 
which signals are generated by glycan adhesions. Following bleb adhesion subsequent 
molecular steps are required to stabilize the bleb-matrix contact, generate actin 
polymerization and myosi n-med iated contraction1151, but how does glycan adhesion 
enable downstream signaling events that ultimately lead to migration? One should note, 
also integrins comprise over 20 potential N-glycosylation binding sites that have crucia l 
functions in the regulation of integrin-mediated migrat ionl 16 1, but further studies are 
needed to understand how glycan-mediated adhesions cooperate with integrin-mediated 
interactions. In this thesis, col lagen I, the main structural protein in the extracellular 
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space'17', was exclusively used for adhesion and migration assays. Further studies should 
also implement matrices others than collagen I to define the glycocalyx- mediated 
adhesion as a general mechanism in the heterogeneous system of the body. Fibronectin 
e.g. was found to comprise highly basic triple helical domains including disaccharide 
acceptor sitesl9a· 9b· 18l as specific binding sites for negative ly charged glycosaminoglycans, 
indicating a pro-adhesive function for glycans, similar to fibrillar collagen. The results 
will provide significant contribution to the understanding of processes underlying ce ll 
adhesion and migration in steadily changing environments, which require dynamic 
adaptations diverse sets of adhesion strategies to deal w ith complex substrate topologies 
and molecular composition and maintain mobility. 
Studies related to glycomics are generally cost-intensive. A combination of experimental 
approaches by e.g. implementing computer simulations or molecular dynamics (MD) 
simulations might contribute to the understanding of glycocalyx-mediated functions and 
mechanisms in these processes prior to in vitro or even in vivo experiments. Current in situ 
approaches such as MD provide the technical requirements for a detailed and dynamic 
representation and simulation of biological mechanisms, that are recently accurately 
described for the glycocalyx_l19l The ability to witness such changes in the context of 
living organisms would augment our understanding of systems biology and provide new 
clinical tools for disease diagnosis. 
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Samenvatting 
Dit proefschrift biedt een eerste bewijs van een dir-ecte relatie tussen de polariteit 
van de glycocalyx en integrine-onafhankelijke celadhesie en migratie. Om deze relatie 
te bewijzen zijn nieuwe methoden opgezet, waaronder glycaan detectie en digestie, of 
aangepast, om glycaan-gemedieerde adhesie, krachten, en celmigratie in vitro en in vivote 
bestuderen. Deze nieuwe inzichten en verdere moleculaire karakterisering zal bijdragen 
aan het beter begrijpen van de glycocalyx in verschillende vor-men van celmigratie en 
invasie en hebben mogelijk voorspellende waarde in de targeting van tumor progressie 
en metastase. 
Kanker is wereldwijd de belangrijkste doodsoorzaak, met 14 miljoen nieuwe gevallen 
en 8,2 miljoen kanker gerelateerde doden in 2012 (World Health Organization 
2016). Tijdens en na transformatie tot neoplasie maken kankercellen gebruik van het 
intrinsiek ver-mogen van elke normale eel in het weefsel: het vermogen om te migreren 
na activatie, een proces dat cellen normaal gesproken gebruiken tijdens morfogenese, 
immuunrespons en wondgenezing. 
Belangrijke beginstappen in het verspreiden van tumorcellen en metastasevorming zijn 
penetratie en degradatie van het basale membraan, het loslaten van tummcellen van 
de primaire tumor, en invasie in het extracellulaire matrix (ECM) -rijke bindweefsel[ 11 
Het gemeenschappelijk onderiiggende proces waar-mee cellen door ECM migreren is 
gepolariseerde actine polymer-isatie-gemedieerde protrusie en actomyosine-gedreven 
contr-actie, resulterend in verandering van vorm en voortbeweging van het cellichaam. 
121 Om contact te maken met de ECM en om er actomyosine-gedreven kracht op uit te 
oefenen, ontwikkelt de eel protrusies die adhesie aan het weefsel biedt door integrines 
en alternatieve adhesiereceptoren.131 Anderzijds kunnen cellen zich met lage adhesie en 
stuwkrachttussen ECM-vrije spleten voegen, of met behulp van frictie tegen nauwgelegen 
ECM vezels.l41 De rol van integrines in celmigratie is de laatste decennia afdoende 
beschreven, maar hoe alternatieve adhesie-systemen betrokken zijn in het adhesie en de-
adhesie proces is nog een uitdagende vraag en blijft grotendeels onduidelijk. 
De aanleiding om de bijdrage van de glycocalyx in tumorcel adhesie en migratie te 
bestuderen kwam door de bevinding dat cellen, ondanks inhibitie van r31 integrine 
(de dominante adhesiereceptor voor nbrillair collageen I), nog konden migreren in 
driedimensionaal fibril lair collageen.ISI Na integrine inhibitie ondergingen MV3 humane 
melanoomcellen en muis embryonale nbroblasten (MEFs) een overgang in morfologie 
en migratie, van mesenchymaal naar een "amoebo·t·d nlopodal" of "amoebo"ld blebbing" 
fenotype en hielden langzamere migratie en contact met het substraat in stand 
(Hoofdstuk 5). Humane T-leukemie eel len daarentegen, hielden na integrine inhibitie de 
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adhesie en migratie op constante snelheid in 3D nbrillair collageen, corresponderend 
met een natuurlijk amoebo.lde morfologie en migratievorm doot- integrine-onafhankelijke 
mechanismen.16· 4d· sb. 71 De mechanismen die eel len gebruiken om te compenseren 
voot- verlies van integrine-gemedieerde adhesie en migratie, wet-den mede door deze 
bevindingen de focus van dit proefschrift. 
Alternatieve adhesie mechanismen in celadhesie en -migratie 
Zoals samengevat in Hoofdstuk 2, is er behalve de integrine superfamilie van 
adhesiereceptoren nog een verzameling van alternatieve celoppervlakte-receptoren 
die bijdragen aan eel verankering en migratie. De expressie van een set van vermeende 
collageen receptoren werd gemeten in MV3 melanoomcellen, waaronder de 
proteoglycanen CD44, syndecan-4 (SDC-4), en receptor tyrosine kinase discoidin 
domein receptoren (DDR) 1 en 2. Terwijl CD44 consistent tot expressie kwam, werd 
geen expressie van DDR-1 en -2 of SDC-4 gedetecteerd (Hoofdstuk 5). Toevoeging van 
een CD44 verstorend antilichaam had geen invloed op de migratie van MV3 cellen in 
3D ftbrillair collageen.181 Dit werd hier onafhankelijk bevestigd met cellen na inhibitie 
van ~1 en ~3 integrines, want de CD44 blokkade had geen effect op de overgebleven 
amoebo.tde celmigratie. Er was dus geen indicatie dat CD44 een compensatierol 
speelde als receptor in deze eel len. Omdat elke eel een sterk polaire buitenlaag heeft, de 
glycocalyx, werd de focus voor dit proefschrift de rol van de glycocalyx in het medieren 
van de overgebleven adhesie en migratievan ee l len. De gepresenteerde nieuwe inzichten 
ident inceren de plakkerige eigenschap van de glycocalyx als adhesiemechanisme 
waarmee cellen adhesiekracht aan collageen genereren (in de orde van grootte van 
piconewtons), en ondersteunen integrine-onafhankelijke adhesie en migratie in vitro en 
in vivo. Samengevat, is een nieuw adhesiemechanisme geYdentinceerd dat cel-substraat 
interacties medieet·t met "solid-state" liganden, welke relevant kunnen zijn wanneer 
integrine-gemedieerde verbindingen beperkt of onmogelijk zijn, bijvoorbeeld door 
integt·ine receptor downregulatie en/of beperkte toegang tot ligand en. 
Detectie en enzymatische degradatie van de glycocalyx op levende eel len 
In Hoofdstuk 3 werd Bicyclo [6.1.0) nonyne (BCN) ge·lntroduceerd als een nieuwe 
probe voor bio-orthogonale labeling, een geschikt hulpmiddel voor het visualiseren van 
glycanen, waaronder siaalzuur, in levende eel len. Er is grote behoefte aan hulpmiddelen 
die de detectie van glycanen mogelijk maakt, omdat reporter technieken zoals 
f1uorescente fusie-prote.lnen niet toepasbaar zijn voor beeldvormend onderzoek naar 
glycanen. Verder be.lnvloeden glycaan-bindende prote'lnen (lectines) de celfunctie omdat 
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ze celoppervlakte receptoren crosslinken, en antilichamen die de kleine glycaanstructuur 
herkennen zijn zeldzaam. Cellen ge·lncubeerd met BCN behielden hun morfologische 
integriteit en levensvatbaarheid, waardoor functionele studies (zoals analyse van 
celmigratie) mogelijk werden. 
Hoofdstuk 4 beschrijft de ontwikkeling van een protocol waarmee op geleidelijke 
wijze de koolhydraatketens van de glycocalyx enzymatisch worden gedegradeerd, om 
daarmee de invloed van de glycocalyx als polaire laag in celmigratie te onderzoeken. Met 
dit protocol blijven de eel len optimaallevensvatbaar. De efflciente digestie van de bulk 
glycocalyx werd aangetoond met gangbare antilichamen tegen glycosaminoglycanen 
(GAGs) en lectine voor ~-1,4 galactose (Gal), maar ook met bio-orthogonale labeling 
van siaalzuren (SAs). Lectines herkennen hun epitopen met een bepaalde koolhydraat 
speciflciteit. Bio-orthogonale labeling daarentegen kan gebruikt worden voor detectie 
van "globale" residuen van siaalzuur en hun enzymatische degradatie in een stap, 
onafhankelijk van de orientatie van de glucosebinding. Het resultaat identiflceerde 
verschillen in de samenstelling van de glycocalyx tussen de geanalyseerde celtypen. 
MV3 humane melanoomcellen en muis embryonale flbroblasten (MEFs) hadden hoge 
expressie van GAGs, Sas en Gal, terwijl Molt-4 immuuncellen lage expressie van GAGs 
had den, maar vergelijkbare hoeveelheden Sas en Gal. 
Door de staat van glycaandigestie identiek te houden voor aile eel len konden ze direct 
met elkaar vergeleken worden. Molt-Ll eel len werden dus op dezelfde manier behandeld 
als MV3 cellen en MEFs. De digestieprocedut-e combineert een ongeevenaard aantal 
en type glucosidasen van hoge zuiverheid in een twee-staps procedure waarbij eer-st 
de buitenste laag van de glycocalyx wordt verwijderd, gevolgd door een kwantitatieve 
verwijdering de bulk van de meeste glycocalyx lagen, terwijl - belangrijk - de 
levensvatbaarheid van de eel behouden blijft. Deze digestiestrategie was uuciaal in de 
studie naar cellula ire functies zoals adhesie, migratie en formatie van contactstructuren 
met complex gevormd flbrillair collageen, en om specifleke functies van de glycocalyx in 
cel-matr·ix interacties te identiflceren. 
Digestie van de glycaclyx om zijn rol celmigratie in vitro en in vivo te 
bestuderen 
Om de invloed van de glycocalyx op celmigratie te bestuderen werd het digestieprotocol 
(Hoofdstuk 4) gecombineerd met de integrine interferentie str-ategie uit Hoofdstuk 5 
om celmigratie analyses in vitro en in vivo uit te voeren. Digestie van de GAGs, inclusief 
heparansulfaat (HS), chondro.lt inesulfaat (CS), dermatansulfaat (DS) en siaalzuren (Sas), 
was onvoldoende om de migratie negatief te be.lnvloeden. Aanvullende digestie van ~-1,4 
galactose (Gal) veroorzaakte een tijdelijk verlies van migratie in integrine-ge·r·nhibeerde 
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cellen ingebed in een 3D collageen I gel in vitro, of in de co ll ageen-rijke dermis van de 
muis in vivo. Daarbij werd een overgang waargenomen van de amoebo.id-gepolariseerde 
naat· een compleet rondachtig fenotype. De ronde morfologie en het verlies van migratie 
hielden 7 tot 10 uur aan, afhankelijk van de gebruikte cellijn, en werd gevolgd door een 
stapsgewijs herstel van het amoebo'ide migratie fenotype, welke tegelijk plaatsvond met 
her-expressie van endogene oppervlakte glycanen. Deze resultaten geven de indicatie 
dat glycaan-matrix interact ies niet exclusief gereserveerd zijn voor negatief geladen 
glycaanketens of residuen191, maar eerder dat aanvu llende bijd rag en van m inder complexe 
koolhydraten zoals ~-1,4 ga lactoses. Dus, behalve negatieve ce loppervlakte lading 
gemedieerd door GAGs en siaalzuren, zijn bipolaire interacties gemedieerd door ~- 1,4 
ga lactose essentieel om het contact met collageen 1-fibers te faciliteren, en zodoende 
gelegenheid geven voor integrine-onafha nkelijke adhesie en migratie. Het vermogen 
van cellen om aspecifieke zwakke moleculaire interacties met de ECM te genereren, 
onafhankelijk van voorspelde epitopen, geeft een sneller aanpassingsvermogen aan een 
gestaag veranderende omgeving (die overvloedig zijn in biologische systemen) waa rbij 
normaal gesproken een hersch ikk ing in receptor expressie vere ist zou zijn. 
Glycocalyx-gemedieerde adhesiekrachten in vitro 
Om te onderzoeken of de glycocalyx als een directe adhesie "steiger" (scaffold) dient 
om integrine-onafhankelijke migratie te medieren, werd de glycaan-gemedieerde kracht 
gekwantificeerd in Hoofdstuk 5. Single-cell force spectroscopy (SCFS) werd gebruikt om 
de dynamische vorming van ce llulaire adhesie aan een fibril lair collageen oppervlak te 
bestuderen. Met SCFS kan gecontroleerd en nauwkeurig een screen ing van cel-substraat 
interact ies worden gedaan, zelfs voor korte contacttijden, een vere iste voor vroege 
metingen van glycaan-gemedieerde integt·ine-onafhankelijke adhesie,l lDI met pi co newton 
nauwkeurigheid.llll De resultaten die samengevat zijn in Hoofdstuk 5 Iaten substantiele 
interactiekrachten zien tussen de glycoca lyx van MV3 humane melanoomcellen en 
co ll ageen na integrine interferentie. Na enzymatische verwijd ering van glycanen was 
deze interactiekracht verdwenen. De gemeten bindingskrachten kwamen al snel boven 
500pN bij korte interactieti jden (0,5 sec). Dit gaf de indicatie dat integrine- en glycaan-
gemedieerde adhesie gelijktijdig plaatsvinden, maar interferentie van integrines was 
nodig om de glycocalyx gemedieerde adhesie nauwkeurig te meten. Toekomstig werk 
za l nodig zijn om de mechanismen van glycaan-collageen binding (zoals elektrostatische 
bindingen, waterstofbruggen en vanderwaalskrachten)1121 t e identificeren. 
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Glycocalyx-gemedieerde adhesie ontwikkelt verschillende contact 
nanotopologieen 
In Hoofdstuk 5 werd buigingsbegrensde 3D confocale microscopie gecombineerd met 
3D scannende elektronenmicroscopie. Dit werd toegepast op MV3 controle en enzym-
behandelde cellen om te demonstreren dat glycaan-afhankelijke celinteracties met 
collageenn bers bestaan uit actine-rijke cell "fl lopodal" of"bleb-achtige" protrusies. Omdat 
ze afhankel ij kzij n van glycaa n beschi kbaa rhe id, vot-men de protrusies morfologisch diverse 
raakvlakken. Ze bevatten gefocaliseerde galactosylresiduen, inclusief enkele blebs die 
gt-ip-achtige structuren vormen, die een complex gevormd "grasp-like" raakvlak met de 
collageen nbers maakt. Tussenvoegingen van laterale blebs in collageen nbers met diepe 
afdrukken in het cellichaam waren bijkomstige interactiesoorten die onafhankelijk van 
glycaan beschikbaarheid verschenen in ECM-regio's van hoge dichtheid. Dit identiflceert 
de glycocalyx als mediator voor complex gevormde membt-aan topologieen. Glycocalyx-
gemedieerde adhesie door adaptieve raakvlakken gaf de aanwijzingvoor identincatie van 
nieuwe adhesie mechanismen buiten integrine-gemedieerde mechanotransductie. Deze 
bevindingen zullen bijdragen aan een beter begrip van het brede scala van adaptaties die 
cellen kunnen verkrijgen om adhesie en migratie, in reactie op de heterogene omgeving 
in het lichaam-, te faciliteren en behouden. 
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